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Propargylic aryldiazoesters, which possess multiple reactive 
functional groups in a single molecule, were expected to undergo 
divergent reaction pathways as a function of catalysts. A variety of 
transition metal complexes including rhodium(II), palladium(II), silver(I), 
mercury(II), copper(I and II), and cationic gold (I) complexes have been 
examined to be effective in the catalytic domino reactions of propargylic 
aryldiazoesters. An unexpected Lewis acid catalyzed pathway was also 
discovered by using FeCl3 as the catalyst. 
Under the catalysis of selected gold catalysts, propargylic 
aryldiazoesters exist in equilibrium with 1-aryl-1,2-dien-1-yl diazoacetate 
allenes that are rapidly formed at room temperature through 1,3-acyloxy 
migration. The newly formed allenes further undergo a metal-free 
rearrangement in which the terminal nitrogen of the diazo functional 
group adds to the central carbon of the allene initiating a sequence of 
bond forming reactions resulting in the production of 1,5-dihydro-4H-
pyrazol-4-ones in good yields. These 1,5-dihydro-4H-pyrazol-4-ones 
undergo intramolecular 1,3-acyl migration to form an equilibrium 
mixture or quantitatively transfer the acyl group to an external 
nucleophile with formation of 4-hydroxypyrazoles.  
In the presence of a pyridine-N-oxide, both E- and Z-1,3-dienyl 
aryldiazoacetates are formed in high combined yields by Au(I)-catalyzed 
rearrangement of propargyl arylyldiazoacetates at short reaction times. 
Under thermal reactions the E-isomers form the products from 
intramolecular [4+2]-cycloaddition with H
‡
298 = 15.6 kcal/mol and 
S
‡
298= -27.3 cal/ (mol•degree). The Z-isomer is inert to [4+2]-
cycloaddition under these conditions. The Hammett relationships from 
aryl-substituted diazo esters ( = +0.89) and aryl-substituted dienes ( = -
1.65) are consistent with the dipolar nature of this transformation. 
An unexpected reaction for the synthesis of seven-membered 
conjugated 1,4-diketones from propargylic diazoesters with unsaturated 
imines was disclosed. To undergo this process vinyl gold carbene 
intermediates generated by 1,2-acyloxy migration of propargylic 
aryldiazoesters undergo a formal [4+3]-cycloaddition, and the resulting 
aryldiazoesters tethered dihydroazepines undergo an intricate metal-free 
process to form observed seven-membered conjugated 1,4-diketones with 
moderate to high yields. 
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Chapter 1: Catalyst Classification in 
Catalytic Reaction of Propargylic 
Diazoesters 
I. Introduction  
1.1 General Information for Diazo Compounds 
Diazo compounds are high energy organic compounds bearing a 
C=N=N functional group. Their general formula can be described as 
R1R2C=N2. Two resonance contributing structures describe the general 
electronic characteristics of diazo compounds (Figure 1.1). These 
electronic structures describe an electropositive center on the central 
nitrogen and nucleophilic centers at the terminal nitrogen and the carbon.  
 
Figure 1.1 Resonance Structures of Diazo Compounds. 
Diazo compounds are capable of undergoing a variety of 
transformations, and numerous reactions involving diazo compounds 
have been studied over the past hundred years. In general, four types of 
reactions have been recognized and described in the literature (Scheme 




a surprising electrophilic addition to nucleophiles from the terminal 
nitrogen position;
2
 (c) nucleophilic addition reactions with electrophiles 
that occur at the nucleophilic carbon position,
3
 and (d) reactions 




Scheme 1.1 General Reactions of Diazo Compounds. 
1.2 Transition Metal-Catalyzed reactions of Diazo 
Compounds 
Catalytic decomposition of diazo compounds occurs by the 
extrusion of dinitrogen to produce a variety of reaction products 
dependent on the catalyst that is employed.
5
 Because of back-bonding 




 The proposed process involves 
the use of a transition metal complex as a Lewis acid by coordination to 
the negatively-polarized carbon of the diazo compound to produce an 
organometallic diazonium ion followed by loss of dinitrogen to furnish 
the metal-stabilized carbene.
6b,7
 The metal-stabilized carbene may be 
depicted by two resonance contributing structures: one that describes a 
metal-carbon double bond, not unlike that used to depict stable Fischer 
carbene,
6-7
 and another having a charge separated structure that places a 
formal positive charge on carbon and a formal negative charge on the 
metal (Scheme 1.2).
8
 The depiction of the carbene as a charge-separated 
species (metal-stabilized carbocation), while deemphasizing back 
bonding from metal into the carbene, provides focus on their electrophilic 
reactivity.  
 
Scheme 1.2 Transition Metal-Catalyzed Decomposition of the Diazo 
Compounds. 
Due to their high electrophilic reactivity, metal-stabilized carbenes 
have been reported to undergo a wide array of transformations including 
 4 
cyclopropanation, cyclopropenation, C-H insertion and ylide formation 
(Scheme 1.3).
5a,9
 For these processes a simplified catalytic cycle is 
described in Scheme 1.4, and in some cases catalyst loading is under 0.1 
mol %.
10
 Addition to the carbon-carbon double bond to form 
cyclopropanes is perhaps the most studied transformation, but C-H 
insertion and ylide-derived transformations have emerged during the past 
two decades as viable and synthetically useful transformations.
5b,10-11 
 
Scheme 1.3 Transition Metal-Catalyzed Reactions of Metal Carbenes 
Formed from Diazo Compounds. 
 5 
 
Scheme 1.4 Generally Accepted Mechanism for Metal Catalyzed 
Decomposition of Diazo Compounds. 
1.2.1 Classification of Metal Carbenes 
The reactivity profile of metal carbenes is greatly influenced by the 
electronic nature of the substituents that adorn the carbene center.
12
 
Because of their relative stabilities and general ease of formation and 
handling, diazocarbonyl compounds are the most commonly used metal 
carbene precursors.
13
 Three types of metal carbenes have been classified 
and described by Davies and coworkers: acceptor, acceptor/acceptor, and 
donor/acceptor metal carbenes (Scheme 1.5);
5d,11b,11c
 the term “acceptor” 
refers to an electron-withdrawing group (keto, cyano, nitro, phosphonyl 
and sulfonyl) bonded to the carbene center, whereas “donor” refers to an 
electron-donating group (vinyl, aryl and heteroaryl) bonded to the 
 6 
carbene center; both terms are relative to hydrogen in their electronic 
effects. 
 
Scheme 1.5 Classification of Substituted Metal Carbene Intermediates. 
Due to the electrophilic character of metal carbenes, the electron-
donating group bonded to the carbene center will stabilize metal carbenes, 
which results in their increased selectivity compared to the acceptor and 




Scheme 1.6 General Reactivity Profiles of Metal Carbenes. 
For the past two decades, numerous efforts have been devoted to 
the study of catalytically selective reactions of donor/acceptor metal 
carbenes, especially aryldiazoacetates.
5c
 These donor/acceptor diazo 
 7 
compounds are easily prepared from corresponding arylacetate esters via 
a diazo transfer reaction, usually with 4-acetamidobenzenesulfonyl azide 
(p-ABSA).
14
 They are stable and storable at room temperature for 
extended periods of time; and they are capable of undergoing a variety of 
transformations ranging from cyclopropanation, cyclopropenation, C-H 




Scheme 1.7 Synthesis of Donor/Acceptor Diazo Compounds and 
Transformations involving Donor/Acceptor Metal Carbenes. 
1.2.2 Transition Metal Complexes for Metal Carbene 
Transformations 
 8 
Transition metal complexes have played an important role in the 
development of synthetic methodology;
4b,16
 and their applications to the 
decomposition of diazo compounds, as well as their subsequent 
transformations involving metal carbenes, are particular attractive. 
Transition metal complexes, including those of copper, rhodium, cobalt, 
iron, palladium, ruthenium, silver, iridium,
17
 and gold have been reported 
to mediate these transformations effectively;
 13b
 and recent results have 
shown that the ligands for these transition metals have great influence on 
the reactivity and selectivity.
18
 Copper and rhodium complexes are well-
established systems, and their activities and selectivities have been 
summarized in several excellent reviews.
6a,6b,9,11d 
 
1.2.2.1 Copper Catalysts in the Decomposition of Diazo Compounds 
Since the first discovery of copper-catalyzed decomposition of 
diazo compounds over a century ago,
19
 a variety of copper salts and 
complexes have been widely used in the catalytic reactions of diazo 









 The commercial 








shown advantages over other copper salts in several transformations.  
Copper(I) is understood to be the catalytically active oxidation 
state in copper catalyzed reactions of diazo compounds.
21
 With four 
coordination sites copper(I) can be linked to ligands that influence its 
reactivity and selectivity in reactions with diazo compounds. The first 
effective chiral ligands used to control enantioselectivity were introduced 
on copper,
26a
 and the most effective of these ligands were multidentate.
5b, 
26b
 Copper complexes formed from chiral ligands have been widely used 





 and [3+3]-cycloaddition of diazo compounds,
29
 and the major 




Figure 1.2 Selected Chiral Ligands for Copper Catalysts. 
1.2.2.2 Rhodium Complexes in Dinitrogen Extrusion from Diazo 
Compounds 
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Dirhodium(II) complexes have emerged as the dominant catalysts 
for reactions with diazo compounds.
5b,5d,10,15a,31
 They possess a 
paddlewheel structure containing two rhodium atoms that are connected 
by a rhodium-rhodium single bond and four bidentate ligands that bridge 
two rhodium atoms in 16-electron rhodium complexes (Figure 1.3). The 
bridging ligands are most commonly carboxylates or carboxamidates, 





have also been reported. Dependent on the bridging ligands, they may 
have water solubility; but most uses have occurred in solvents of 
moderate polarity such as dichloromethane. Two open coordination sites 
exist at the axial positions of these paddlewheel complexes, and the axial 
coordination site is the electrophilic center at which reaction with diazo 
compounds occurs.  
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Figure 1.3 General Structural Formula for Homoleptic Dirhodium(II) 
Carboxylates (X = Y = O) and Carboxamidates (X = O; Y = N). 
Chiral dirhodium(II) carboxylates or carboxamidates can be easily 
prepared from rhodium acetate and corresponding enantiomerically pure 
amino-protected amino acids or enantiomerically pure amino acid-
derived lactams.
8,34
 Several excellent reviews describe their catalytic 
advantages.
5a,5b,5d,10
 Recently, these chiral dirhodium(II) complexes have 
been broadly classified and well summarized according to generality and 
selectivity in the transformations of rhodium carbenes by a compressive 




Figure 1.4 Representative Examples of Chiral Dirhodium(II) 
Carboxylates and Carboxamidates.  
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1.2.2.3 Gold Complexes in Reactions with Diazo Compounds 
Gold complexes have emerged in recent years as powerful 
catalysts for the construction of C–C, C–N, and C–O bonds in organic 
synthesis.
36
 During the past decade, the chemical community has 
witnessed a rapidly increasing interest in the gold-catalyzed 




Gold(I) complexes, simply described as [LAuY], are two-
coordinate, linear species; they are air- and moisture-stable. When Y is a 
coordinating anion (halides, carboxylates, sulfonates, and triflimide), 
they are neutral gold(I) complexes. Cationic gold(I) complexes with 















which can be generated in situ via ionization of neutral gold(I) complexes 
(LAuCl) with soluble silver or sodium salts (AgSbF6, AgBF4, NaBAr
F
4), 
are the most commonly used gold complexes for reactions with α-
diazocarbonyl compounds; and the reactivity profiles of formed gold 
carbene complexes is greatly dependent on the nature of the ligand that is 
bound to gold. Phosphines, phosphites, and N-heterocyclic carbenes are 
the most commonly used ligands. The most commonly used ligands are 





Figure 1.5 Selected Chiral Ligands for Gold(I) Catalysts. 
Beside the cationic gold(I) complexes, some simple gold(III) salts 
such as AuCl3 and AuCl3(pyridine), also have been reported as catalysts 
in decomposition of diazo compounds (Figure 1.6). These complexes are 
subject to disproportionation at higher temperatures, generally observed 
through the formation of metallic gold. 
 
Figure 1.6 Structures for AuCl3 and AuCl3(Pyridine). 
1.2.2.4 Other Transition Metal Complexes in Reactions with Diazo 
Compounds 
For the past several decades, several other transition metals 
including cobalt, iron, palladium, ruthenium, silver, iridium also have 
been investigated, and important progress has been achieved. 
6a, 6c, 11a, 17
 It 
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is worthy noted that the ligands for these transition metal complexes 
always play an important role on the selectivity and reactivity in the 
transformations of diazo compounds.
18a,34e,39
 
1.3 General Information for Alkynes 
Alkynes are organic compounds containing a carbon-carbon triple 
bond. The simplest alkyne is acetylene with the formula C2H2, whose 
four atoms are linear; there are two π-bonds and one σ-bond between two 
carbon atoms; the hybridization on each carbon atom is sp. Based on the 
substituents of each acetylenic carbon, alkynes can be simply categorized 
as terminal and internal alkynes; both of them share the similar linear 
structure with acetylene (Figure 1.7).  
 
Figure 1.7 Two Classes of Alkynes. 
Alkynes have played an extremely important role in the history of 
organic chemistry.
40
 Several traditional transformations including 
hydrogenation, additions of electrophilic reagents, 1,3-dipolar 
cycloaddition reactions, hydroboration and oxidations have been reported 
in the last century; these transformations have been commonly used 
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methods for constructing C-C, C-O, C-B, C-X (X = Cl, Br) bonds 
(Scheme 1.8).
40a, 40c, 40d
 Also, their applications in the total synthesis of 




Scheme 1.8 Traditional Transformations of Alkynes. 
The transition metal complexes catalyzed transformations of 
alkynes are particularly attractive because they provide a wide range of 
synthetically meaningful transformations with high efficiency under mild 
reaction conditions.
42
 Transition metal alkyne complexes, which are 
formed through -coordination of an alkyne ligand (or two and more 
alkyne ligands) to a transition metal center, are proposed as key 
intermediates in many catalytic transformations.
41b,43
 It should be noted 
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that the alkynes that coordinate to transition metal complexes are usually 
non-linear; the transition metal alkyne complexes can undergo a variety 





 and cycloaddition reactions (Scheme 
1.9).
46

































 have been reported.  
 
Scheme 1.9 Transition Metal Complexes Catalyzed Reactions of 
Alkynes. 
1.4 My Research Goal 
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Since both diazo compounds and alkynes can react with a wide 
array of transition metal complexes to form reactive transition metal 
complexes which are capable of undergoing further transformations,  we 
asked the question “Is there diversity in product formation if both 
acetylenic and diazo functionalities are present in the same molecule?” 
To answer this question, easily accessible propargylic 
phenyldiazoacetates that combines diazo functionality and a propargylic 
ester were synthesized for this evaluation.  
 
Scheme 1.10 Synthesis of Propargylic Phenyldiazoacetates. 
1.4.1 Transition Metal Catalyzed-Domino Reactions 
involving Diazo Decomposition and Carbene/Alkyne 
Cascade. 
Domino reactions, which are also known as cascade reactions or 
tandem reactions, are defined as a consecutive series of transformations 
occurring in one step via highly reactive intermediates.
61
 Transition metal 
complexes catalyzed domino reactions of diazo compounds with tethered 
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alkynes have been investigated over the past three decades;
 4a
 the 
mechanism for these domino processes always involves dinitrogen 
extrusion and a subsequent carbene/alkyne cascade to produce a new 
cyclic metal carbene species, sometimes involving formation of a highly 
strained cyclopropene that can react with transition metal complex to 
produce the same cyclic metal carbene species.
64
 The newly formed 
cyclic metal carbene species has been reported to undergo a variety of 





 and 1,3-dipolar cycloaddition.
64
 Transition metal 
complexes including Rh2(OAc)4, Pd(OAc)2, Ni(COD)2, Cu(hfacac)2, and 
other dirhodium(II) carboxylates have been reported as the catalysts for 
selected domino processes.  
 19 
 
Scheme 1.11 Transition Metal Complexes-Catalyzed Domino Reactions 
of Diazo Compounds with Tethered Alkynes. 
Padwa and coworkers have reported that propargylic 
phenyldiazoesters can undergo intramolecular domino reactions to 
produce indene-fused lactone upon treatment with catalytic amount 
Rh2(OAc)4; the authors propose that the domino reaction proceeds 
through rhodium-catalyzed diazo decomposition, carbene/alkyne 
metathesis and subsequent aromatic substitution.
65
 However, the 
substrate scope of this domino reaction was not fully investigated; other 
transition metal complexes that can catalyze decomposition of diazo 
compounds have not been examined in this domino reaction. 
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Scheme 1.12 Rh2(OAc)4-Catalyzed Domino Reactions of Propargylic 
Phenyldiazoesters. 
1.4.2 Transition Metal Complexes-Catalyzed Reactions of 
Propargylic Esters 
Propargylic esters are one of the most easily accessible substrates 
for reactions with transition metals that are initiated at the carbon-carbon 
triple bond. Numerous examples have been reported;
66
 and all involve 
rearrangement of the ester as the initial step. Two rearrangement 
pathways are common (Scheme 1.13). In one the transition metal 
complex coordinates with the triple bond to form alkyne complexes I, 
and then the carbonyl oxygen undergoes a 5-exo-dig cyclization to form 
intermediate II, which with back-bonding from gold and successive ring 
opening finally forms the vinyl transition metal-stabilized carbene 
intermediates III. An alternative pathway is also possible. Instead of 5-
exo-dig cyclization, intermediate I undergoes a 6-endo-dig cyclization to 
generate a six-membered-ring intermediates IV, which forms allenylic 
 21 
ester intermediate V via a similar back-bonding and ring opening process. 
In most cases outcomes of the transition metal complexes-catalyzed 
regioselectivity of propargylic esters can be predicted: if the R
3
 unit is a 
hydrogen atom (terminal alkynes) or an electron-withdrawing group that 
includes ester, the formation of the metal vinylcarbene complexes though 
5-exo-dig cyclization is preferred; alternatively, while when R
3
 is an aryl 
group or alkyl group, allenyl esters, which are generated by 6-endo-dig 
cyclization, will be the corresponding reaction intermediates. However, a 
few cases that are not consistent with this simple rule have also been 
reported.
67
 These results indicate that the outcome of regioselectivity can 
be also influenced by other factors ranging from the structure of 
transition metal complexes, the substitution pattern at the propargylic 
moiety, and reaction conditions.  
 
 22 
Scheme 1.13 Competitive 1,2- and 1,3-Acyl Migration of Transition 
Metal Complexes Catalyzed Rearrangement of Propargylic Esters. 


















been unveiled to be effective for those reactions of propargylic esters. 
However, propargylic esters bearing a diazo group have not yet been 
examined with these transition metal complexes. 
1.4.3 Reactivity of Propargylic Phenyldiazoacetates 
Two divergent reaction pathways are possible for reactions of 
propargyl diazoacetates: (a) the diazo functionality reacts with the -
bond acceptor to displace dinitrogen through back-donation and 
formation of a metal carbene, followed by addition to the carbon-carbon 
triple bond to form a derivative metal carbene that completes the domino 
transformation by electrophilic substitution into the aromatic ring of the 
original aryldiazoacetates; (b) -bond-forming reactions that occur 
initially at the carbon-carbon triple bond followed by nucleophilic 
addition at a carbonyl oxygen and 1,3-acyloxy migration to produce 
allene intermediates,
68,74
 and then to undetermined product(s) based on 
subsequent reactions that, although diverse examples are known, the 
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possible outcome with propargylic diazoacetates is unknown. (Scheme 
1.14) 
 
Scheme 1.14 Catalyst-Dependent Divergence of Reaction Pathway 
Based on -Bond Association with a Diazo Functional Group versus -
Bond Association with an Alkyne. 
II. Results and Discussion 
2.1 Initial Assessments of Transition Metal Complexes 
Assessments of transition metal complexes catalysis with 
phenylpropargyl phenyldiazoacetate 1a were performed at 20 ℃  in 
CH2Cl2 using 1-5 mol % of catalyst. With 1 mol% Rh2(OAc)4 the product 
(2) from the cascade transformation of an intermediate metal carbene was 
formed in 76% isolated yield (Table 1.1, entry 1). The more Lewis acidic 
catalyst Rh2(TFA)4 was also tested and gave improved yield (83% yield) 
indicating that dirhodium catalysts prefer the domino process (Table 1.1, 
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entry 2). Three commonly used palladium catalysts Pd(OAc)2, 
PdCl2(PhCN)2, and [Pd(η3-C₃H₅)Cl]₂,were further examined. Although 
all of them produced the cascade product 2a as the dominated product, 
their catalytic activities are much lower compared to Rh2(OAc)4. These 
reactions were monitored every 12 h by TLC (Thin Layer 
Chromatography), and the starting material 1a was completely consumed 
after 48 h. The cascade product was obtained in moderate yields (Table 
1.1, entries 3-5), but an unexpected elimination product 3a was observed 
during the process. AgSbF6, which is widely used in decomposition of 
diazo compounds, also worked well in the domino cascade reaction. With 
5 mol % AgSbF6, the cascade cascade product 2a was obtained in 
reasonable yield, and the elimination product 3a was isolated as another 
product (Table 1.1, entry 6). Au(JohnPhos)SbF6 and IPrAuBF4, recently 
were reported as effective catalysts in decomposition donor/acceptor 
diazoacetates,
75
 were also surveyed. Au(JohnPhos)SbF6 gave the cascade 
product in 86% yield, whereas the cascade product 1a was obtained in 50% 
yield with IPrAuBF4 (Table 1.1, entries 7 and 8). When more Lewis 
acidic catalysts such as Hg(OTf)2 were employed, the competing product 
3a was obtained as the dominant product, and only 10% of the domino 
product 2a was observed. With the Cu(OTf)2 catalysis, the cascade 
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product 2a and elimination product 3a almost were formed in similar 
yield (Table 1.1, entry 11). We found that CuBF4(MeCN)4 and 
CuPF6(MeCN)4 were very effective for this domino reaction (Table 1.1, 
entries 12-13); with 5 mol% CuPF6(MeCN)4 2a was obtained in 90% 
isolated yield (94% 
1
H NMR yield) in DCM for 1 h at room temperature, 
and no other discernable product was observed. Under the catalysis of 
FeCl3, the elimination product 3a was isolated as the dominant product in 
70% yield (Table 1.1, entry 14). Surprisingly, no cascade product 2a was 
observed but instead unexpected product 4a was obtained in 20% yield, 
which can be easily separated from 2a by normal phase column 
chromatography (this part will be discussed later). Moreover, reaction 
with tetrahydrothiophene gold(I) chloride, AuCl(C4H8S), was more 
complex, forming none of 2a but produced two isomeric 1H-pyrazolines 
as the dominant products (discussed in the chapter 2). We also performed 
several reactions of 1a under the catalysis of chiral catalysts including 
chiral dirhodium carboxylates such as Rh2(S-PTTL)4 and 
CuPF6(CH3CN)4 with chiral BOX ligands (i-Pr, t-Bu, Bn and etc.). 
Although 2a is formed in reasonable yield, the analyses from chiral 
HPLC have shown that the only racemic product 2a was observed.  
 26 

















 6 h >95 76 <5 
2 Rh2(TFA)4
c
 3 h >95 83 <5 
3 Pd(OAc)2 48h >95 71 10 
4 PdCl2(PhCN)2 48 h >95 76 11 
5 [Pd(η
3
-C₃H₅)Cl]₂ 48 h >95 65 15 
6 AgSbF6 1 h >95 65 30 
7 Au(JohnPhos)SbF6 10 h >95 86 4 
8 IPrAuBF4 10 h >95 50 16 
9 Hg(OTf)2 48 h >95 10 80 
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10 HgCl2 24 h 50 15 76 
11 Cu(OTf)2 6 h >95 40 50 
12 CuBF4(MeCN)4 1 h >95 92 <5 





 12 h >95 <5 70 
15 AuCl(C4H8S) 72h >95 <5 <5 
a 
Reactions were carried out at 20 ℃ on a 0.20 mmol scale: a solution of 1a in 2.0 mL CH2Cl2 
was added dropwise to a 5 mol % solution of -catalyst in 2.0 mL CH2Cl2 under a nitrogen 
atmosphere within 10 min, and the resulting reaction mixture was stirred for the stated 
reaction time. 
b 
The percent conversion of 1a, the yield of 2a and yield of 3a (in parenthesis) 
were determined by 
1
H NMR spectroscopy using 2,4,6-trimethoxy-benzaldehyde as an 
internal standard. 
c 
Catalyst loading is 1 mol %. 
d





DCE was solvent.  
2.2 Substrate Scope with CuPF6(MeCN)4 
Since CuPF6(MeCN)4 has exhibited very high efficiency and 
excellent selectivity in formation of domino cascade reaction product 
during the catalyst screening of 1a, we became interested in the 
generality of CuPF6(MeCN)4 to the domino process The propargyl 
aryldiazoacetates 1b-1j with different substituents were prepared in the 
following investigation. First, the influence of substituents on the phenyl 
group at the para position was examined to further understand the 
formation of the cascade products. Substituents 1b-c with electron 
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donating groups (EDG) such as methoxy group and methyl group gave 
higher yields compared with 1a (Table 1.2, entries 1 and 2); bromo- and 
chloro-substituted propargylic aryldiazoacetates 1d-e resulted in 
corresponding products with slightly decreased yields because 
elimination product 3a was formed as a by-product (Table 1.2, entries 3 
and 4);  however, 1f with a nitro group, which is a strong electron-
withdrawing group (EWG), only produced a trace of product (15% yield) 
under same reaction conditions (elimination product 3a was obtained in 
65% yield separately; Table 1.2, entry 5) . Then, substrates with 
dimethyl as well as other carbocycles that include cyclohexyl and 
cyclobutyl 1g-i were found to be compatible in this domino cascade 
process and furnished the products 2g-i in good yields (Table 1.2, entries 
6-8). The substituents on alkyne were also investigated: substrate 1j, 
which is derived from cyclopropylacetylene, produces corresponding 
cascade product 2j in 85% yield under the same reaction conditions 
(Table 1.2, entry 9).  












 yield of 2(%)
b
 
1 b OMe -(CH2)4- Ph 98 
2 c Me -(CH2)4- Ph 95 
3 d Br -(CH2)4- Ph 86 (6)
c
 
4 e Cl -(CH2)4- Ph 78 (12)
 c
 
5 f NO2 -(CH2)4- Ph 15 (65)
 c
 
6 g H Me Ph 90 
7 h H -(CH2)3- Ph 90 
8 i H -(CH2)5- Ph 80 
9 j H -(CH2)4- cyclopropyl  85 
a Reactions were performed at 20 ℃ on a 0.20 mmol scale: a solution of 1 in 2.0 mL CH2Cl2 was added dropwise 
to a 5 mol % solution of CuPF6(MeCN)4 in 2.0 mL solvent under a nitrogen atmosphere within 10 min, and the 
resulting reaction mixture was stirred for 1 h. b Isolated yield. c Isolated yield of elimination product 3a. 
2.3 Proposed Mechanism for Copper-Catalyzed Carbene 
Domino Cascade Process 
As shown in Scheme 1.15, a plausible mechanism is proposed 
based on previous reports by Padwa and coworkers.
64,76
 The Cu(I) 
complex reacts with phenyldiazoacetate A to produce metal carbene 
intermediate B, which readily undergoes a carbene/alkyne metathesis or 
cyclopropenation/spontaneous ring opening process to form the cyclic 
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vinyl carbene intermediate C,
77
 followed by an intramolecular 
electrophilic aromatic substitution to furnish indene product E.  
 
Scheme 1.15 Postulated Copper-Catalyzed Reaction Pathway. 
2.4 The Lewis Acid Catalyzed Reactions of Propargyl 
Phenyldiazoesters 
As mentioned before, under the catalysis of FeCl3 an unexpected 
reaction of 1a occurred with formation of unexpected lactone 4a albeit 
with relatively lower yield. However, the elimination product 3a was 
obtained as the dominant product under selected reaction conditions 
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(Table 1.3, entry 1). Other Lewis acids also were examined for this 
process. Sc(OTf)3, In(OTf)3, and Zn(OTf)2 failed to give the lactone 4a 
(Table 1.3, entries 2-4). With 10 mol% ZnBr2, lactone 4a was obtained 
in 4% yield (Table 1.3, entry 5); increasing the catalyst loading of ZnBr2 
to 100 mol% resulted in higher yield (Table 1.3, entry 6). BF3•Et2O was 





C upon the consumption of starting material (Table 1.3, entries 7 
and 8). However, the formation of elimination product 3a was always the 
dominant process with these Lewis acids. 











 Yield of 3a
c
 
1 FeCl3 12 h >95% 21% 75% 
2 Sc(OTf)3 10 h >95% <1% 80% 
3 In(OTf)3 10 h >95% <1% 95% 
4 Zn(OTf)2 24 h >95% <1% 80% 
5 ZnBr2 24 h >95% 4% 90% 
6 ZnBr2
d
 12 h >95% 17% 75% 
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7 BF3•Et2O 1 h >95% 20% 80% 
8
e
 BF3•Et2O 12 h >95% 20% 65% 
9
e
 FeCl3 24 h 50%  3% 45% 
10
f
 FeCl3 6 h >95% 15% 75% 
aReactions were performed at 60℃ on a 0.20 mmol scale: a solution of 1a in 2.0 mL ClCH2CH2Cl was added to a 
solution of 10 mol% of catalyst in 2.0 mL ClCH2CH2Cl under a nitrogen atmosphere, and the resulting reaction 
mixture was stirred for stated reaction time. bThe percent conversion of 1a was determined 1H NMR spectroscopy 
using 2,4,6-trimethoxy-benzaldehyde as an internal standard. cIsolated yield. d1.0 eq. of ZnBr2 was used. 
eReaction 
temperature was 20 ºC. fReaction temperature was 80 ºC. 
 
Major efforts were devoted to understanding the mechanism for 
this unique process. A control experiment was conducted by using 
propargyl acetate with tert-butyl diazoacetate under catalysis of FeCl3; 
the rearrangement product analog 4g was obtained in 17% isolated yield 
together with the major elimination product 3g (Scheme 1.16).  
 
Scheme 1.16 FeCl3-Catalyzed Reaction of Propargyl Acetate with tert-
Butyl Diazo Acetate. 
Based on this experiment and previous reports,
78
 we propose a 
plausible mechanism for the above rearrangement reaction as shown in 
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Scheme 1.17. Under the catalysis of FeCl3, ester C-O bond cleavage of A 
occurs, which forms cationic species G and anionic species F. The 
conversion of cationic species G to the allene carbocation H via 
Meyer−Schuster rearrangement has been documented 
79
. The allene 
carbocation H was proposed to be trapped by nucleophilic attack of F to 
produce a key intermediate aryl allene derived compound I, and finally 
cyclization of I furnishes product J. Also, the formed cationic species G 





Scheme 1.17 Proposed Mechanism for FeCl3-Catalyzed Reaction of 1a. 
III. Conclusion 
 34 
In summary, we have disclosed that propargylic phenyldiazoesters 
were converted into three structurally different products as a function of 
catalysts. A variety of transition metal complexes that include 
rhodium(II), palladium(II), silver(I), mercury(II), copper(I and II), and 
cationic gold (I) complexes have been examined to be effective in the 
catalytic domino reactions of propargylic aryldiazoesters. CuPF6(MeCN)4 
has been demonstrated as a superior catalyst in the domino cascade 
reaction for formation of indene derivatives. A Lewis acid catalyzed 
pathway was also discovered: FeCl3 works as a Lewis acid and 
selectively gives furanone 4 as a reaction product. Selected gold catalysts 
exhibit a unique catalytic reactivity, which not only selectively activates 
the alkyne group but also retains the dinitrogen in the final product, 
which has been thoroughly investigated and will be reported in the next 
three chapters. 
IV. Experimental Section 
4.1 General Information 
Unless noted all reactions were carried out under inert atmosphere 
of dinitrogen in oven-dried glassware with magnetic stirring using freshly 
distilled solvents. All solvents were purified and dried using standard 
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methods. Analytical thin layer chromatography (TLC) plates were 
purchased from EM Science (silica gel 60 F254 plates). High-resolution 
mass spectra (HRMS) were performed on a microTOF-ESI mass 
spectrometer using CsI as the standard. Accurate masses are reported for 






. Melting points were 
determined on an Electrothermo Mel-Temp DLX 104 device and were 
uncorrected. Column chromatography was performed on CombiFlash
®
 
Rf 200 purification system using normal phase disposable columns. IR 
spectra were recorded using Bruker Vectcr 22 spectrometer. All NMR 
spectra were recorded on a Bruker spectrometer at 400 MHz (
1
H NMR) 
and 100 MHz (
13
C NMR) or an Agilent spectrometer at 500 MHz (
1
H 
NMR) and 125 MHz (
13
C NMR). Chemical shifts are reported in ppm 
with the solvent signals as reference (in CDCl3 as solvent), and coupling 
constants (J) are given in Hertz (Hz). The peak information is described 
as: br = broad singlet, s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, comp = composite of magnetically non-equivalent protons. 
4.2 Materials 
Rh2(OAc)4 was purchased from Pressure Chemical Co. and 
Rh2(TFA)4, Pd(OAc)2, PdCl2(PhCN)2, [Pd(η3-C₃H₅)Cl]₂, AgSbF6, 
Au(JohnPhos)SbF6, IPrAuBF4, Hg(OTf)2, Cu(OTf)2, CuBF4(MeCN), 
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CuPF6(MeCN)4, and FeCl3 were purchased from Sigma-Aldrich. 
AuCl(C4H8S) was purchased from Strem Chemicals. Other chemicals 
were obtained from commercial sources and used without further 
purification.  
4.3 Experimental Procedures 
 
General Procedures for Preparation of 1-
(Phenylethynyl)cyclopentyl α-Diazo-α-phenylacetate 1a: To a solution 
of phenylacetylene (1.02 g, 10.0 mmol) in dry THF (50 mL) was added 
n-BuLi ( 4.4 mL, 11.0 mmol) dropwise under nitrogen atmosphere at -
78
o
C. After stirring at -78
o
C for 1 h, cyclopentanone ( 924 mg, 11 mmol) 
was added, and the reaction mixture was allowed to warm to room 
temperature over 1 h. After stirring for another 10 h, the reaction mixture 
was quenched with aqueous NH4Cl solution (50 mL), and then extracted 
with diethyl ether (50 mL×2) and dried over anhydrous MgSO4. After 
evaporating the solvent, the crude product was purified by column 
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chromatography (hexane/ethyl acetate = 10/1) to give 1-
(phenylethynyl)cyclopentan-1-ol as a white solid (1.76 g, 95% yield) 
To a solution of 1-(phenylethynyl)cyclopentan-1-ol (930 mg, 5 
mmol), phenylacetic acid (816 mg, 6mmol) and DMAP (122 mg, 1 mmol) 
in dry DCM (30 mL) was added to a solution of DCC (1.24g, 6 mmol) in 
dry DCM (20 mL) via addition funnel over 20 min at 0
o
C. The resulting 
mixture was allowed to warm to room temperature over 1 h, and stirred 
for another 10 h, and a white solid was formed in the process. The 
reaction solution was added to 30 mL of hexanes and filtered by Büchner 
funnel. After evaporating the solvent under reduced pressure, the 
resulting reaction mixture was purified by column chromatography 
(hexane/ethyl acetate = 25/1) to give 1-(phenylethynyl)cyclopentyl 2-
phenylacetate as a colorless oil (1.29 g, 85% yield). 
To a solution of 1-(phenylethynyl)cyclopentyl 2-phenylacetate 
(1.29 g, 4.2 mmol) and 4-acetamidobenzenesulfonyl azide (p-ABSA) 
(1.20 g, 5 mmol) in dry CH3CN (30 mL) was added 1,8-
diazabicycloundec-7-ene (DBU) (0.76g, 5mmol) dropwise at 0
o
C. The 
resulting mixture was allowed to warm to room temperature over 30 min 
and stirred for another 10 h. The reaction was quenched with aqueous 
NH4Cl solution (60 mL) and then extracted with diethyl ether (50 mL×2) 
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and dried over anhydrous MgSO4. After evaporating the solvent, the 
resulting mixture was purified by column chromatography (hexane/ethyl 
acetate = 30/1) to give 1-(phenylethynyl)cyclopentyl α-diazo-α-
phenylacetate 1a as a yellow solid (1.13 g, 82% yield). 
Compounds 1b – 1j were prepared from the corresponding arylacetic 
acids, ketones, or alkynes using the same synthetic procedure as 1a. 
 
General Procedure for Catalyst Screening: To a flame-dried 10 
mL Schlenk flask charged with a magnetic stirring bar, transition metal 
catalyst (0.010 mmol) and 2.0 mL DCM were added under nitrogen 
atmosphere [for Rh2(OAc)4 and Rh2(TFA)4, only 1 mol% catalyst was 
used]. . 1-(Phenylethynyl)cyclopentyl 2-diazo-2-phenylacetate 1a (0.20 
mmol) dissolved in 2.0 mL of DCM was added in one portion into the 
solution under a flow of nitrogen. The resulting mixture was stirred at 
room temperature and monitored periodically by TLC. Upon 
consumption of the 2-diazo-2-phenylacetate 1a (1 – 48 h), the reaction 
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mixture was purified by column chromatography (100:1 to 10:1 gradient 
of hexanes: ethyl acetate as eluents) to afford pure 8'-
phenylspiro[cyclopentane-1,1'-indeno[1,2-c]furan]-3'(8'H)-one 2a and  
 
General Procedure for Copper-Catalyzed Domino Cascade 
Reaction of 1-(Phenylethynyl)cyclopentyl α-Diazo-α-phenylacetate 1a: 
To a flame-dried 10 mL Schlenk flask charged with a magnetic stirring 
bar, CuPF6(MeCN)4 (0.010 mmol) and 2.0 mL DCM were added under 
nitrogen atmosphere. 1-(Phenylethynyl)cyclopentyl 2-diazo-2-
phenylacetate 1a (0.20 mmol) dissolved in 2.0 mL of DCM was added in 
one portion into the solution under a flow of nitrogen. The resulting 
mixture was stirred for 1 h at room temperature (20 °C). The reaction 
mixture was purified by column chromatography (100:1 to 10:1 gradient 
of hexanes: ethyl acetate as eluents) to afford pure 8'-
phenylspiro[cyclopentane-1,1'-indeno[1,2-c]furan]-3'[8'H]-one 2a as a 
white solid (90% yield) 
The same procedure was used with other transition metal complexes.  
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General Procedure for FeCl3-Catalyzed Reaction of 1-
(Phenylethynyl)cyclopentyl α-Diazo-α-phenylacetate 1a: To a flame-
dried 10 mL Schlenk flask charged with a magnetic stirbar. FeCl3 (0.020 
mmol) and 2.0 mL DCE were added under nitrogen atmosphere. 1-
(Phenylethynyl)cyclopentyl 2-diazo-2-phenylacetate 1a (0.20 mmol) 
dissolved in 2.0 mL of DCE was added in one portion into the solution 
under the flow of nitrogen. The resulting mixture was stirred for 12 h at 
60 °C; crude product was purified by column chromatography (100:1 to 
10:1 gradient of hexanes: ethyl acetate as eluents) to afford pure 3a (70%) 
yield as colorless oil and 4a (20 % yield) as a white solid.  
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General Procedure for FeCl3-Catalyzed Reaction of tert-Butyl 2-
Diazo-2-phenylacetate and 2-Methyl-4-phenylbut-3-yn-2-yl acetate: 
To a flame-dried 10 mL Schlenk flask charged with a magnetic stirring 
bar. FeCl3 (0.020 mmol) and 2.0 mL DCE were added under a nitrogen 
atmosphere. tert-Butyl 2-diazo-2-phenylacetate (0.20 mmol) and 2-
methyl-4-phenylbut-3-yn-2-yl acetate (0.20 mmol) dissolved in 2.0 mL 
of DCE were added in one portion into the solution under the flow of 
nitrogen. The resulting mixture was stirred for 12 h at 60 °C; the reaction 
mixture was purified by column chromatography (100:1 to 10:1 gradient 
of hexanes: ethyl acetate as eluents) to afford pure 3g (70% yield) as 
colorless oil and 4g (12 % yield) as a white solid. 
4.4 Characterization Data 
 
1-(Phenylethynyl)cyclopentyl α-Diazo-α-phenylacetate 1a: 66% 
yield. Yellow solid, m.p. 52.7 – 54.1℃. 1H NMR (500 MHz, CDCl3) δ 
7.51 (d, J = 7.9 Hz, 2H), 7.47 – 7.43 (comp, 2H), 7.38 (t, J = 7.9 Hz, 2H), 
7.31 – 7.27 (comp, 3H), 7.18 (t, J = 7.4 Hz, 1H), 2.46 – 3.39 (comp, 2H), 
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2.35 – 2.27 (comp, 2H), 1.89 – 1.80 (comp, 4H). 
13
C NMR (125 MHz, 
CDCl3) δ 163.50, 131.82, 128.85, 128.28, 128.11, 125.69, 125.63, 123.95, 
122.66, 89.34, 85.08, 82.16, 40.77, 23.44. IR (neat) 2089, 1704, 1353, 
1250, 1151, 905 cm
-1





 463.0417, found: 463.0419. 
 
1-(Phenylethynyl)cyclopentyl 2-Diazo-2-(4-
methoxyphenyl)acetate 1b: 69% yield. Orange oil. 
1
H NMR (500 MHz, 
CDCl3) δ 7.49 – 7.44 (comp, 2H), 7.44 – 7.39 (comp, 2H), 7.33 – 7.28 
(comp, 3H), 6.97 – 6.92 (comp, 2H), 3.82 (s, 3H), 2.42 (ddd, J = 12.3, 
7.8, 3.7 Hz, 2H), 2.35 – 2.26 (comp, 2H), 1.90 – 1.78 (comp, 4H).
 13
C 
NMR (125 MHz, CDCl3) δ 164.06, 157.97, 131.84, 128.27, 128.11, 
125.87, 122.72, 117.07, 114.56, 89.46, 85.01, 82.04, 55.35, 40.79, 23.46. 
IR (neat) 2954, 2075, 1702, 1512, 1255, 1145, 997 cm
-1
; HRMS (ESI) 
m/z calculated for C22H20N2O3Na [M+Na]
+
 383.1366, found: 383.1361. 
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1-(Phenylethynyl)cyclopentyl α-Diazo-α-(p-tolyl)acetate 1c: 
64%. Yellow solid, m.p. 60.2 – 61.5℃. 1H NMR (500 MHz, CDCl3) δ 
7.49 – 7.44 (comp, 2H), 7.41 (d, J = 8.1 Hz, 2H), 7.32 – 7.27 (comp, 3H), 
7.21 (d, J = 8.1 Hz, 2H), 2.46 – 2.40 (comp, 2H), 2.35 (s, 3H), 2.34 – 
2.26 (comp, 2H), 1.89 – 1.82 (comp, 4H).
 13
C NMR (125 MHz, CDCl3) δ 
163.69, 135.50, 131.77, 129.55, 128.22, 128.06, 124.03, 122.66, 122.22, 
89.39, 84.99, 82.01, 40.73, 23.41, 20.93. IR (neat) 2087, 1703, 1250, 
1150, 906 cm
-1









diazoacetate 1d: 68% yield. Yellow solid, m.p. 80.5 – 82℃.  1H NMR 
(500 MHz, CDCl3) δ 7.49 (d, J = 8.8 Hz, 2H), 7.46 – 7.42 (comp, 2H), 
7.38 (d, J = 8.8 Hz, 2H), 7.31 – 7.26 (comp, 3H), 2.45 – 2.36 (comp, 2H), 
2.34 – 2.26 (comp, 2H), 1.86 – 1.78 (comp, 4H). 
13
C NMR (125 MHz, 
CDCl3) δ 163.12, 131.92, 131.81, 128.36, 128.14, 125.34, 124.87, 122.57, 
119.20, 89.14, 85.24, 82.43, 40.77, 23.44. IR (neat) 2088, 1702, 1491, 
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1245, 1150, 903 cm
-1










diazoacetate 1e: 65% yield. Yellow solid, m.p. 56.5 – 58.1℃. 1H NMR 
(500 MHz, CDCl3) δ 7.47 – 7.40 (comp, 4H), 7.34 (d, J = 7.1 Hz, 2H), 
7.30 – 7.26 (comp, 3H), 2.44 – 2.38 (comp, 2H), 2.34 – 2.27 (comp, 2H), 
1.87 – 1.79 (comp, 4H). 
13
C NMR (125 MHz, CDCl3) δ 163.18, 131.81, 
131.33, 128.99, 128.34, 128.13, 125.06, 124.29, 122.57, 89.15, 85.21, 
82.40, 40.76, 23.43. IR (neat) 2088, 1702, 1250, 1150, 745 cm
-1
. HRMS 








1f: 54% yield. Yellow solid, m.p. 113.4 – 114.5℃. 1H NMR (500 MHz, 
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CDCl3) δ 8.22 (d, J = 9.0 Hz, 2H), 7.68 (d, J = 9.0 Hz, 2H), 7.47 – 
7.42 (comp, 2H), 7.32 – 7.27 (comp, 3H), 2.46 – 2.38 (comp, 2H), 
2.35 – 2.28 (comp, 2H), 1.92 – 1.78 (comp, 4H). 
13
C NMR (125 MHz, 
CDCl3) δ 162.03, 144.95, 134.04, 131.80, 128.49, 128.18, 124.20, 
123.18, 122.38, 88.72, 85.57, 83.07, 40.75, 23.42. IR (neat) 2095, 1708, 
1594, 1335, 1245, 1152, 903 cm
-1





 398.1111, found: 398.1135. 
 
2-Methyl-4-phenylbut-3-yn-2-yl 2-Diazo-2-phenylacetate 1g: 63% 
yield. Orange oil. 
1
H NMR (300 MHz, CDCl3) δ 7.53 – 7.43 (comp, 4H), 
7.41 – 7.35 (comp, 2H), 7.32 – 7.27 (comp, 3H), 7.21 – 7.14 (m, 1H), 
1.85 (s, 6H).
 13
C NMR (125 MHz, CDCl3) δ 163.35, 131.85, 128.86, 
128.39, 128.15, 125.73, 125.70, 124.03, 122.52, 89.95, 84.47, 73.81, 
29.44. IR (neat) 2936, 2079, 1705, 1498, 1349, 1247, 1120, 754, 691 cm
-
1






1-(Phenylethynyl)cyclobutyl 2-Diazo-2-phenylacetate 1h: 52% 
yield. Yellow solid, m.p. 76 – 77 °C.
 1
H NMR (500 MHz, CDCl3) δ 7.52 
(dd, J = 8.5, 1.1 Hz, 2H), 7.50 – 7.45 (comp, 2H), 7.42 – 7.36 (comp, 2H), 
7.34 – 7.29 (comp, 3H), 7.23 – 7.16 (m, 1H), 2.81 – 2.71 (comp, 2H), 
2.62 (ddd, J = 12.7, 9.7, 2.6 Hz, 2H), 2.15 – 2.05 (m, 1H), 2.00 (qdd, J = 
9.9, 8.6, 4.9 Hz, 1H). 
13
C NMR (125 MHz, CDCl3) δ 163.24, 131.94, 
128.90, 128.43, 128.16, 125.80, 125.45, 123.98, 122.54, 89.16, 84.79, 
73.26, 37.18, 14.65. IR (neat) 2952, 2081, 1704, 1497, 1351, 1242, 1144, 
1088, 754, 691 cm
-1
; HRMS (ESI) m/z calculated for C20H16N2O2Na 
[M+Na]
+
 339.1104, found: 339.1107. 
 
1-(Phenylethynyl)cyclohexyl 2-Diazo-2-phenylacetate 1i: 66% 
yield. Yellow solid, m.p. 50 – 51 °C. 
1
H NMR (500 MHz, CDCl3) δ 7.53 
(dd, J = 8.5, 1.1 Hz, 2H), 7.50 – 7.45 (comp, 2H), 7.42 – 7.36 (comp, 2H), 
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7.34 – 7.28 (comp, 3H), 7.21 – 7.16 (m, 1H), 2.36 – 2.21 (comp, 2H), 
2.09 (comp, 2H), 1.81 – 1.65 (comp, 4H), 1.62 – 1.53 (m, 1H), 1.45 (ddd, 
J = 13.1, 8.5, 4.8 Hz, 1H). 
13
C NMR (125 MHz, CDCl3) δ 163.07, 131.87, 
128.85, 128.32, 128.14, 125.79, 125.66, 124.02, 122.70, 89.06, 86.54, 
77.10, 37.48, 25.17, 22.72. IR (neat) 2936, 2083, 1707, 1241, 754, 691 
cm
-1








yield. White solid, m.p. 128 – 129 °C. 
1
H NMR (400 MHz, CDCl3) δ 
7.74 (d, J = 8.0 Hz, 1H), 7.40 - 7.36 (m, 1H), 7.33 - 7.30 (comp., 3H), 
7.27 - 7.24 (comp., 2H), 7.08 - 7.06 (comp., 2H), 4.80 (s, 1H), 2.11 - 2.08 
(comp., 2H), 2.07 -2.02, (m, 1H), 2.01 - 1.98 (m, 1H), 1.98 – 1.82 m, 1H), 
1.81 – 1.69 (m, 1H), 1.67 – 1.55 (m, 1H), 1.33-1.25 (m, 1H); 
13
C NMR 
(100 MHz, CDCl3) δ 179.0, 166.4, 152.0, 136.1, 135.9, 134.3, 129.1, 
128.1, 127.9, 127.7, 125.0,120.9, 95.5, 52.4, 38.5, 36.7, 24.4. HRMS 
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(ESI) m/z calculated for C21H18O2Na [M+Na]
+




c]furan)-3'(8'H)-one 2b: 98% yield. White solid, m.p. 152 – 153 °C.
1
H 
NMR (400 MHz, CDCl3) δ 7.51 (d, J= 8.3 Hz, 1H), 7.22 - 7.20 (comp., 
3H), 6.98 - 6.96 (comp., 2H), 6.81 - 6.78 (m, 1H), 6.70 - 6.69 (m, 1H), 
4.65 (s, 1H), 3.66 (s, 3H), 1.98 - 1.94 (comp., 2H), 1.88 – 1.86 (m, 1H), 
1.78 – 1.74 (m, 1H), 1.71 – 1.66 ( m, 1H),1.59 – 1.54 (m, 1H), 1.47 – 
1.40 (m, 1H), 1.20-1.12 (m, 1H); 
13
C NMR (100 MHz, CDCl3) 176.9, 
166.5, 159.2, 153.9, 136.1, 135.6, 129.0, 128.1, 127.8, 127.0, 121.3, 
112.6, 111.8, 95.4, 55.4, 52.4, 38.3, 36.7, 24.3. HRMS (ESI) m/z 
calculated for C22H21O3Na [M+Na]
+




c]furan]-3'[8'H]-one 2c: 98% yield. White solid, m.p. 98 – 99 °C. 
1
H 
NMR (400 MHz, CDCl3) δ 7.51 (d, J = 8.4 Hz, 1H), 7.24 - 7.18 (comp., 
3H), 7.09 (d, J = 8.4 Hz, 1H), 6.98-6.95 (comp., 3H), 4.66 (s, 1H), 2.24 (s, 
3H), 1.99 - 1.96 (comp., 2H), 1.93 – 1.86 (m, 1H), 1.82 – 1.75 (m, 1H), 
1.73 – 1.64 (m, 1H), 1.63 - 1.56 (m, 4H),1.50-1.41 (m,1H),1.21-1.14 (m, 
1H); 
13
C NMR (100 MHz, CDCl3) δ 178.1, 166.6, 152.3, 136.9, 136.2, 
136.0, 131.5, 129.1, 128.4, 128.1, 127.8, 125.8, 120.5, 95.4, 52.3, 38.4, 
36.7, 24.3, 21.5. HRMS (ESI) m/z calculated for C22H20O2Na [M+Na]
+
 









NMR (500 MHz, CDCl3) δ 7.57 (d, J = 8.1 Hz, 1H), 7.49 (d, J = 8.1 Hz, 
1H), 7.34 – 7.32 (m, 1H), 7.33 – 7.29 (comp., 3H), 7.08 – 6.99 (comp., 
2H), 4.77 (s, 1H), 2.10 – 2.04 (comp., 2H), 2.01 – 1.93 (m, 1H), 1.90 – 
1.83 (m, 1H), 1.79 – 1.73 (m, 1H), 1.70 – 1.65 (m, 1H), 1.55 – 1.51, (m, 
1H), 1.29 – 1.22 (m, 1H). 
13
C NMR (125 MHz, CDCl3) δ 179.09, 165.92, 
153.83, 135.45, 134.89, 133.20, 130.91, 129.27, 128.40, 128.19, 128.05, 
122.04, 120.96, 95.44, 52.42, 38.41, 36.72, 24.42, 24.33. C21H17O2BrNa 
[M+Na]
+
 403.0310, found: 403.0306. 
 
5'-Chloro-8'-phenylspiro[cyclopentane-1,1'-indeno[1,2-
c]furan]-3'(8'H)-one 2e: 78% yield. White solid, m.p. 101 – 102 °C. 
1
H 
NMR (400 MHz, CDCl3) δ 7.56 (d, J = 8.2 Hz, 1H), 7.29-7.24 (comp., 
4H), 7.19-7.12 (m, 1H), 6.98-6.96 (comp., 2H), 4.70 (s, 1H), 2.02 – 1.97 
(comp., 2H), 1.93 – 1.87 (m, 1H), 1.83 – 1.77 (m , 1H), 1.72 – 1.67 (m, 
1H), 1.64 – 1.57 (m, 1H), 1.51 - 1.45 (m, 1H), 1.23-1.15 (m, 1H); 
13
C 
NMR (100 MHz, CDCl3) δ 179.1, 166.0, 153.6, 135.5, 135.0, 133.0, 
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132.8, 129.3, 128.2, 128.1, 125.6, 121.7, 95.5, 52.5, 38.5, 36.8, 24.5, 24.4. 
C21H17O2ClNa [M+Na]
+




3'(8'H)-one 2f: 15% yield. White solid, m.p. 162 – 163 °C.
1
H NMR (500 
MHz, CDCl3) δ 8.34 – 8.30 (m, 1H), 8.09 – 8.06 (m, 1H), 7.87 – 7.82 (m, 
1H), 7.36 – 7.32 (m, 3H), 7.05 (s, 2H), 4.90 (s, 1H), 2.15 – 2.07 (m, 2H), 
2.03 – 1.98 (m, 1H), 1.92 – 1.87 (m, 1H), 1.84 – 1.78 (m, 1H), 1.75 – 
1.71 (m, 1H), 1.59 – 1.56 (m, 1H), 1.33 – 1.29 (m, 1H).
13
C NMR (125 
MHz, CDCl3) δ 183.53, 165.26, 153.04, 146.99, 140.43, 135.21, 133.69, 
129.60, 128.72, 128.05, 124.30, 121.13, 120.42, 95.84, 52.92, 38.64, 
36.88, 24.54, 24.46. C21H17NO4Na [M+Na]
+
 370.1055, found: 370.1047. 
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2-Methyl-4-phenylbut-3-yn-2-yl 2-diazo-2-phenylacetate 2g: 90% 
yield; white solid, m.p. 88 – 89 °C.
1
H NMR (400 MHz, CDCl3) δ 7.66 (d, 
J = 8.0 Hz, 1H), 7.32-7.28 (m, 1H), 7.24-7.14 (comp., 5H), 6.98-6.96 
(comp., 2H), 4.70 (s, 1H), 1.54 (s, 3H), 1.03 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ
 
181.9, 166.2, 151.6, 135.6, 135.1, 134.3, 129.1, 128.2, 127.9, 
127.8, 127.0, 121.1, 85.4, 52.5, 26.4, 25.7. C19H16O2Na [M+Na]
+
 







90% yield; white solid, m.p. 150 – 151 °C.
1
H NMR (400 MHz, 
CDCl3) δ 7.72 (d, J= 8.2 Hz, 1H), 7.38-7.32 (comp., 4H), 7.27-7.21 
(comp., 2H), 7.15-7.13 (comp., 2H), 4.89 (s, 1H), 2.82-2.74 (m, 1H), 
2.51-2.47 (comp., 2H), 1.84-1.73 (comp., 2H), 1.60-1.50(m, 1H); 
13
C 
NMR (100 MHz, CDCl3) δ 178.2, 166.2, 152.2, 135.8, 135.5, 133.8, 
129.0, 128.1, 127.9, 127.0, 125.0, 120.9, 85.9, 52.4, 33.3, 31.7, 12.2. 
C20H16O2Na [M+Na]
+




one 2i: 80% yield; white solid, m.p. 175 – 176 °C. 
1
H NMR (500 MHz, 
CDCl3) δ 7.75 (d, J = 7.4 Hz, 1H), 7.39 – 7.35 (m, 1H), 7.33 – 7.29 (m, 
3H), 7.24 (d, J = 7.4 Hz, 1H), 7.21 (d, J = 7.4 Hz, 1H), 7.07 – 7.03 
(comp., 2H), 4.76 (s, 1H), 1.85 – 1.77 (comp., 3H), 1.75 – 1.46 (comp., 
3H), 1.43 – 1.39 (comp., 2H), 1.19 – 1.08 (m, 1H), 1.06 – 0.97 (m, 1H).
 
13
C NMR (125 MHz, CDCl3) δ 182.00, 166.60, 151.83, 135.67, 135.23, 
134.24, 129.05, 128.25, 127.85, 127.69, 126.94, 125.01, 121.01, 87.36, 










(500 MHz, CDCl3) δ 7.68 (d, J = 7.4 Hz, 1H), 7.63 (d, J = 7.5 Hz, 1H), 
7.37 (t, J = 7.4 Hz, 1H), 7.30 (t, J = 7.5 Hz, 1H), 2.89 (d, J = 9.6 Hz, 1H), 
2.57 – 2.47 (m, 1H), 2.17 – 1.89 (m, 7H), 0.93 – 0.83 (m, 1H), 0.81 – 
0.69 (m, 3H), 0.46 (td, J = 9.6, 5.0 Hz, 1H). 
13
C NMR (125 MHz, CDCl3) 
δ 179.22, 150.67, 135.79, 134.10, 127.70, 126.46, 124.41, 120.80, 95.64, 
51.79, 38.78, 36.84, 25.07, 24.92, 11.84, 4.82, 4.33. C18H18O2Na 
[M+Na]
+
 289.1024, found: 289.1026. 
 
5-Cyclopentylidene-3,4-diphenylfuran-2[5H]-one 4a: 20% yield; 
White solid, m.p. 93 – 94 °C. 
1
H NMR (500 MHz, CDCl3) δ 7.47 – 7.42 
(comp., 3H), 7.41 – 7.37 (comp., 2H), 7.29 – 7.25 (comp., 2H), 7.25 – 
7.19 (comp., 3H), 2.77 (t, J = 6.9 Hz, 2H), 1.87 (t, J = 7.2 Hz, 2H), 1.71 – 
1.63 (comp., 2H), 1.62 – 1.56 (comp., 2H). 
13
C NMR (125 MHz, CDCl3) 
δ 168.88, 148.98, 141.50, 136.31, 132.76, 129.82, 128.96, 128.95, 128.39, 
128.21, 128.08, 125.69, 32.54, 30.49, 27.32, 25.31. HRMS (ESI) m/z 
calculated for C21H18O2Na [M+Na]
+
 325.1199, found: 325.1191. 
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3,4-Diphenyl-5-(propan-2-ylidene)furan-2[5H]-one 4g: 17 % 
yield; White solid, m.p. 87 – 88 °C.
1
H NMR (500 MHz, CDCl3) δ 7.45 – 
7.40 (m, 3H), 7.35 – 7.31 (m, 2H), 7.29 – 7.26 (m, 2H), 7.23 – 7.18 (m, 
3H), 2.10 (s, 3H), 1.47 (s, 3H).
 13
C NMR (125 MHz, CDCl3) δ 168.40, 
148.80, 144.04, 133.33, 129.71, 129.03, 129.00, 128.90, 128.48, 128.24, 




NMR graphs will be obtained from the supporting information of the 
upcoming published paper. 
V. References: 
 (1) Regitz, M.; Maas, G. In Diazo Compounds; Academic Press: 
1986, 199.  
 (2) (a) Li, W.; Liu, X.; Hao, X.; Hu, X.; Chu, Y.; Cao, W.; Qin, S.; 
Hu, C.; Lin, L.; Feng, X. J. Am. Chem. Soc. 2011, 133, 15268-15271;  (b) 
Liu, Y.; Bakshi, K.; Zavalij, P.; Doyle, M. P. Org. Lett. 2010, 12, 4304-
4307; (c) Matsuya, Y.; Ohsawa, N.; Nemoto, H. J. Am. Chem. Soc. 2006, 
128, 13072-13073. 
 (3) Candeias, N. R.; Paterna, R.; Gois, P. M. P. Chem. Rev. 2016, 
116, 2937-2981. 
 (4) (a) Padwa, A.; Weingarten, M. D. Chem. Rev. 1996, 96, 223-
270; (b) Cardin, D. J.; Cetinkaya, B.; Lappert, M. F. Chem. Rev. 1972, 72, 
545-574; (c) Padwa, A. Chem. Rev. 1977, 77, 37-68. 
 56 
 (5) (a) Doyle, M. P. Chem. Rev. 1986, 86, 919-939; (b) Doyle, M. 
P.; Forbes, D. C. Chem. Rev. 1998, 98, 911-936; (c) Padwa, A.; 
Hornbuckle, S. F. Chem. Rev. 1991, 91, 263-309; (d) Davies, H. M. L.; 
Beckwith, R. E. J. Chem. Rev. 2003, 103, 2861-2904. 
 (6) (a) Sierra, M. A. Chem. Rev. 2000, 100, 3591-3638; (b) Dötz, 
K. H.; Stendel, J. Chem. Rev. 2009, 109, 3227-3274. 
 (7) (a) Barluenga, J.; Santamaría, J.; Tomás, M. Chem. Rev. 2004, 
104, 2259-2284;  (b) Mindiola, D. J. Acc. Chem. Res. 2006, 39, 813-821; 
(c) Whited, M. T.; Grubbs, R. H. Acc. Chem. Res. 2009, 42, 1607-1616. 
 (8) Doyle, M. P.; Winchester, W. R.; Simonsen, S. H.; Ghosh, R. 
Inorg. Chim. Acta. 1994, 220, 193-199. 
 (9) Doyle, M. P. Acc. Chem. Res. 1986, 19, 348-356. 
 (10) Doyle, M. P.; Duffy, R.; Ratnikov, M.; Zhou, L. Chem. Rev. 
2010, 110, 704-724. 
 (11) (a) Zhang, Y.; Wang, J. Chem. commun. 2009, 5350-5361; (b) 
Davies, H. M. L.; Denton, J. R. Chem. Soc. Rev. 2009, 38, 3061-3071; 
 (c) Davies, H. M. L.; Alford, J. S. Chem. Soc. Rev. 2014, 43, 5151-
5162. 
 (12) (a) Doyle, M. P.; Bagheri, V.; Pearson, M. M.; Edwards, J. D. 
Tetrahedron Lett. 1989, 30, 7001-7004;  (b) Doyle, M. P.; Westrum, 
L. J.; Wolthuis, W. N. E.; See, M. M.; Boone, W. P.; Bagheri, V.; 
Pearson, M. M. J. Am. Chem. Soc. 1993, 115, 958-964; (c) Davies, H. M. 
L.; Antoulinakis, E. G. J. Organomet. Chem. 2001, 617–618, 47-55; (d) 
Wang, J.; Liang, F.; Chen, B. J. Org. Chem. 1998, 63, 8589-8594. 
 (13) (a) Ye, T.; McKervey, M. A. Chem. Rev. 1994, 94, 1091-1160; 
 (b) Ford, A.; Miel, H.; Ring, A.; Slattery, C. N.; Maguire, A. R.; 
McKervey, M. A. Chem. Rev. 2015, 115, 9981-10080. 
 (14) Maas, G. Angew. Chem., Int. Ed.2009, 48, 8186-8195. 
 (15) (a) Davies, H. M. L.; Manning, J. R. Nature 2008, 451, 417-
424; (b)Doyle, M. P.; Shanklin, M. S.; Pho, H. Q.; Mahapatro, S. N. J. 
Org. Chem.  1988, 53, 1017-1022; (c) Guo, X.; Hu, W. Acc. Chem. Res. 
2013, 46, 2427-2440;  (d) Zhu, S.-F.; Zhou, Q.-L. Acc. Chem. Res. 
2012, 45, 1365-1377. 
 (16) (a) Joergensen, K. A. Chem. Rev. 1989, 89, 431-458; (b) 
Brothers, P. J.; Roper, W. R. Chem. Rev. 1988, 88, 1293-1326; (c) Pape, 
A. R.; Kaliappan, K. P.; Kündig, E. P. Chem. Rev. 2000, 100, 2917-2940; 
(d) Lautens, M.; Klute, W.; Tam, W. Chem. Rev. 1996, 96, 49-92. 
 (17) Kubo, T.; Sakaguchi, S.; Ishii, Y. Chem. commun. 2000, 625-
626. 
 57 
 (18) (a) Doyle, M. P.; Protopopova, M. N.; Poulter, C. D.; Rogers, 
D. H. J. Am. Chem. Soc. 1995, 117, 7281-7282; (b) Park, E. J.; Kim, S. 
H.; Chang, S. J. Am. Chem. Soc. 2008, 130, 17268-17269. 
 (19) Silberrad, O.; Roy, C. S. J. Chem. Soc., Dalton Trans. 1906, 
89, 179-182. 
 (20) Suárez, A.; Fu, G. C. Angew. Chem., Int. Ed.2004, 43, 3580-
3582. 
 (21) Salomon, R. G.; Kochi, J. K. J. Am. Chem. Soc. 1973, 95, 
3300-3310. 
 (22) Saha, B.; Bhattacharjee, G.; Ghatak, U. R. Tetrahedron Lett. 
1986, 27, 3913-3914. 
 (23) Zhu, Y.; Zhai, C.; Yang, L.; Hu, W. Chem. commun. 2010, 46, 
2865-2867. 
 (24) Kubas, G. J.; Monzyk, B.; Crumbliss, A. L. In Inorganic 
Syntheses; John Wiley & Sons, Inc.: 2007, 90-92. 
 (25) Moore, J. A.; Partain, E. M. J. Org. Chem. 1983, 48, 1105-
1106. 
 (26) (a) Nozaki, H.; Moriuti, S.; Takaya, H.; Noyori, R. 
Tetrahedron Lett. 1966, 5239-5244; (b) Salomon, R. G.; Kochi, J. K. J. 
Am. Chem. Soc. 1973, 95, 1889-1897. 
 (27) Li, J.; Liao, S.-H.; Xiong, H.; Zhou, Y.-Y.; Sun, X.-L.; Zhang, 
Y.; Zhou, X.-G.; Tang, Y. Angew. Chem., Int. Ed.2012, 51, 8838-8841. 
 (28) Slattery, C. N.; Maguire, A. R. Org. Biomol. Chem.2011, 9, 
667-669. 
 (29) Cheng, Q.-Q.; Yedoyan, J.; Arman, H.; Doyle, M. P. J. Am. 
Chem. Soc. 2016, 138, 44-47. 
 (30) (a) Evans, D. A.; Woerpel, K. A.; Hinman, M. M.; Faul, M. M. 
J. Am. Chem. Soc. 1991, 113, 726-728; (b) Liu, B.; Zhu, S.-F.; Zhang, W.; 
Chen, C.; Zhou, Q.-L. J. Am. Chem. Soc. 2007, 129, 5834-5835; (c) Chen, 
C.; Zhu, S.-F.; Liu, B.; Wang, L.-X.; Zhou, Q.-L. J. Am. Chem. Soc. 2007, 
129, 12616-12617.  
 (31) (a) Paulissen, R.; Reimlinger, H.; Hayez, E.; Hubert, A. J.; 
Teyssié, P. Tetrahedron Lett. 1973, 14, 2233-2236; (b) Davies, H. M. L.; 
Lian, Y. Acc. Chem. Res. 2012, 45, 923-935. 
 (32) (a) Pirrung, M. C.; Zhang, J. Tetrahedron Lett. 1992, 33, 
5987-5990; (b) McCarthy, N.; McKervey, M. A.; Ye, T.; McCann, M.; 
Murphy, E.; Doyle, M. P. Tetrahedron Lett. 1992, 33, 5983-5986. 
 (33) (a) Estevan, F.; Herbst, K.; Lahuerta, P.; Barberis, M.; Pérez-
Prieto, J. Organometallics 2001, 20, 950-957; (b) Barberis, M.; Pérez-
Prieto, J.; Stiriba, S.-E.; Lahuerta, P. Org. Lett.2001, 3, 3317-3319. 
 58 
 (34) (a) Frantz, D. E.; Fässler, R.; Tomooka, C. S.; Carreira, E. M. 
Acc. Chem. Res. 2000, 33, 373-381;  (b) Davies, H. M. L.; Hutcheson, 
D. K. Tetrahedron Lett. 1993, 34, 7243-7246; (c) Minami, K.; Saito, H.; 
Tsutsui, H.; Nambu, H.; Anada, M.; Hashimoto, S. Adv. Synth. Catal. 
2005, 347, 1483-1487. (d) Tsutsui, H.; Shimada, N.; Abe, T.; Anada, M.; 
Nakajima, M.; Nakamura, S.; Nambu, H.; Hashimoto, S. Adv. Synth. 
Catal. 2007, 349, 521-526; (e) Doyle, M. P.; Colyer, J. T. Tetrahedron: 
Asymmetry 2003, 14, 3601-3604; (f) Doyle, M. P.; Davies, S. B.; Hu, W. 
Org. Lett.2000, 2, 1145-1147. 
 (35) Robinson, R. P.; Buckbinder, L.; Haugeto, A. I.; McNiff, P. 
A.; Millham, M. L.; Reese, M. R.; Schaefer, J. F.; Abramov, Y. A.; 
Bordner, J.; Chantigny, Y. A.; Kleinman, E. F.; Laird, E. R.; Morgan, B. 
P.; Murray, J. C.; Salter, E. D.; Wessel, M. D.; Yocum, S. A. J. Med. 
Chem. 2009, 52, 1731-1743. 
 (36) (a) Gorin, D. J.; Sherry, B. D.; Toste, F. D. Chem. Rev. 2008, 
108, 3351-3378;  (b) Li, Z.; Brouwer, C.; He, C. Chem. Rev. 2008, 108, 
3239-3265; (c) Wang, Y.; Zhang, L. Synthesis 2015, 47, 289-305;  (d) 
Hashmi, A. S. K. Catal. Today 2007, 122, 211-214; (e) Pyykkö, P. 
Angew. Chem., Int. Ed.2004, 43, 4412-4456. 
 (37) Liu, L.; Zhang, J. Chem. Soc. Rev. 2016, 45, 506-516. 
 (38) Witham, C. A.; Mauleón, P.; Shapiro, N. D.; Sherry, B. D.; 
Toste, F. D. J. Am. Chem. Soc. 2007, 129, 5838-5839. 
 (39) (a) Xiao, Q.; Zhang, Y.; Wang, J. Acc. Chem. Res. 2013, 46, 
236-247; (b) Zhang, L. Acc. Chem. Res. 2014, 47, 877-888;  (c) 
DeAngelis, A.; Panish, R.; Fox, J. M. Acc. Chem. Res. 2016, 49, 115-127; 
(d) Burtoloso, A. C. B.; Dias, R. M. P.; Bernardim, B. Acc. Chem. Res. 
2015, 48, 921-934; (e) Sutton, D. Chem. Rev. 1993, 93, 995-1022. 
 (40) (a) Gleiter, R.; Werz, D. B. Chem. Rev. 2010, 110, 4447-
4488;  (b) Müller, T. E.; Hultzsch, K. C.; Yus, M.; Foubelo, F.; Tada, M. 
Chem. Rev. 2008, 108, 3795-3892; (c) Gorgues, A.; Hudhomme, P.; Sallé, 
M. Chem. Rev. 2004, 104, 5151-5184;  (d) Alonso, F.; Yus, M. ACS 
Catal. 2012, 2, 1441-1451; (e) Manjolinho, F.; Arndt, M.; Gooßen, K.; 
Gooßen, L. J. ACS Catal. 2012, 2, 2014-2021; (f) Jiang, X.; Chu, L.; 
Qing, F.-L. J. Org. Chem. 2012, 77, 1251-1257; (g) Zhu, Y.; Sun, L.; Lu, 
P.; Wang, Y. ACS Catal. 2014, 4, 1911-1925; (h) Anderson, C. E.; 
Braunschweig, H.; Dewhurst, R. D. Organometallics 2008, 27, 6381-
6389. 
 (41) (a) Perez, L. J.; Shimp, H. L.; Micalizio, G. C. J. Org. Chem. 
2009, 74, 7211-7219; (b) Yamamoto, Y. J. Org. Chem. 2007, 72, 7817-
7831. 
 59 
 (42) Wille, U. Chem. Rev. 2013, 113, 813-853. 
 (43) Zoellner, R. W.; Klabunde, K. J. Chem. Rev. 1984, 84, 545-
559. 
 (44) (a) Godoi, B.; Schumacher, R. F.; Zeni, G. Chem. Rev. 2011, 
111, 2937-2980;  (b) Müller, T. E.; Beller, M. Chem. Rev. 1998, 98, 
675-704; (c) Rosenberg, L. ACS Catal. 2013, 3, 2845-2855.  
 (45) (a) Chemler, S. R.; Bovino, M. T. ACS Catal. 2013, 3, 1076-
1091; (b) Meldal, M.; Tornøe, C. W. Chem. Rev. 2008, 108, 2952-3015. 
 (46) (a) Gilmore, K.; Alabugin, I. V. Chem. Rev. 2011, 111, 6513-
6556; (b) Schore, N. E. Chem. Rev. 1988, 88, 1081-1119; (c) Alabugin, I. 
V.; Gold, B. J. Org. Chem. 2013, 78, 7777-7784. 
 (47) Sun, J.; Deng, L. ACS Catal. 2016, 6, 290-300. 
 (48) Sato, F.; Urabe, H.; Okamoto, S. Chem. Rev. 2000, 100, 
2835-2886. 
 (49) (a) Buchwald, S. L.; Nielsen, R. B. J. Am. Chem. Soc. 1989, 
111, 2870-2874;  (b) Negishi, E.-I.; Kondakov, D. Y. Chem. Soc. Rev.  
1996, 25, 417-426. 
 (50) (a)Yoshida, H. ACS Catal. 2016, 6, 1799-1811; (b) Park, J.; 
Yeon, J.; Lee, P. H.; Lee, K. Tetrahedron Lett 2013, 54, 4414-4417. 
 (51) Schrock, R. R.; Czekelius, C. Adv. Synth. Catal.  2007, 349, 
55-77. 
 (52) (a)Templeton, J. L. In Advances in Organometallic Chemistry; 
Stone, F. G. A., Robert, W., Eds.; Academic Press: 1989; Vol. Volume 
29, 1-100; (b) Bauer, E. B.; Szafert, S.; Hampel, F.; Gladysz, J. A. 
Organometallics 2003, 22, 2184-2186. 
 (53) Holte, D.; Götz, D. C. G.; Baran, P. S. J. Org. Chem.  2012, 
77, 825-842. 
 (54) Umeda, N.; Hirano, K.; Satoh, T.; Shibata, N.; Sato, H.; Miura, 
M. J. Org. Chem.  2011, 76, 13-24. 
 (55) (a) Schmidbaur, H.; Schier, A. Organometallics 2010, 29, 2-
23; (b) Fürstner, A. Angew. Chem., Int. Ed.2013, 52, 2794-2819. 
 (56) Nagata, T.; Hirano, K.; Satoh, T.; Miura, M. J. Org. Chem.  
2014, 79, 8960-8967. 
 (57) (a) Chinchilla, R.; Nájera, C. Chem. Rev. 2014, 114, 1783-
1826; (b) Lin, Y.-D.; Cho, C.-L.; Ko, C.-W.; Pulte, A.; Wu, Y.-T. J. Org. 
Chem.  2012, 77, 9979-9988;  (c)Tsukamoto, H.; Ikeda, T.; Doi, T. J. 
Org. Chem.  2016, 81, 1733-1745; (d) Zhang, Z.; Ouyang, L.; Wu, W.; Li, 
J.; Zhang, Z.; Jiang, H. J. Org. Chem.  2014, 79, 10734-10742. 
 (58) Hintermann, L.; Labonne, A. Synthesis 2007, 2007, 1121-
1150. 
 60 
 (59) (a) Lewis, L. N.; Sy, K. G.; Bryant, G. L.; Donahue, P. E. 
Organometallics 1991, 10, 3750-3759; (b) Zriba, R.; Gandon, V.; Aubert, 
C.; Fensterbank, L.; Malacria, M. Chem. Eur. J.  2008, 14, 1482-1491. 
 (60) Fang, G.; Bi, X. Chem. Soc. Rev.  2015, 44, 8124-8173. 
 (61) Tietze, L. F.; Brasche, G.; Gericke, K. M. Domino Reactions 
in Organic Synthesis; John Wiley & Sons: New York, 2006. 
 (62) Jansone-Popova, S.; May, J. A. J. Am. Chem. Soc. 2012, 134, 
17877-17880. 
 (63) Padwa, A.; Kassir, J. M.; Semones, M. A.; Weingarten, M. D. 
Tetrahedron Lett. 1993, 34, 7853-7856. 
 (64) Padwa, A.; Krumpe, K. E.; Zhi, L. Tetrahedron Lett. 1989, 30, 
2633-2636. 
 (65) Padwa, A.; Weingarten, M. D. J. Org. Chem.  2000, 65, 3722-
3732. 
 (66) (a) Shu, X.-Z.; Shu, D.; Schienebeck, C. M.; Tang, W. Chem. 
Soc. Rev.  2012, 41, 7698-7711; (b) Kazem Shiroodi, R.; Gevorgyan, V. 
Chem. Soc. Rev.  2013, 42, 4991-5001; (c) Dudnik, A. S.; Schwier, T.; 
Gevorgyan, V. Tetrahedron 2009, 65, 1859-1870; (d) Hashmi, A. S. K. 
Chem. Rev. 2007, 107, 3180-3211; (e) Hashmi, A. S. K.; Rudolph, M. 
Chem. Soc. Rev.  2008, 37, 1766-1775. 
 (67) (a) Moreau, X.; Goddard, J.-P.; Bernard, M.; Lemière, G.; 
López-Romero, J. M.; Mainetti, E.; Marion, N.; Mouriès, V.; Thorimbert, 
S.; Fensterbank, L.; Malacria, M. Adv. Synth. Catal.  2008, 350, 43-48; (b) 
Garayalde, D.; Gómez-Bengoa, E.; Huang, X.; Goeke, A.; Nevado, C. J. 
Am. Chem. Soc. 2010, 132, 4720-4730;  (c) Cho, E. J. Chem. Eur. J.  
2012, 18, 4495-4498; (d) Harrak, Y.; Blaszykowski, C.; Bernard, M.; 
Cariou, K.; Mainetti, E.; Mouriès, V.; Dhimane, A.-L.; Fensterbank, L.; 
Malacria, M. J. Am. Chem. Soc. 2004, 126, 8656-8657. 
 (68) Saucy, G.; Marbet, R.; Lindlar, H.; Isler, O. Helv. Chim. Acta. 
1959, 42, 1945-1955. 
 (69) Strickler, H.; Davis, J. B.; Ohloff, G. Helv. Chim. Acta. 1976, 
59, 1328-1332. 
 (70) Rautenstrauch, V. J. Org. Chem.  1984, 49, 950-952. 
 (71) Miki, K.; Ohe, K.; Uemura, S. J. Org. Chem.  2003, 68, 8505-
8513. 
 (72) Zhang, L.; Sun, J.; Kozmin, S. A. Adv. Synth. Catal.  2006, 
348, 2271-2296. 
 (73) (a) Gorin, D. J.; Toste, F. D. Nature 2007, 446, 395-403; 
 bArcadi, A. Chem. Rev. 2008, 108, 3266-3325. 
 (74) Zhang, L. J. Am. Chem. Soc. 2005, 127, 16804-16805. 
 61 
 (75) (a) Pagar, V. V.; Jadhav, A. M.; Liu, R.-S. J. Am. Chem. Soc. 
2011, 133, 20728-20731; (b) Jadhav, A. M.; Pagar, V. V.; Liu, R.-S. 
Angew. Chem., Int. Ed.2012, 51, 11809-11813. 
 (76) Padwa, A.; Kinder, F. R. J. Org. Chem. 1993, 58, 21-28. 
 (77) (a) Jansone-Popova, S.; Le, P. Q.; May, J. A. Tetrahedron 
2014, 70, 4118-4127; (b) Le, P. Q.; May, J. A. J. Am. Chem. Soc. 2015, 
137, 12219-12222. 
 (78) Muthusamy, S.; Sivaguru, M. Org. Lett.2014, 16, 4248-4251. 
 (79) Cui, D.-M.; Zhu, K.; Chen, L.; Qi, L.-J.; Zhang, C.-Z.; Zhang, 
C. Synth. Commun. 2013, 43, 2380-2384;  
(80) Yang, F.; Zhao, G.; Ding, Y.; Zhao, Z.; Zheng, Y. 





Chapter 2: Unprecedented Rearrangement 
of Propargyl Aryldiazoacetates. Gold 
Catalysis Forms Allenes Whose 
Intramolecular Reaction with the Terminal 
Diazo Nitrogen Yields 1,5-Dihydro-4H-
pyrazol-4-ones 
I Introduction  
1.1 Discovery of the Rearrangement Process 
Because of the positioning of their two reaction centers (diazo and 
alkyne), we have been intrigued with the reactions of propargyl 
diazoacetates since both reaction centers are known to initiate reaction 
processes that are characteristic of their requisite functional groups. In 
Chapter 1, we disclosed that a variety of transition metal complexes that 
include Rh2(OAc)4, Rh2(tfa)4, Pd(OAc)2, PdCl2(PhCN)2, [Pd(η
3
-
C₃H₅)Cl]₂, AgSbF6, Au(JohnPhos)SbF6, IPrAuBF4, Cu(OTf)2, 
CuBF4(MeCN)4, and CuPF6(MeCN)4 undergo carbene/alkyne domino 
cascade reactions. During the screening of the transition metal complexes 
with propargyl phenyldiazoacetate, we found that the carbene/alkyne 
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domino cascade product was not observed under catalysis by 
AuCl(C4H8S); but, instead, two isomeric 1H-pyrazolines that retain 
dinitrogen were obtained (Scheme 2.1).  
 
Scheme 2.1 Catalysts Screening Leads to Discovery of the 
Rearrangement Process. 
1.2 General Information for Gold Catalysis 
Gold catalysis provides powerful methodologies for unique 
metallo-organic transformations.
1
 Activation of organic functional groups 
by gold(I) and gold(III) complexes initiates diverse pathways for often 
unique reactions.
2
 Many of the transformations developed with gold 
complexes involve activating carbon-carbon unsaturated bonds as 
electrophiles.
3
 Alkynes have been recognized as the most successful 
substrates in gold catalyzed reactions.
4
 The most common reaction 
pattern involves the coordination of gold complexes with internal alkynes 
that lead to a loss of π-electron density, which allows nucleophilic attack 
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on the activated alkynes to produce trans-alkenyl gold complexes 
(Scheme 2.2).  
 
Scheme 2.2 Equation for Gold-Catalyzed Activation of Alkynes toward a 
variety of Nucleophiles. 
1.3 Gold-Catalyzed 1,3-Acyloxy Migration of Propargyl 
Esters and Subsequent Transformations 
One of the most useful of these transformations has been that of 
propargyl esters, which form allenes by 1,3-acyloxy migration, then 
undergo varied catalytic reactions.
5
 A wide array of subsequent 
transformations that involve this highly valuable intermediate have been 
widely used in constructing mono-, bicycles, and other important 





Scheme 2.3 Formation of Allenes and Subsequent Transformations to 
Form Diverse Carbocycles and Heterocycles. 
II. Results and Discussion 
2.1 Initial Assessment of Gold Catalysts and Attempts to 
Determine the Structure of Rearrangement Products 
Initial assessment of gold catalysis was evaluated with propargyl 
aryldiazoacetates using cationic gold(I) catalysts, including those formed 
from ligated gold(I) chloride and silver salts. Cationic gold catalysts are 
well-established -bond acceptors with aryldiazoacetates,
7
 and they have 
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been widely used for dinitrogen extrusion reactions of diazo compounds 
that are reported to produce the corresponding gold carbenes.
8
 Catalytic 
reactions of phenylpropargyl phenyldiazoacetate 1 with representative 
Au(I)
+
 catalysts formed the product from the carbene-initiated domino 
transformation 2 in good yield (Scheme 2.4). Complete conversion of the 
reactant was observed at room temperature, and no other discernable 
product was identified. Each of the gold catalysts was soluble in the 
reaction solution. 
 
Scheme 2.4 Domino Reaction of Propargyl Phenyldiazoacetate 1 
Catalyzed by Cationic Gold(I). 
Neutral gold(I) and gold(III) compounds are reported to have 
varying influences on reactions with diazo and alkyne functional groups.
9
 
A survey of representative compounds for reactions with 1 at 20 °C 
revealed that 5 mol % of chloro(tetrahydrothiophene)gold(I) 
[AuCl(C4H8S)] catalyzed its complete conversion to three discernable 
products in the highest yield (Scheme 2.5). The surprising conversion of 
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1 to 3 and 4 retained all of the atoms of the reactant but gave extensive 
rearrangement, including the conversion of the reactant ester to product 
1,5-dihydro-4H-pyrazol-4-ones. 
 
Scheme 2.5 Products from Gold(I)-Catalyzed Rearrangement of 
Phenylpropargyl Phenyldiazoacetate 1. 
Compounds 3 and 4 were observed spectroscopically to be related 
as structural isomers, and the crystal structure of 4 was obtained (Figure 
2.1a) after its isolation from the reaction mixture. Recognition of 3 and 4 
as potential benzoyl transfer agents prompted us to convert 3 and 4, 
individually and as a mixture, quantitatively to the same 4-
hydroxypyrazole 6 by treatment with nucleophilic bases that included 
hydrazines and amines (X-Ray structure of analog 6ʹ, Figure 2.1b). 
Compound 5, although present in very low yield, was confirmed by 
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spectral and chromatographic comparison with the characterized 




Figure 2.1 X-Ray Structures of 1,5-Dihydro-4H-Pyrazol-4-One 4 and 
Deacylation Product 6ʹ. 
2.2 Optimization of Reaction Conditions and Monitoring the 
Reaction Process 
Under the catalysis of 5 mol% AuCl(C4H8S), different solvents 
were examined in attempts to increase the yield of 1,5-dihydro-4H-
pyrazol-4-ones as well as improve the ratios of 3:4 at room temperature. 
Use of chloroform and dichloromethane failed to increase product yields 
and resulted in the decreased 3:4 product ratios (Table 2.1, entries 2 and 
3). Toluene gave the improved 3:4 product ratios compared to 1,2-
dichloroethane, but the yield of 1,5-dihydro-4H-pyrazol-4-ones was only 
29% (Table 2.1, entry 4). Polar solvents that include tetrahydrofuran and 
acetonitrile showed lower yield of product, but had a great influence on 
the 3:4 product ratios (Table 2.1, entries 5 and 6). Overall, examination 
of this reaction as a function of solvent did not provide any improvement 
in the product yield, but did show significant variation in the 3:4 product 
ratios.  
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>95 76 72:25 2 
2 Chloroform >95 57 65:35 3 
3 Dichloromethane >95 43 40:60 5 
4 Toluene >95 29 80:20 10 
5 Tetrahydrofuran >95 40 65:35 3 
6 Acetonitrile >95 30 37:63 1 
aReactions were carried out on 0.20 mmol scale: a solution of 1 (0.20 mmol) in 2.0 mL of solvent was added to a 
solution of 5 mol % AuCl(C4H8S) in 2.0 mL of solvent under a nitrogen atmosphere at 20 
oC, and the resulting 
reaction mixture was stirred for 72 h. bNo reaction occurred for reactions performed in hexane or nitromethane. 
cConversion of 1, yields of (3+4), 5. Ratios 3:4 were determined by 1H NMR analysis of characteristic peaks using 
2,4,6-trimethoxybenzene as the internal standard. 
To determine if this product variation could be due to an 
equilibrium between 3 and 4 under the reaction conditions, the formation 
of 3 and 4 in DCE was followed as a function of time over ten days at 
room temperature with high product accountability, and the results from 
this investigation (Figure 2.2) clearly show an equilibrium between 3 and 
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4. Slow deacylation resulting in 6 complicates the overall picture, but 
conclusions can be drawn that compound 3 is the product of kinetic 




Figure 2.2 Time Course for the Formation of 3, 4, and 6 in DCE at 20 ⁰C. 
(Yields were determined by 
1
H NMR and HPLC analyses of the reaction 
mixture after selected periods of time using 1,3,5-trimethoxybenzene as 
the internal standard; reported yields are the averages of two runs; 
reactions and analyses performed by Kostiantyn Marichev.) 
Experiments performed at higher temperatures (50 and 84 °C) are 
consistent with this interpretation (Table 2.2). Compound 4 is the major 
isomer even at lower conversions of diazo compound 1. At 50 °C the 
maximum total yield of 3+4 is 81% at a 12 h reaction time, and the ratio 
3:4 is 2:3; whereas at 84 °C the reaction is complete (total yield of 3+4 is 
80%) after 6 h, and 3:4 is 1:1. Continuing the reaction further at these 
higher temperatures leads to lower product yield as the result of 
deacylation from which 4-hydroxypyrazole 6 is formed. 
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1 50 3 35 45:55 
2 50 6 56 42:58 
3 50 12 81 40:60 
4 50 24 64 37:63 
5 84 3 53 48:52 
6 84 6 80 45:55 
7 84 12 79 43:57 
8 84 24 48 45:55 
a
Reactions were carried out on 0.20 mmol scale: a solution of 1 (0.20 mmol) in 2.0 mL of 
solvent was added to a solution of 5 mol % AuCl(C4H8S) in 2.0 mL of solvent under a 
nitrogen atmosphere at 20 
o
C, and the resulting reaction mixture was heated for defined 
periods of time. 
b
Yields and ratios were determined by 
1
H NMR analyses of the reaction 
mixture using 1,3,5-trimethoxybenzene as the internal standard. 
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Cationic gold(I) and the neutral chloro(tetrahydrothiophene)gold(I) 
catalysts are mutually exclusive for product formation from reactions 
with 1. Both catalysts are active at room temperature, and their 
application provides products from reactions at the diazo functional 
group [2 from cationic gold(I)] and the alkyne functional group [3, 4, and 
5 from AuCl(C4H8S)] in good yields. Neutral gold(I) chloride complexes 
having strongly coordinating ligands (Table 2.3) show very low or 
negligible conversion of phenylpropargyl phenyldiazoacetate 1 under the 
same conditions, even to reaction times of three days. However, heating 
these complexes to the temperature of refluxing 1,2-dichloroethane for up 
to 48 h gives the domino reaction product 2 exclusively or as the major 
product (Table 2.3, entries 1-6), albeit usually with low product yield 
and, generally, low % conversion. The dimethylsulfide coordinated AuCl 
(Table 2.3, entries 9-10) is not as effective a catalyst as its 
tetrahydrothiophene analog (Table 2.3, entries 7-8) with product yields 
only about half those found with AuCl(C4H8S). Gold(III) catalysts (Table 
2.3, entries 11-14) are also less efficient than the AuCl(R2S) catalysts in 
the formation of compounds 3 and 4, but they afford diene 5 in yields up 
to 39% and give no evidence for the formation of 2. 
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Table 2.3 Screening of Gold(I) and Gold(III) Catalysts in Reactions with 
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>95  76 75:25 2 
8 AuCl(C4H8S) 84 >95  80 45:55 4 
9
 
AuCl(Me2S) 20 >95  42 62:38 3 





















 84 >95  18 45:55 39 
aReactions were performed on 0.10 mmol scale: a solution of 1 (0.10 mmol) in DCE (1.0 mL) was added to a 
solution of Au-catalyst (5 mol %) in DCE (1.0 mL) under a nitrogen atmosphere at 20 °C (% conversion in 
parenthesis for entries 1-6) or in refluxing DCE, and the resulting reaction mixture was stirred for defined periods 
of time. bConversion of 1, yields of 2, (3+4), 5, and ratios 3:4 were determined by 1H NMR analysis of 
characteristic peaks using 2,4,6-trimethoxybenzene as the internal standard. Reaction times were 72 h for the 
reactions carried out at 20 °C, and 6 h at 84 °C. Reaction times: c12 h; d48 h. Yield of product 6: e24%; f27%; 
g32%; h38%. iAt 50 °C after 12 h: 81% yield of 3+4 with 3:4 = 40:60. jReduction of the catalyst to elemental gold 
is significant. 
 
2.3 Reaction Mechanism  
A stepwise mechanism for the neutral gold(I)-catalyzed 
rearrangement of arylpropargyl aryldiazoacetate 9 is given in Scheme 
2.6. The AuCl(R2S) catalyzed 1,3-acyloxy rearrangement of 9 produces 
carboxyallene C that undergoes a unique rearrangement between allene C 
and the diazo functional group to form the observed 3 directly in a 
concerted fashion or stepwise through intermediate D. Diene 12 is 
formed from gold-activated carboxyallene A, presumably through gold-
coordinated acylium ion intermediate B. Compound 10 is formed initially 
from A and undergoes acyl migration to reach equilibrium with 11. This 
mechanism explains the formation of 10 from carboxyallene C, the 
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equilibrium that exists between 10 and 11, and the formation of (Z)-diene 
12. 
 
Scheme 2.6 Proposed Mechanism for the Formation of 10, 11, and 12 
from 9. 
2.3a Formation of Allene  
Close examination of the reaction process by NMR spectroscopy 
revealed that the key transformation in the formation of 3 and 4 was the 
generation of allene (Scheme 2.6), which occurred within 5 min at 20 C. 
For these investigations the dimethyl analog (7) of cyclopentylpropargyl 
phenyldiazoacetate 1 was used (Eq 1) to assess the course of the reaction. 
Allene 8 formation,
6b
 which occurs by 1,3-acyloxy transfer, begins to 
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take place immediately upon addition of the catalyst [5 mol % 
AuCl(Me2S) or AuCl(C4H8S)] as the only reaction product, and reaches 
an apparent equilibrium (7:8 = 45:55 with either catalyst).  
 
With added gold catalyst up to 2 equiv. based on 7 no further 
change in the 7:8 ratio occurred. Confirmation of this process was made 
with phenyldimethylpropargyl benzoate under the same conditions 
(allene:alkyne = 3:2) and with 1 (allene:alkyne = 1:2).  
The validity of the reversibility of Au(I)-catalyzed [3,3]-
rearrangements of propargylic esters has been reported by Toste and 
coworkers.
6h
 By introducing a stereochemically defined cyclopropane 
probe, the authors have disclosed both isomerization of the cyclopropyl 
moiety and propargyl moiety which indicates the reversibility of the 
gold(I)-catalyzed rearrangement propargylic esters. DFT studies on the 
reversibility of propargylic esters supported the experimental evidence. 
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Scheme 2.7 Further Insight into the Mechanism of Au(I)-Catalyzed 
[3,3]-Rearrangements of Propargylic Esters 
With propargyl diazoacetates additional stabilization by the diazo 
group of the cyclic carbocation intermediate on the pathway to allene 
formation could be expected. Furthermore, when the allene was isolated 
from the reaction mixture free of gold catalyst, the allene was observed to 
undergo slow conversion to the rearranged products corresponding to 3 
and 4, but without any obvious formation of 5. This conversion was first 
order in 7 with a rate constant of 1.05 × 10−5 sec−1 at 20 °C, and addition 
of AuCl(Me2S) did not influence the reaction rate. The activation energy 
measured over 20−60 °C was 18.8 kcal/mol (R
2
 = 0.999) with ΔH
‡
 = 18.2 
kcal/mol and ΔS
‡
 = −19.4 cal/deg-mol at 298 K (reaction and analysis 
performed by Kostiantyn Marichev).  
2.3b Diazo Compounds as Electrophiles in Organic Transformations 
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Although diazo compounds are normally regarded as nucleophiles, 
with both the diazo carbon and the terminal nitrogen as nucleophilic 
centers,
11
 there are examples in which the terminal nitrogen atom of diazo 
compounds exhibits electrophilic reactivity.
12
 The formation of 10 can be 
considered to be initiated by intramolecular electrophilic addition of the 
N-terminus of the aryldiazoacetates onto the central carbon of the allene 
that is continued with hydrogen. 
 
Feng and coworkers discovered a scandium-catalyzed nucleophilic 
addition to α-diazoesters, in which ketones were the nucleophiles.
13
 With 
chiral N,N’-dioxide as the ligands for Sc(OTf)3, the reaction produces the 
addition products in excellent yields and enantioselectivities. To better  
understand this unusual process, the authors performed theoretical 
calculations, which showed that the positive charge on the terminal 
nitrogen atom greatly increases when the carbonyl oxygen of α-
diazoesters coordinates with Sc(OTf)3 These reactions are intermolecular 
and involve obvious nucleophilic attack on the terminal nitrogen of 
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diazocarbonyl compounds and result in the formation of hydrazone 
derivatives (Scheme 2.8). 
 
Scheme 2.8 Intermolecular Electrophilic Addition of α-Diazoesters with 
Ketones. 
The intramolecular transformations that involve the electrophilic 
capability of diazo compounds are also documented in several other 
reports,
14
 which are also referred to as electrocyclization of the diazo 
group.
15
 For instance, in the process of investigating synthetic 
applications of benzocyclobutenes, Nemoto and coworkers have 
developed a one-pot reaction for synthesis of 2,3-benzodiazepines. In this 
reaction, the electrophilic capability of diazo compounds plays an 
important role in the formation of the cyclic product, which was 
obviously formed by intramolecular nucleophilic addition to the terminal 
nitrogen of the diazo group (Scheme 2.9).
15b
 Enolates were also reported 
as efficient nucleophiles in the reactions with diazo compounds by Doyle 
and coworkers, who have discovered that the enedione-diazoester 
undergoes intramolecular cycloaddition reaction to produce 1,2-diazepine 
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under basic conditions. The authors proposed a mechanism by which a 





Scheme 2.9 Synthesis of 2,3-Benzodiazepines from Benzocyclobutenes 
 
Scheme 2.10 Synthesis of 1,2-Diazepine from Enedione-Diazoester. 
2.3c Formation of 1,3-Diene 
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Isomerization of allenes into 1,3-dienes under the catalysis of gold 
complexes has been reported previously.
16
 Gold-allene complexes are 
considered to be the initial intermediates in these transformations. Based 
on those reports,
17
 we propose a plausible mechanism for formation of 
1,3-diene 12. The (Z)-diene 12 was considered to be generated from 
gold-allene complexes A, presumably through gold-coordinated acylium 
ion intermediate B. Acylium ion intermediate B underwent 
intermolecular 1,5-hydrogen shift, which produced the (Z)-diene-gold 
complex Bʹ, followed by a proton transfer process of the newly formed 
(Z)-diene-gold complex Bʹ, to furnish (Z)-diene 12. It should be noted 
that when the same reaction was performed in the presence of 4-
chloropyridine-N-oxide, the isomeric (E)-diene could be observed 
(discussed in next chapter).  
Rearrangement of propargyl esters into 1,3-dienes in presence of 
gold catalysts has also been documented,
18
 and this rearrangement has 
been considered to occur though allene intermediates. Gevorgyan and 
coworkers developed a cascade process of double 1,3-acyloxy group 
migration/1,2-migration of hydrogen to produce (E)-1,3-dienes from 
alkynes via a gold-catalyzed cycloisomerization of propargylic esters. 
The authors proposed a pathway in which a gold-catalyzed 1,3-acyloxy 
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migration occurs via cyclic intermediates into allenes, followed by 
hydrogen migration to produce the (Z)-1,3-dienes (Scheme 2.11). 
 
Scheme 2.11 Formation of 1,3-diene from Gold-Catalyzed Propargyl 
Esters. 
2.4 Substrate Scope 
The substrate scope of phenylpropargyl aryldiazoacetates 9a─k 
(Table 2.4) demonstrates that the AuCl(C4H8S)-catalyzed reaction is 
broadly appropriate for the synthesis of the 1,5-dihydro-4H-pyrazol-4-
ones 10 and 11, and these reactions are tolerant of both electron-donating 
and electron-withdrawing substituents in the aryl group of the 
aryldiazoacetate. High total yields of the 10+11 composites are observed, 
and their 10:11 ratio is near 3:1 (Table 2.4). Substrate 9j with a 12-
membered ring gives a high yield of the 10j+11j composite, but its 10:11 
ratio is 3:2. Tetrahydropyranyl derivatives 10k+11k are obtained in only 
46% yield and a 78:22 10:11 ratio. 









a C6H5 76 75:25 
b p-MeO-C6H4 75 72:28 
c p-Me-C6H4 85 72:28 
d p-Ph-C6H4 78 88:12 
e p-Br-C6H4 87 85:15 
f p-Cl-C6H4 83 83:17 









i (CH2)2 73 78:22 
j (CH2)8 86 59:41 
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k CH2O 46 78:22 
aReactions were carried out at 20 °C on a 0.20 mmol scale: a solution of 1 in 2.0 mL DCE was added to a 5 mol % 
solution of AuCl(C4H8S) in 2.0 mL DCE under a nitrogen atmosphere, and the resulting reaction mixture was 
stirred for 72 h. bRatios and yields were determined by 1H NMR spectroscopy using 2,4,6-
trimethoxybenzaldehyde as the internal standard. cIndividual compounds 10 and 11 were isolated and fully 
characterized (see Supporting Information). d2-C4H3S = 2-Thiophene. 
 
With substrates having electron-withdrawing or electron-donating 
groups (EWG or EDG) in both arene rings, the product outcome is quite 
similar (Scheme 2.12) to those presented in Table 2.4. However, having 
an EWG as Z and an EDG as X (compound 9o) results in a lower yield of 
10o+11o (47%) but a higher 10:11 ratio of 89:11. High yield (79%) and 
almost exclusive formation of compound 10q (10:11 = 91:9) are observed 
from the dimethyl analog 9q, whereas the unsubstituted aryl analog 9p 
results in lower yield of 10p+11p (68%) with a 88:12 10:11 ratio. 
 
Scheme 2.12 Substrate Scope of Gold(I)-Catalyzed Reaction of 
Arylpropargyl Aryldiazoacetates 9. 
 85 
The cyclobutyl analog 9r forms neither 10 nor 11. Instead, 
treatment of 9r with 5 mol % AuCl(C4H8S) affords 13 in good yield 
(70%), but only at 80 °C over 12 h. This product is consistent with initial 
formation of a gold-carbene intermediate through the diazo functional 
group. The alternate pathway through a strained allene intermediate is 
apparently too restrictive and, although the initial step in the 1,3-acyl 
rearrangement that produces the stabilized intermediate E is favorable, 
release of the C-O bond to form the allene does not occur (Scheme 2.13). 
 
Scheme 2.13 Outcome of Gold(I)-Catalyzed Reaction of Cyclobutyl 
Propargyl Reactant 9r. 
III. Conclusion 
We have discovered a unique gold(I)-catalyzed rearrangement of 
propargyl aryldiazoacetates and a platform on which catalytic activity of 
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gold complexes can be assessed. Phenylpropargyl phenyldiazoacetates 
have two reactive sites for reactions with gold complexes. If initial 
interaction occurs at the diazo carbon, a gold carbene is the outcome, and 
a subsequent cascade process results in the formation of a product that is 
uniquely characteristic of this pathway. If gold coordination occurs with 
the carbon-carbon triple bond, 1,3-acyloxy migration of the propargylic 
ester promoted by the diazoester takes place. The corresponding allene 
formed rapidly is a stable intermediate, and it determines the course of 
subsequent processes, one of which is to undergo gold-catalyzed 
formation of a gold-acylacylium ion intermediate to form stable products 
by cleavage or intramolecular hydrogen migration. Alternatively, the 
allene intermediate undergoes a complex transformation, not catalyzed by 
gold, in which the terminal nitrogen of the diazo functional group adds at 
the central carbon of the allene to initiate a sequence of bond forming 
reactions resulting in the production of 1,5-dihydro-4H-pyrazol-4-ones in 
good yields. As acyl transfer agents these unique products undergo 
intramolecular 1,3-acyl migration to form an equilibrium mixture of two 
isomeric 1,5-dihydro-4H-pyrazol-4-ones under the reaction conditions or 
quantitatively transfer the acyl group to an external nucleophile with 
formation of 4-hydroxypyrazoles. Cationic gold(I) complexes initiate 
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their reactions at room temperature exclusively with the diazo functional 
group of propargyl phenyldiazoacetates, whereas both AuCl(R2S) and 
gold(III) catalysts undergo initial reaction exclusively at the carbon-
carbon triple bond. Neutral gold(I) chloride complexes having strongly 
coordinating ligands show very low or negligible conversion of propargyl 
phenyldiazoacetates at room temperature, but they undergo slow reaction 
at higher temperatures to give mainly the product from reaction at the 
diazo functional group, which may have occurred after chloride 
dissociation,
19
 sometimes in competition with products from reaction at 
the carbon-carbon triple bond. 
IV. Experimental Section 
4.1 General Information 
Unless noted all reactions were carried out under inert atmosphere 
of dinitrogen in oven-dried glassware with magnetic stirring using freshly 
distilled solvents. All solvents were purified and dried using standard 
methods. Analytical thin layer chromatography (TLC) plates were 
purchased from EM Science (silica gel 60 F254 plates). High-resolution 
mass spectra (HRMS) were performed on a microTOF-ESI mass 
spectrometer using CsI as the standard. Accurate masses are reported for 






. Melting points were 
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determined on an Electrothermo Mel-Temp DLX 104 device and were 
uncorrected. Column chromatography was performed on CombiFlash
®
 
Rf 200 purification system using normal phase disposable columns. IR 
spectra were recorded using Bruker Vector 22 spectrometer. All NMR 
spectra were recorded on a Bruker spectrometer at 400 MHz (
1
H NMR) 
and 100 MHz (
13
C NMR) or an Agilent spectrometer at 500 MHz (
1
H 
NMR) and 125 MHz (
13
C NMR). Chemical shifts are reported in ppm 
with the solvent signals as reference (in CDCl3 as solvent), and coupling 
constants (J) are given in Hertz (Hz). The peak information is described 
as: br = broad singlet, s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, comp = composite of magnetically non-equivalent protons. 
4.2 Materials 
AuCl(PPh3), AuCl(PMe3), AuCl[P(OMe)3], Chloro[2-
dicyclohexyl(2′,6′-dimethoxybiphenyl)phosphine] gold(I), and AuPicCl2 
were purchased from Sigma-Aldrich; AuCl(C4H8S), AuCl(Me2S), 
AuCl(CO), (IPr)AuCl, and AuCl3(Py) were purchased from Strem 
Chemicals. All other chemicals were obtained from commercial sources 
and used as received without further purification.  
4.3 Experimental Procedures. 
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General Procedure for Gold(I)-Catalyzed Domino Cascade 
Transformation of Phenylpropargyl Phenyldiazoacetates 1: To a 
flame-dried 10 mL Schlenk flask charged with a magnetic stirring bar 
cationic gold(I) catalyst (0.010 mmol) and 2.0 mL DCM were added 
under nitrogen atmosphere. 1-(Phenylethynyl)cyclopentyl 2-diazo-2-
phenylacetate 1 (0.20 mmol) dissolved in 2.0 mL of DCM was added in 
one portion into the solution under the flow of nitrogen. The resulting 
mixture was stirred for 12 h at room temperature (20 °C); the reaction 
mixture was purified by column chromatography (100:1 to 10:1 gradient 
of hexanes:ethyl acetate as eluents) to afford pure 8'-




General Procedure for the Synthesis of 1,5-Dihydro-4H-
pyrazol-4-ones 10 and 11: To a flame-dried 10 mL Schlenk flask 
charged with a magnetic stirring bar, AuCl(C4H8S) catalyst (0.010 mmol) 
and 2.0 mL DCE were added under nitrogen atmosphere. Propargyl 
aryldiazoacetate 1 or 9 (0.20 mmol) dissolved in 2.0 mL of DCE was 
added in one portion into the solution under the flow of nitrogen. The 
resulting mixture was stirred for 72 h at room temperature (20 °C). 
Solvent was evaporated, and products were purified by column 
chromatography (100:1 to 10:1 gradient of hexanes: ethyl acetate as 
eluents) to afford pure compounds 10 and 11.  
 
Procedure for the Synthesis of 6d from a Reaction Mixture 
Containing 10d and 11d: To the reaction mixture after the gold(I)-
catalyzed reaction of 9d that contained 1,5-dihydro-4H-pyrazol-4-ones 
10d and 11d (156 mg, 0.384 mmol) of in DCE (8.0 mL) benzylamine 
(49.4 mg, 0.461 mmol) dissolved in DCE (0.5 mL) was added in one 
portion under a nitrogen atmosphere. The resulting mixture was stirred at 
20 °C for 2 h, and the white precipitate of 6' was formed. The precipitate 
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of 6' was dissolved by adding methanol (5.0 mL); the solution was 
filtered through Celite to remove gold particles. Solvents were 
evaporated, and the obtained mixture of products 6' and N-
benzylbenzamide was separated by column chromatography using 
hexanes/ethyl acetate (v/v 2:1) as the eluent to afford 3-([1,1'-biphenyl]-
4-yl)-5-(cyclopent-1-en-1-yl)-1H-pyrazol-4-ol 6'. 
Procedure for the Synthesis of 6' from Pure 10d: To a solution 
of 10d (81.0 mg, 0.200 mmol) in DCE (4.0 mL) benzylamine (25.7 mg, 
0.240 mmol) dissolved in DCE (0.3 mL) was added in one portion under 
a nitrogen atmosphere. The resulting mixture was stirred at 20 °C for 2 h. 
Afterward, DCE was evaporated, and the obtained mixture of products 6' 
and N-benzylbenzamide was separated by column chromatography using 
hexanes/ethyl acetate (v/v 2:1) as the eluent to afford compound 6' (54.0 
mg, 89% yield). 
Table 2.5 Deacylation of 10d and 11d by Nucleophiles 
Entry Substrate Nucleophile Isolated yield (%) 6' 
1
a
 10d+11d PhNHNH2 80 
2
a







4 10d BnNH2 89 
5 11d BnNH2 88 
6 10d CyNH2 90 
7 11d CyNH2 86 
aIsolated yields are given only for the deacylation reaction. bThe reaction was carried out at 65 °C for 12h. 
4.4 Kinetic Experiments  
Rate constants for the conversion of 8 to 10q were determined by 
1
H 
NMR spectroscopy. The equilibrium mixture 7+8 was formed by 
treatment of 7 (0.1 mmol) with 5 mol % AuCl(Me2S) in DCM. After 5 
min the mixture 7+8 was separated from gold via silica gel column 
chromatography (with 19:1 to 9:1 gradient of hexanes:ethyl acetate as 
eluents). Solvents were evaporated under vacuum at room temperature to 
afford pure mixture 7+8 (See 
1
H NMR and 
13
C NMR spectra confirming 




Data collection for the intramolecular conversion of 8 to 10p was 
performed at at 20 ⁰C: since 7 is stable in CDCl3 in the absence of 
catalyst and not self-reactive, we decided to use the mixture 7+8 for data 
collection with 7 as the internal standard. The obtained mixture of 7+8 
was dissolved in 0.35 mL CDCl3 and placed in an NMR tube. The ratio 
of 7 [following peak at δ 1.86 (s, 6H, CH3) ppm] to 8 [following peak at δ 
1.98 (s, 6H, CH3) ppm] and % conversion of 8 to 10p (Figure 2.3) were 
determined by 
1








 at 20 ⁰C was 
calculated from the plot of ln[8]/[8t=0] vs. time (Figure 2.4). 
Other first-order rate constants at different temperatures [40 ⁰C 
(Figure 2.5), 45 ⁰C (Figure 2.6), 60 ⁰C (Figure 2.7)] were determined in 
the same way: an NMR tube with CDCl3 solution of 7+8 was placed into 
an oil bath with a temperature stability of ±1 ⁰C. Temperature control at 
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60 ⁰C was provided by the Agilent 500 MHz spectrometer with a 
temperature stability of ±0.1 ⁰C.  
An Arrhenius plot (Table 2.6, Figure 2.8) was obtained from the 
first-order rate constants determined at the corresponding temperatures. 
The activation energy Eact = 18.8 kcal/mol (R
2
 = 0.999) was calculated 
from the slope of Arrhenius plot (Eact = −slope × R). ΔH
‡
 = 18.2 kcal/mol 
and ΔS
‡
 = −19.4 cal/deg-mol
 





Figure 2.3 Stacked 
1
H NMR Spectra: Determination of Rate Constant for 




Figure 2.4 First-order Rate Constant at 20 ⁰C. (k = 1.05 × 10-5 s-1) 
 
Figure 2.5 First-order Rate Constant at 40 ⁰C. (k = 7.67 × 10-5 s-1) 
 
Figure 2.6 First-order Rate Constant at 45 ⁰C. (k = 1.19 × 10-4 s-1) 
 
Figure 2.7 First-order Rate Constant at 60 ⁰C. (k = 5.17 × 10-4 s-1) 
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Table 2.6 Data for Arrhenius Plot Measured within 20−60 ⁰C 
lnk −11.46 −9.48 −9.04 −7.57 
1/T, K
-1 
0.003413 0.003195 0.003145 0.003003 
 
 
Figure 2.8 Arrhenius Plot: Compound 8 Activation Energy. 














0 0 0 0 0 
3 13 2 1 16 
6 19 5 2.5 26.5 
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12 26.5 7 3 36.5 
24 39.5 9.5 4 53 
36 47 12.5 4 63.5 
48 51 15.5 4 70.5 
60 54 17.5 4 75.5 
72 56 20 5 81 
84 55 22.5 5 82.5 
96 50.5 25.5 7 83 
108 45 29.5 8 82.5 
120 40.5 32 10 82.5 
132 37 33 11 81 
144 35 34 11 80 
156 33 34 12 79 
168 31.5 35.5 12 79 
180 30 36.5 12.5 79 
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192 29 38 12.5 79.5 
204 28 39 13 80 
216 28 40 12.5 80.5 
228 28 40 12.5 80.5 
240 28 40 12.5 80.5 
aRecords the formation of 3, 4, and 6 in DCE at 20 ºC in reactions of 1 with 5 mol % AuCl(C4H8S). Yields were 
determined by 1H NMR analyses of the reaction mixture at the recorded times in the presence of 1,3,5-
trimethoxybenzene as the internal standard. Reported yields are the averages of two runs. aYield of 5 was about 
2−3% and remained constant within 10 days. 
4.5 Characterization Data for New Compounds 
 
1-(Phenylethynyl)cyclopentyl 2-Diazo-2-(thiophen-2-yl)acetate 
9h: 52% yield. Dark-red oil. 
1
H NMR (500 MHz, CDCl3) δ 7.46 (dd, J = 
6.4, 2.9 Hz, 2H), 7.34 – 7.28 (m, 4H), 7.07 – 7.03 (m, 1H), 6.84 (d, J = 
3.6 Hz, 1H), 2.49 – 2.41 (m, 2H), 2.31 (dt, J = 15.3, 7.7 Hz, 2H), 1.87 – 
1.81 (m, 4H). 
13
C NMR (126 MHz, CDCl3) δ 163.38, 131.85, 128.34, 
128.12, 126.90, 125.92, 125.44, 122.61, 120.88, 89.03, 85.33, 82.90, 
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40.76, 23.43. IR (neat) 2928, 2076, 1701, 1443, 1285, 1231, 1127, 974, 
691 cm
-1
; HRMS (ESI) m/z calculated for C19H16N2O2SNa [M+Na]
+
 
359.0825, found: 359.0822. 
 
1-(Phenylethynyl)cyclododecyl 2-Diazo-2-phenylacetate 9j: 62% 
yield. Yellow solid, m.p. 92.5 – 93.5 °C. 
1
H NMR (500 MHz, CDCl3) δ 
7.53 (dd, J = 7.6, 0.9 Hz, 2H), 7.50 – 7.44 (comp, 2H), 7.42 – 7.35 (comp, 
2H), 7.34 – 7.27 (comp, 3H), 7.19 (ddd, J = 8.6, 2.2, 1.1 Hz, 1H), 2.37 – 
2.23 (comp, 2H), 2.12 – 1.98 (comp, 2H), 1.68 (d, J = 8.8 Hz, 2H), 1.43 
(comp, 16H).
 13
C NMR (126 MHz, CDCl3) δ 163.08, 131.87, 128.85, 
128.31, 128.14, 125.79, 125.66, 124.01, 122.71, 89.38, 86.21, 79.61, 
33.36, 26.08, 25.86, 22.29, 22.07, 19.44. IR (neat) 2928, 2079, 1705, 
1470, 1241, 1146, 1006, 754 cm
-1
; HRMS (ESI) m/z calculated for 
C28H32N2O2Na [M+Na]
+




phenylacetate 9k: 65% yield. Yellow solid, m.p. 85 – 86 °C. 
1
H NMR 
(500 MHz, CDCl3) δ 7.57 – 7.45 (comp, 4H), 7.44 – 7.36 (comp, 2H), 
7.36 – 7.28 (comp, 3H), 7.23 – 7.17 (m, 1H), 3.93 (dt, J = 9.2, 4.4 Hz, 
2H), 3.85 (ddd, J = 11.9, 9.0, 2.9 Hz, 2H), 2.45 – 2.38 (comp, 2H), 2.23 
(ddd, J = 13.1, 9.0, 4.0 Hz, 2H).
 13
C NMR (126 MHz, CDCl3) δ 163.00, 
131.92, 128.92, 128.70, 128.24, 125.89, 125.43, 124.07, 122.15, 87.48, 
87.46, 74.12, 64.51, 37.96. IR (neat) 2960, 2086, 1707, 1498, 1241, 1140, 
755 cm
-1
; HRMS (ESI) m/z calculated for C21H18N2O3Na [M+Na]
+
 




methoxyphenyl)acetate 9n: 58% yield. Orange oil. 
1
H NMR (500 MHz, 
CDCl3) δ 7.41 (dd, J = 10.1, 9.0 Hz, 4H), 6.94 (d, J = 9.0 Hz, 2H), 6.82 
(d, J = 8.9 Hz, 2H), 3.81 (s, 3H), 3.80 (s, 3H), 2.46 – 2.37 (m, 2H), 2.34 – 
2.24 (m, 2H), 1.87 – 1.78 (m, 4H).
 13
C NMR (126 MHz, CDCl3) δ 164.08, 
159.61, 157.94, 133.33, 125.86, 117.13, 114.84, 114.54, 113.75, 88.06, 
84.91, 82.25, 55.34, 55.25, 40.83, 23.45. IR (neat) 2956, 2080, 1703, 
1511, 1248, 1147, 830, 734 cm
-1
; HRMS (ESI) m/z calculated for 
C23H22N2O4Na [M+Na]
+
 413.1472, found: 413.1483. 
 
1-((4-Methoxyphenyl)ethynyl)cyclopentyl 2-Diazo-2-(4-
(trifluoromethyl)phenyl)acetate 9o: 55% yield. Orange oil. 
1
H NMR 
(500 MHz, CDCl3) δ 7.72 – 7.52 (comp, 4H), 7.40 (d, J = 8.6 Hz, 2H), 
6.83 (d, J = 8.7 Hz, 2H), 3.81 (s, 3H), 2.50 – 2.37 (comp, 2H), 2.37 – 
2.22 (comp, 2H), 1.85 (comp, 4H).
 13
C NMR (126 MHz, CDCl3) δ 162.76, 
159.72, 133.34, 130.32, 127.47 (q, J = 32.5 Hz), 125.73 (q, J = 3.8 Hz), 
 101 
123.45, 114.62, 113.79, 87.63, 85.31, 82.90, 77.26, 77.00, 76.75, 55.25, 
40.82, 23.44. IR (neat) 2957, 2087, 1706, 1509, 1323, 1244, 1070, 832 
cm
-1
; HRMS (ESI) m/z calculated for C23H19F3N2O2Na [M+Na]
+
 
451.1240, found: 451.1225. 
 
2-Methyl-4-phenylbut-3-yn-2-yl 2-Diazo-2-(4-
methoxyphenyl)acetate 9q: 68% yield. Orange oil. 
1
H NMR (500 MHz, 
CDCl3) δ 7.49 – 7.44 (comp, 2H), 7.42 (d, J = 9.0 Hz, 2H), 7.34 – 7.28 
(comp, 3H), 6.95 (d, J = 9.0 Hz, 2H), 3.82 (s, 3H), 1.85 (s, 6H).
 13
C NMR 
(126 MHz, CDCl3) δ 163.90, 157.97, 131.85, 128.36, 128.14, 125.94, 
122.56, 117.15, 114.55, 90.05, 84.39, 73.66, 55.35, 29.45. IR (neat) 2988, 
2079, 1705, 1514, 1258, 1122, 998, 827 cm
-1
; HRMS (ESI) m/z 
calculated for C20H18N2O3Na [M+Na]
+





pyrazol-4-one 3: 57% yield. Yellow solid, m.p. 115–116 °C. 
1
H NMR 
(500 MHz, CDCl3) δ 8.18 (dd, J = 7.9, 1.2 Hz, 2H), 8.08 (dd, J = 7.9, 1.2 
Hz, 2H), 7.90 (br, 1H), 7.62 – 7.57 (m, 1H), 7.47 (t, J = 7.7 Hz, 2H), 7.42 
– 7.36 (comp, 3H), 5.88 – 5.84 (m, 1H), 2.50 – 2.41 (comp, 3H), 2.35 – 
2.29 (m, 1H), 1.98 – 1.89 (comp, 2H).
 13
C NMR (126 MHz, CDCl3) δ 
192.05, 189.74, 143.83, 138.50, 133.97, 133.43, 131.63, 130.71, 129.19, 
129.09, 128.49, 128.35, 125.98, 81.54, 32.43, 32.42, 22.96. IR (neat) 
3358, 1721, 1674, 1246, 903 cm
-1
; HRMS (ESI) m/z calculated for 
C21H18N2O2Na [M+Na]
+
 353.1260, found: 353.1247. 
 
5-Benzoyl-3-(cyclopent-1-en-1-yl)-5-phenyl-1,5-dihydro-4H-
pyrazol-4-one 4: 19% yield. Yellow solid, m.p. 130–131 °C. 
1
H NMR 
(500 MHz, CDCl3) δ 7.84 (d, J = 7.5 Hz, 2H), 7.66 (br, 1H), 7.50 (t, J = 
7.5 Hz, 1H), 7.42 – 7.33 (comp, 7H), 6.84 – 6.80 (m, 1H), 2.75 – 2.70 
(comp, 2H), 2.56 – 2.49 (comp, 2H), 1.96 – 1.89 (comp, 2H).
 13
C NMR 
(126 MHz, CDCl3) δ 192.74, 189.45, 143.16, 135.74, 134.05, 133.70, 
133.07, 131.98, 130.94, 129.49, 128.79, 128.46, 126.49, 81.80, 34.07, 
 103 
32.68, 22.20. IR (neat) 3343, 1732, 1675, 1447, 1231, 738 cm
-1
; HRMS 
(ESI) m/z calculated for C21H18N2O2Na [M+Na]
+




dihydro-4H-pyrazol-4-one 10b: 54% yield. Yellow solid, m.p. 44–
46 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.18 (d, J = 7.3 Hz, 2H), 8.03 (d, J 
= 9.0 Hz, 2H), 7.73 (s, 1H), 7.62 – 7.56 (m, 1H), 7.50 – 7.44 (comp, 2H), 
6.92 (d, J = 9.0 Hz, 2H), 5.87 – 5.82 (m, 1H), 3.84 (s, 3H), 2.52 – 2.39 
(comp, 3H), 2.31 (dddd, J = 17.5, 9.3, 5.8, 2.1 Hz, 1H), 2.02 – 1.84 
(comp, 2H).
 13
C NMR (126 MHz, CDCl3) δ 192.53, 189.89, 160.49, 
144.20, 138.71, 133.93, 133.48, 131.43, 130.72, 128.34, 127.58, 121.69, 
113.96, 81.31, 55.30, 32.46, 32.43, 22.96. IR (neat) 3338, 2931, 1712, 
1674, 1608, 1510, 1251, 1176, 835 cm
-1
; HRMS (EI) m/z calculated for 
C22H19N2O3 [M−H]
−




dihydro-4H-pyrazol-4-one 11b: 21% yield. Yellow solid, m.p. 60.5–
61.5 °C. 
1
H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 8.5 Hz, 2H), 7.73 (s, 
1H), 7.53 – 7.47 (m, 1H), 7.36 (dd, J = 11.7, 4.0 Hz, 2H), 7.26 (d, J = 7.8 
Hz, 2H), 6.92 (d, J = 7.8 Hz, 2H), 6.82-6.81 (m, 1H), 3.80 (s, 3H), 2.76 – 
2.68 (m, 2H), 2.52 (d, J = 5.6 Hz, 2H), 1.96 – 1.88 (m, 2H).
 13
C NMR 
(126 MHz, CDCl3) δ 193.12, 189.71, 159.84, 143.16, 133.85, 133.64, 
133.12, 132.07, 131.02, 128.42, 127.87, 127.78, 114.89, 81.58, 55.31, 
34.07, 32.69, 22.21. IR (neat) 3344, 2954, 1736, 1673, 1608, 1510, 1252, 
692 cm
-1







pyrazol-4-one 10c: 61% yield. Yellow oil.
 1
H NMR (500 MHz, CDCl3) 
δ 8.19 – 8.14 (comp, 2H), 7.97 – 7.92 (comp, 2H), 7.78 (s, 1H), 7.60 – 
7.56 (m, 1H), 7.47 – 7.43 (comp, 2H), 7.21 – 7.18 (comp, 2H), 5.85 – 
5.82 (m, 1H), 2.46 – 2.38 (comp, 3H), 2.36 (s, 3H), 2.31 – 2.26 (m, 1H), 
1.96 – 1.88 (comp, 2H).
 13
C NMR (126 MHz, CDCl3) δ 192.31, 189.84, 
144.23, 139.34, 138.63, 133.95, 133.46, 131.52, 130.73, 129.21, 128.42, 
128.34, 125.96, 81.40, 32.45, 32.42, 22.96, 21.42. IR (neat) 3344, 1722, 
1676, 1231, 951 cm
-1
; HRMS (ESI) m/z calculated for C22H20N2O2Na 
[M+Na]
+
 367.1417, found: 367.1404. 
 
5-Benzoyl-3-(cyclopent-1-en-1-yl)-5-(p-tolyl)-1,5-dihydro-4H-
pyrazol-4-one 11c: 24% yield. Yellow oil. 1H NMR (500 MHz, CDCl3) 
δ 7.88 – 7.80 (comp, 2H), 7.67 (s, 1H), 7.51 – 7.47 (m, 1H), 7.37 – 7.32 
(comp, 2H), 7.24 – 7.16 (comp, 4H), 6.83 – 6.78 (m, 1H), 2.74 – 2.68 




C NMR (126 MHz, CDCl3) δ 192.94, 189.61, 143.22, 138.79, 
133.91, 133.65, 133.11, 132.85, 132.04, 131.03, 130.19, 128.42, 126.40, 
81.81, 34.07, 32.68, 22.21, 21.14. IR (neat) 3348, 1737, 1675, 1230, 809 
cm
-1






dihydro-4H-pyrazol-4-one 10d: 69% yield. Yellow solid, m.p. 49–
51 °C. 
1
H NMR (500 MHz, CDCl3) δ 8.23 – 8.15 (comp, 2H), 7.98 (s, 
1H), 7.68 – 7.58 (comp, 6H), 7.47 (dt, J = 12.5, 7.9 Hz, 5H), 7.37 (t, J = 
7.4 Hz, 1H), 5.89 (m, 1H), 2.59 – 2.40 (comp, 3H), 2.35 (ddd, J = 15.2, 
11.0, 4.0 Hz, 1H), 2.04 – 1.86 (comp, 2H).
 13
C NMR (126 MHz, CDCl3) 
δ 192.14, 189.76, 143.50, 141.83, 140.49, 138.50, 134.02, 133.48, 131.68, 
130.73, 128.82, 128.39, 128.08, 127.58, 127.18, 127.03, 126.38, 81.61, 
32.46, 23.00. IR (neat) 3346, 2957, 1725, 1674, 1233, 907, 733 cm
-1
; 
HRMS (EI) m/z calculated for C27H21N2O2 [M−H]
−





dihydro-4H-pyrazol-4-one 11d: 9% yield. Yellow solid, m.p. 80–81 °C. 
1
H NMR (500 MHz, CDCl3) δ 7.92 – 7.88 (comp, 2H), 7.78 (s, 1H), 7.67 
– 7.61 (comp, 3H), 7.60 – 7.55 (comp, 2H), 7.52 (dd, J = 11.1, 3.7 Hz, 
1H), 7.48 – 7.42 (comp, 3H), 7.38 (dd, J = 15.9, 7.7 Hz, 3H), 6.88 – 6.83 
(m, 1H), 2.79 – 2.72 (comp, 2H), 2.58 – 2.51 (comp, 2H), 1.98 – 1.90 
(comp, 2H).
 13
C NMR (126 MHz, CDCl3) δ 192.83, 189.49, 143.22, 
141.67, 140.00, 134.63, 134.15, 133.79, 133.14, 132.02, 130.95, 128.86, 
128.55, 128.15, 127.73, 127.08, 126.93, 81.60, 34.11, 32.72, 22.24. IR 
(neat) 3342, 2953, 1728, 1674, 1487, 1229, 1008, 735, 696 cm
-1
; HRMS 
(EI) m/z calculated for C27H21N2O2 [M−H]
−




dihydro-4H-pyrazol-4-one 10e: 74% yield. Yellow oil. 
1
H NMR (500 
MHz, CDCl3) δ 8.19 – 8.14 (comp, 2H), 7.97 – 7.92 (comp, 3H), 7.61 – 
7.57 (m, 1H), 7.52 – 7.49 (comp, 2H), 7.47 – 7.43 (comp, 2H), 5.86 – 
5.83 (m, 1H), 2.47 – 2.39 (comp, 3H), 2.32 – 2.26 (m, 1H), 1.96 – 1.89 
(comp, 2H). 
13
C NMR (126 MHz, CDCl3) δ 191.68, 189.49, 142.70, 
138.29, 134.09, 133.31, 131.82, 131.68, 130.75, 128.39, 128.07, 127.39, 
123.36, 81.67, 32.45, 32.43, 22.94. IR (neat) 3336, 1724, 1673, 1231, 
1009 cm
-1
; HRMS (ESI) m/z calculated for C21H17N2O2NaBr [M+Na]
+
 
431.0366, found: 431.0350. 
 
5-Benzoyl-5-(4-bromophenyl)-3-(cyclopent-1-en-1-yl)-1,5-
dihydro-4H-pyrazol-4-one 11e: 13% yield. Yellow oil. 
1
H NMR (500 
MHz, CDCl3) δ 7.83 – 7.79 (comp, 2H), 7.62 (s, 1H), 7.54 – 7.50 (comp, 
3H), 7.39 – 7.35 (comp, 2H), 7.26 – 7.23 (comp, 2H), 6.83 – 6.80 (m, 




C NMR (126 MHz, CDCl3) δ 192.40, 189.05, 143.33, 134.67, 
134.55, 133.94, 132.88, 132.62, 131.85, 130.77, 128.66, 128.17, 123.20, 
80.98, 77.25, 77.00, 76.75, 34.10, 32.66, 22.19. IR (neat) 3338, 1719, 
1674, 1230, 908 cm
-1
; HRMS (ESI) m/z calculated for C21H17N2O2NaBr 
[M+Na]
+
 431.0366, found: 431.0345. 
 
5-Benzoyl-3-(4-chlorophenyl)-5-(cyclopent-1-en-1-yl)-1,5-
dihydro-4H-pyrazol-4-one 10f: 69% yield. Yellow solid, m.p. 77.5–
78.5 °C.
 1
H NMR (500 MHz, CDCl3) δ 8.17 (d, J = 8.5 Hz, 2H), 8.02 (d, 
J = 8.5 Hz, 2H), 7.91 (s, 1H), 7.62 – 7.57 (m, 1H), 7.49 – 7.45 (comp, 
2H), 7.38 – 7.34 (comp, 2H), 5.87 – 5.83 (m, 1H), 2.49 – 2.39 (comp, 
3H), 2.33 – 2.26 (m, 1H), 1.97 – 1.88 (comp, 2H). 
13
C NMR (126 MHz, 
CDCl3) δ 191.75, 189.51, 142.73, 138.33, 135.04, 134.09, 133.32, 131.79, 
130.73, 128.73, 128.39, 127.62, 127.17, 81.66, 32.45, 32.43, 22.94. IR 
(neat) 3345, 1716, 1673, 1231, 1116 cm
-1
; HRMS (ESI) m/z calculated 
for C21H17N2O2NaCl [M+Na]
+




dihydro-4H-pyrazol-4-one 11f: 14% yield. Yellow solid, m.p. 94–95 °C.
 
1
H NMR (500 MHz, CDCl3) δ 7.84 – 7.80 (comp, 2H), 7.67 (s, 1H), 7.55 
– 7.51 (m, 1H), 7.40 – 7.36 (comp, 4H), 7.34 – 7.30 (comp, 2H), 6.85 – 
6.81 (m, 1H), 2.75 – 2.69 (comp, 2H), 2.56 – 2.51 (copm, 2H), 1.96 – 
1.90 (comp, 2H). 13C NMR (126 MHz, CDCl3) δ 192.48, 189.12, 143.30, 
134.99, 134.50, 134.13, 133.92, 132.89, 131.86, 130.77, 129.67, 128.63, 
127.89, 80.94, 34.09, 32.66, 22.19. IR (neat) 3344, 1717, 1671, 1228, 
933 cm
-1
; HRMS (ESI) m/z calculated for C21H17N2O2NaCl [M+Na]
+
 




(trifluoromethyl)phenyl]-1,5-dihydro-4H-pyrazol-4-one 10g: 51% 
yield. Yellow oil.
 1
H NMR (500 MHz, CDCl3) δ 8.22 – 8.16 (comp, 4H), 
8.07 (br, 1H), 7.63 (d, J = 8.5 Hz, 2H), 7.60 – 7.56 (m, 1H), 7.50 – 7.47 
(comp, 2H), 5.88 – 5.86 (m, 1H), 2.47 – 2.40 (comp, 3H), 2.33 – 2.27 (m, 
1H), 1.98 – 1.89 (comp, 2H). 
13
C NMR (126 MHz, CDCl3) δ 191.37, 
189.33, 141.91, 138.11, 134.17, 133.55, 133.27, 132.76, 132.61, 131.92 
(q, J = 30.0 Hz), 129.30, 128.42, 127.85, 125.40 (q, J = 3.8 Hz) 124.51 (q, 
J = 278.8 Hz), 81.91, 32.44, 32.39, 22.95. IR (neat) 3334, 1709, 1673, 
1321, 1120 cm
-1
; HRMS (ESI) m/z calculated for C22H17N2O2F3Na 
[M+Na]
+
 421.1134, found: 421.1116. 
 
5-Benzoyl-3-(cyclopent-1-en-1-yl)-5-[4-
(trifluoromethyl)phenyl]-1,5-dihydro-4H-pyrazol-4-one 11g: 22% 
yield. Yellow solid, m.p. 45.5–46.5 °C.
 1
H NMR (500 MHz, CDCl3) δ 
7.82 – 7.76 (comp, 2H), 7.68 – 7.63 (comp, 3H), 7.55 – 7.50 (comp, 3H), 
 112 
7.38 (t, J = 7.8 Hz, 2H), 6.85 – 6.83 (m, 1H), 2.75 – 2.69 (comp, 2H), 
2.56 – 2.51 (comp, 2H), 1.97 – 1.89 (comp, 2H). 
13
C NMR (126 MHz, 
CDCl3) δ 192.14, 188.85, 143.30, 139.33, 134.84, 134.07, 132.86, 131.76, 
130.99 (q, J = 32.5 Hz) 130.59, 128.78, 126.90, 126.37 (q, J = 3.8 Hz), 
121.54 (q, J = 270 Hz) 80.84, 34.11, 32.67, 22.18. IR (neat) 3335, 1729, 
1675, 1119, 907 cm
-1
; HRMS (ESI) m/z calculated for C22H17N2O2F3Na 
[M+Na]
+
 421.1134, found: 421.1119. 
 
5-Benzoyl-5-(cyclopent-1-en-1-yl)-3-(thiophen-2-yl)-1,5-




H NMR (500 
MHz, CDCl3) δ 8.18 (d, J = 7.3 Hz, 2H), 7.82 (s, 1H), 7.80 (dd, J = 3.7, 
0.8 Hz, 1H), 7.60 (t, J = 7.4 Hz, 1H), 7.47 (t, J = 7.8 Hz, 2H), 7.35 (d, J = 
5.1 Hz, 1H), 7.08 (dd, J = 4.9, 3.8 Hz, 1H), 5.88 – 5.84 (m, 1H), 2.48 – 
2.37 (comp, 3H), 2.37 – 2.26 (m, 1H), 1.91 (comp, 2H). 
13
C NMR (126 
MHz, CDCl3) δ 190.69, 189.48, 141.61, 138.34, 134.05, 130.72, 128.39, 
127.65, 126.69, 81.21, 32.44, 22.96. IR (neat) 3337, 2926, 1722, 1674, 
 113 
1228, 731, 692 cm
-1
; HRMS (ESI) m/z calculated for C19H16N2O2SNa 
[M+Na]
+
 359.0825, found: 359.0823. 
 
5-Benzoyl-5-(cyclohex-1-en-1-yl)-3-phenyl-1,5-dihydro-4H-
pyrazol-4-one 10i: 57% yield. Yellow oil.
 1
H NMR (300 MHz, CDCl3) δ 
8.18 (dd, J = 5.3, 3.3 Hz, 2H), 8.13 – 7.95 (m, 2H), 7.84 (s, 1H), 7.59 
(ddd, J = 6.7, 4.0, 1.3 Hz, 1H), 7.52 – 7.43 (comp, 2H), 7.42 – 7.32 
(comp, 3H), 5.84 (t, J = 2.7 Hz, 1H), 2.11 (comp, 2H), 1.63 (comp, 6H). 
13
C NMR (126 MHz, CDCl3) δ 192.26, 190.41, 143.73, 134.13, 133.91, 
133.45, 130.83, 129.18, 129.10, 128.54, 128.46, 128.33, 128.24, 127.72, 
125.95, 84.94, 25.90, 25.48, 22.57, 21.58. IR (neat) 3343, 2927, 1729, 
1674, 1447, 1231, 695 cm
-1
; HRMS (EI) m/z calculated for C22H19N2O2 
[M−H]
−




pyrazol-4-one 11i: 16% yield. Yellow solid, m.p. 63–64 °C.
 1
H NMR 
(300 MHz, CDCl3) δ 7.83 (dd, J = 8.4, 1.2 Hz, 2H), 7.56 (br, 1H), 7.49 
(dd, J = 10.5, 4.4 Hz, 1H), 7.41 – 7.31 (comp, 7H), 7.02 (m, 1H), 2.40 
(comp, 2H), 2.18 (comp, 2H), 1.76 – 1.55 (comp, 4H). 
13
C NMR (126 
MHz, CDCl3) δ 193.10, 189.61, 145.03, 135.93, 133.67, 133.12, 131.49, 
130.95, 129.45, 128.74, 128.46, 127.74, 126.52, 82.13, 25.72, 25.17, 
22.25, 21.92. IR (neat) 3339, 2927, 1732, 1675, 1447, 1231, 698 cm
-1
; 
HRMS (EI) m/z calculated for C22H19N2O2 [M−H]
−




pyrazol-4-one 10j: 51% yield. Yellow solid, m.p. 69–70 °C.
 1
H NMR 
(500 MHz, CDCl3) δ 8.15 – 8.05 (comp, 2H), 7.89 (s, 1H), 7.64 – 7.31 
(comp, 8H), 5.48 – 5.42 (m, 1H), 2.69 – 2.44 (comp, 2H), 2.32 – 2.18 (m, 
1H), 2.09 – 1.96 (m, 1H), 1.55 – 1.19 (comp, 16H). 
13
C NMR (126 MHz, 
CDCl3) δ 192.16, 190.33, 143.53, 143.47, 135.73, 135.03, 133.72, 131.61, 
 115 
131.36, 129.03, 128.45, 128.23, 127.84, 127.05, 125.94, 85.65, 26.43, 
25.53, 25.48, 25.09, 25.05, 24.74, 24.72, 24.10, 22.64, 22.37. IR (neat) 
3351, 2928, 1699, 1677, 1448, 1344, 693 cm
-1
; HRMS (ESI) m/z 
calculated for C28H32N2O2Na [M+Na]
+
 451.2356, found: 451.2347. 
 
5-Benzoyl-3-(cyclododec-1-en-1-yl)-5-phenyl-1,5-dihydro-4H-
pyrazol-4-one 11j: 35% yield. Yellow solid, m.p. 71–72 °C.
 1
H NMR 
(500 MHz, CDCl3) δ 7.85 (dt, J = 8.5, 1.5 Hz, 2H), 7.66 (s, 1H), 7.52 – 
7.47 (m, 1H), 7.44 – 7.31 (comp, 7H), 6.79 (t, J = 8.1 Hz, 1H), 2.57 (t, J 
= 6.8 Hz, 2H), 2.30 – 2.17 (comp, 2H), 1.67 – 1.59 (comp, 2H), 1.54 (dt, 
J = 9.6, 7.2 Hz, 2H), 1.49 – 1.41 (comp, 4H), 1.40 – 1.31 (comp, 6H), 
1.30 – 1.23 (comp, 2H). 
13
C NMR (126 MHz, CDCl3) δ 193.42, 189.63, 
144.99, 135.98, 135.37, 133.64, 133.23, 130.88, 129.94, 129.45, 128.72, 
128.48, 126.47, 81.94, 26.57, 26.11, 25.60, 25.19, 25.14, 24.89, 24.62, 




; HRMS (ESI) m/z calculated for C28H32N2O2Na [M+Na]
+
 
451.2356, found: 451.2349. 
 
5-Benzoyl-5-(3,6-dihydro-2H-pyran-4-yl)-3-phenyl-1,5-
dihydro-4H-pyrazol-4-one 10k: 36% yield. Yellow solid, m.p. 67–
68 °C.
 1
H NMR (500 MHz, CDCl3) δ 8.23 – 8.12 (comp, 2H), 8.10 – 8.03 
(m, 1H), 7.84 (dd, J = 6.3, 3.1 Hz, 1H), 7.56 – 7.30 (comp, 5H), 7.27 
(comp, 2H), 5.91 – 5.88 (m, 1H), 4.22 (dd, J = 5.3, 2.6 Hz, 2H), 3.89 (ddt, 
J = 16.8, 11.9, 6.2 Hz, 1H), 3.78 – 3.64 (m, 1H), 2.70 – 2.41 (m, 1H), 
2.37 – 2.05 (m, 1H). 
13
C NMR (126 MHz, CDCl3) δ 191.76, 189.62, 
144.05, 134.20, 131.68, 131.58, 130.95, 130.67, 129.36, 128.57, 128.53, 
126.70, 126.03, 83.53, 65.33, 64.00, 25.78. IR (neat) 3332, 2925, 2085, 
1710, 1677, 1447, 1232, 700 cm
-1
; HRMS (EI) m/z calculated for 
C21H17N2O3 [M−H]
−




dihydro-4H-pyrazol-4-one 11k: 10% yield. Yellow solid, m.p. 70–
71 °C.
 1
H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 8.3 Hz, 2H), 7.73 (s, 
1H), 7.52 (td, J = 7.6, 1.0 Hz, 1H), 7.44 – 7.33 (comp, 7H), 6.99 (m, 1H), 
4.29 (comp, 2H), 3.89 (dd, J = 10.5, 5.2 Hz, 2H), 2.54 (comp, 2H). 
13
C 
NMR (126 MHz, CDCl3) δ 192.57, 189.28, 143.24, 135.56, 133.80, 
133.03, 130.94, 129.56, 128.91, 128.52, 128.51, 126.43, 125.14, 82.38, 
65.39, 64.08, 25.06. IR (neat) 3322, 2923, 2085, 1708, 1675, 1447, 1232, 
1131, 694 cm
-1
; HRMS (EI) m/z calculated for C21H17N2O3 [M−H]
−
 
345.1245, found: 345.1239. 
 
5-(4-Chlorobenzoyl)-5-(cyclopent-1-en-1-yl)-3-phenyl-1,5-
dihydro-4H-pyrazol-4-one 10l: 62% yield. Yellow solid, m.p. 85–86 °C.
 
1
H NMR (500 MHz, CDCl3) δ 8.21 – 8.15 (comp, 2H), 8.08 – 8.03 
(comp, 2H), 7.92 (s, 1H), 7.46 – 7.43 (comp, 2H), 7.41 – 7.37 (comp, 
3H), 5.85 – 5.82 (m, 1H), 2.47 – 2.40 (comp, 3H), 2.29 – 2.24 (m, 1H), 
1.97 – 1.88 (comp, 2H). 13C NMR (126 MHz, CDCl3) δ 192.00, 188.67, 
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143.90, 140.74, 138.43, 132.36, 132.06, 131.50, 129.28, 128.97, 128.70, 
128.53, 125.98, 81.58, 77.26, 77.01, 76.75, 32.50, 32.44, 22.92. IR (neat) 
3347, 1724, 1674, 1114, 1010 cm
-1
; HRMS (ESI) m/z calculated for 
C21H17N2O2NaCl [M+Na]
+
 387.0871, found: 387.0855. 
 
5-(4-Chlorobenzoyl)-3-(cyclopent-1-en-1-yl)-5-phenyl-1,5-
dihydro-4H-pyrazol-4-one 11l: 18% yield. Yellow solid, m.p. 92–93 °C.
 
1
H NMR (500 MHz, CDCl3) δ 7.84 – 7.80 (comp, 2H), 7.77 (s, 1H), 7.40 
– 7.36 (comp, 3H), 7.33 – 7.30 (comp, 2H), 7.28 – 7.26 (comp, 2H), 6.82 
– 6.79 (m, 1H), 2.75 – 2.71 (comp, 2H), 2.55 – 2.51 (comp, 2H), 1.95 – 
1.89 (comp, 2H). 
13
C NMR (126 MHz, CDCl3) δ 192.74, 188.42, 143.28, 
140.46, 135.69, 134.13, 132.65, 131.96, 131.03, 129.62, 128.97, 128.75, 
126.69, 82.19, 77.25, 77.00, 76.75, 34.09, 32.69, 22.20. IR (neat) 3342, 
1741, 1676, 1091, 907 cm
-1
; HRMS (ESI) m/z calculated for 
C21H17N2O2NaCl [M+Na]
+




dihydro-4H-pyrazol-4-one 10m: 48% yield. Yellow solid, m.p. 53–
54 °C.
 1
H NMR (500 MHz, CDCl3) δ 8.29 – 8.18 (comp, 2H), 8.11 – 8.02 
(comp, 2H), 7.98 (s, 1H), 7.43 – 7.33 (comp, 3H), 6.98 – 6.90 (comp, 
2H), 5.88 – 5.79 (m, 1H), 3.89 (s, 3H), 2.52 – 2.37 (comp, 3H), 2.32 – 
2.24 (m, 1H), 2.00 – 1.84 (comp, 2H). 
13
C NMR (126 MHz, cdcl3) δ 
192.59, 187.77, 164.22, 144.01, 138.98, 133.58, 131.38, 129.19, 129.12, 
128.47, 126.06, 125.99, 113.58, 81.57, 55.53, 32.55, 32.44, 22.96. IR 
(neat) 3336, 2932, 2842, 1714, 1663, 1596, 1244, 1171, 1028, 842, 732 
cm
-1







dihydro-4H-pyrazol-4-one 11m: 29% yield. Yellow solid, m.p. 72–
73 °C.
 1
H NMR (500 MHz, CDCl3) δ 7.94 – 7.84 (comp, 2H), 7.78 (s, 
1H), 7.50 – 7.42 (m, 1H), 7.41 – 7.34 (comp, 2H), 7.33 – 7.29 (comp, 
2H), 6.86 – 6.77 (comp, 3H), 3.81 (s, 3H), 2.77 – 2.69 (comp, 2H), 2.53 
(ddd, J = 9.6, 4.8, 2.2 Hz, 2H), 1.93 (dt, J = 15.0, 7.4 Hz, 2H). 
13
C NMR 
(126 MHz, CDCl3) δ 193.38, 187.75, 163.91, 143.41, 136.43, 133.87, 
133.84, 132.10, 129.43, 128.87, 128.66, 126.73, 125.50, 113.68, 82.22, 
55.47, 34.07, 32.70, 22.22. IR (neat) 3310, 2933, 2841, 1736, 1667, 1599, 
1510, 1247, 1172, 733 cm
-1
; HRMS (EI) m/z calculated for C22H19N2O3 
[M−H]
−




methoxyphenyl)-1,5-dihydro-4H-pyrazol-4-one 10n: 55% yield. 
Yellow solid, m.p. 52–53 °C.
 1
H NMR (500 MHz, CDCl3) δ 8.29 – 8.17 
(comp, 2H), 8.07 – 7.98 (comp, 2H), 7.90 (s, 1H), 6.97 – 6.87 (comp, 
4H), 5.86 – 5.78 (m, 1H), 3.87 (s, 3H), 3.82 (s, 3H), 2.51 – 2.36 (comp, 
3H), 2.28 (dddd, J = 15.3, 9.3, 5.8, 2.1 Hz, 1H), 1.99 – 1.84 (comp, 2H). 
13
C NMR (126 MHz, CDCl3) δ 193.04, 187.90, 164.17, 160.41, 144.19, 
139.17, 133.52, 131.11, 127.55, 126.15, 121.83, 113.93, 113.56, 81.34, 
55.51, 55.28, 32.54, 32.43, 22.97. IR (neat) 3340, 2956, 2840, 1717, 
1665, 1598, 1508, 1248, 1172, 1029, 837 cm
-1
; HRMS (EI) m/z 
calculated for C23H21N2O4 [M−H]
−




methoxyphenyl)-1,5-dihydro-4H-pyrazol-4-one 11n: 24% yield. 
Yellow solid, m.p. 67–68 °C.
 1
H NMR (500 MHz, CDCl3) δ 7.94 – 7.86 
(comp, 2H), 7.83 (s, 1H), 7.24 – 7.17 (comp, 2H), 6.92 – 6.85 (comp, 
2H), 6.86 – 6.77 (comp, 3H), 3.81 (s, 3H), 3.80 – 3.77 (s, 3H), 2.77 – 
2.67 (comp, 2H), 2.56 – 2.46 (comp, 2H), 1.96 – 1.87 (comp, 2H). 
13
C 
NMR (126 MHz, CDCl3) δ 193.71, 187.98, 163.84, 159.70, 143.27, 
133.91, 133.57, 132.17, 128.46, 128.06, 125.55, 114.81, 113.62, 81.97, 
55.46, 55.29, 34.05, 32.70, 22.22. IR (neat) 3337, 2933, 2839, 1721, 
1663, 1596, 1508, 1241, 1169, 1027, 839, 734 cm
-1
; HRMS (EI) m/z 
calculated for C23H21N2O4 [M−H]
−




(trifluoromethyl)phenyl]-1,5-dihydro-4H-pyrazol-4-one 10o: 42% 
yield. Yellow solid, m.p. 35–36 °C.
 1
H NMR (500 MHz, CDCl3) δ 8.23 
(comp, 5H), 7.63 (d, J = 8.3 Hz, 2H), 6.99 – 6.91 (comp, 2H), 5.89 – 5.83 
(m, 1H), 3.89 (s, 3H), 2.51 – 2.39 (comp, 3H), 2.33 – 2.24 (m, 1H), 2.00 
– 1.87 (comp, 2H). 
13
C NMR (126 MHz, CDCl3) δ 191.90, 187.39, 
164.36, 141.88, 138.55, 133.60, 131.74, 130.47 (q, J = 32.8 Hz), 125.91, 
125.36 (q, J = 3.8 Hz), 113.64, 81.95, 55.54, 32.52, 32.43, 22.95. IR 
(neat) 3326, 2930, 2845, 1663, 1596, 1321, 1243, 1164, 1065, 842 cm
-1
; 
HRMS (EI) m/z calculated for C23H18F3N2O3 [M−H]
−





(trifluoromethyl)phenyl]-1,5-dihydro-4H-pyrazol-4-one 11o: 5% yield. 
Yellow solid, m.p. 67 – 68 °C.
 1
H NMR (500 MHz, CDCl3) δ 7.85 (dd, J 
= 9.3, 2.6 Hz, 2H), 7.71 (s, 1H), 7.66 (dd, J = 8.5, 2.5 Hz, 2H), 7.48 (dd, 
J = 8.5, 2.5 Hz, 2H), 6.92 – 6.76 (comp, 3H), 3.84 (s, 3H), 2.82 – 2.67 
(comp, 2H), 2.61 – 2.42 (comp, 2H), 2.00 – 1.84 (comp, 2H). 
13
C NMR 
(126 MHz, CDCl3) δ 192.82, 187.09, 164.19, 143.61, 140.05, 134.63, 
133.59, 131.88, 130.83 (q, J = 34.0 Hz), 127.65, 127.13, 126.34 (q, J = 
3.8 Hz), 125.21, 125.13, 113.99, 81.24, 55.55, 34.11, 32.68, 22.20. IR 
(neat) 3337, 2930, 1725, 1667, 1598, 1323, 1243, 1170, 1120, 1070, 841 
cm
-1







pyrazol-4-one 10p: 60% yield.
6
 Yellow solid, m.p. 39 – 40 °C.
 1
H NMR 
(500 MHz, CDCl3) δ 8.19 (d, J = 7.4 Hz, 2H), 8.08 (d, J = 6.7 Hz, 2H), 
7.93 (s, 1H), 7.61 (t, J = 7.4 Hz, 1H), 7.48 (t, J = 7.6 Hz, 2H), 7.43 – 7.35 
(comp, 3H), 5.27 (s, 1H), 5.20 (s, 1H), 1.91 (s, 3H). 
13
C NMR (126 MHz, 
CDCl3) δ 191.96, 189.85, 143.73, 140.34, 134.10, 133.37, 130.72, 129.26, 
129.01, 128.51, 128.45, 126.03, 116.67, 84.14, 20.00. IR (neat) 3339, 
1727, 1671, 1447, 1229, 692 cm
-1
; HRMS (ESI) m/z calculated for 
C19H16N2O2Na [M+Na]
+
 327.1104, found: 327.1098. 
 
5-Benzoyl-3-(4-methoxyphenyl)-5-(prop-1-en-2-yl)-1,5-
dihydro-4H-pyrazol-4-one 10q: 72% yield.
6
 Yellow solid, m.p. 44–
45 °C.
 1
H NMR (500 MHz, CDCl3) δ 8.18 (d, J = 7.4 Hz, 2H), 8.03 (d, J 
= 9.0 Hz, 2H), 7.74 (s, 1H), 7.60 (t, J = 7.4 Hz, 1H), 7.48 (t, J = 7.7 Hz, 
2H), 6.92 (d, J = 9.0 Hz, 2H), 5.25 (s, 1H), 5.18 (s, 1H), 3.83 (s, 3H), 
1.90 (s, 3H). 
13
C NMR (126 MHz, CDCl3) δ 192.41, 189.98, 160.52, 
144.08, 140.53, 134.05, 133.39, 130.72, 128.43, 127.61, 121.59, 116.51, 
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113.97, 83.89, 55.30, 20.02. IR (neat) 3342, 2934, 1730, 1674, 1251, 
1231, 1173, 835, 690 cm
-1
; HRMS (EI) m/z calculated for C20H17N2O3 
[M−H]
−
 333.1245, found: 333.1251. 
 
5-(Cyclopent-1-en-1-yl)-3-phenyl-1H-pyrazol-4-ol 6: 90% yield. 
White solid, m. p. 198 – 200 °C (decomp.).
 1
H NMR (500 MHz, CD3OD) 
δ 7.85 (dd, J = 8.1, 0.9 Hz, 2H), 7.43 (dd, J = 10.6, 4.8 Hz, 2H), 7.34 
(ddd, J = 6.8, 2.4, 1.2 Hz, 1H), 6.48 (dt, J = 4.2, 2.1 Hz, 1H), 2.78 (ddd, J 
= 9.8, 4.4, 2.1 Hz, 2H), 2.57 (tdd, J = 7.5, 4.8, 2.4 Hz, 2H), 2.07 – 1.93 
(comp, 2H).
 13
C NMR (126 MHz, CD3OD) δ 136.70, 135.08, 134.32, 
131.59, 130.43, 128.71, 128.19, 127.49, 126.13, 32.87, 32.62, 22.39. IR 
(neat) 3249 (br), 1635, 1482, 1274, 1026, 845 cm
-1
; HRMS (ESI) m/z 
calculated for C14H15N2O [M+H]
+




6’: 87% yield. White solid, m. p. > 300 °C (decomp.). 
1
H NMR (300 
MHz, DMSO-d6) δ 12.54 (br, 1H), 8.04 – 8.01 (comp, 3H), 7.69 (d, J = 
7.3 Hz, 4H), 7.45 (t, J = 7.5 Hz, 2H), 7.34 (t, J = 7.2 Hz, 1H), 6.29 (s, 
1H), 2.70 – 2.68 (comp, 2H), 2.49 – 2.47 (comp, 2H), 1.99 – 1.78 (comp, 
2H). 
13
C NMR (126 MHz, DMSO-d6) δ 140.27, 138.71, 135.96, 129.39, 
127.79, 127.05, 126.88, 126.30, 126.00, 33.41, 33.31, 22.76. IR (neat) 
3246 (br), 1634, 1487, 1269, 1016, 844, 767 cm
-1
; HRMS (ESI) m/z 
calculated for C20H19N2O [M+H]
+
 303.1492, found: 303.1496. 
NMR graphs will be obtained from the supporting information of the 
upcoming published paper. 


















Single crystals of C21H18N2O2 (4) and C20H18N2O (6') were 
prepared by slow evaporation of 4 solution in hexane/dichloromethane 
(4:1) and 6' solution in methanol respectively. A suitable green needle-
like crystal (for C21H18N2O2), with dimensions of 0.42 mm × 0.06 mm × 
0.01 mm, and a suitable colorless prism-like crystal (for C20H18N2O), 
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with dimensions of 0.37 mm × 0.27 mm × 0.07 were mounted, using 
Paratone oil, onto a glass fiber. The data were collected at 98(2) K using 
a Rigaku AFC12 / Saturn 724 CCD fitted with MoKα radiation (λ = 
0.71075 Å). Data collection and unit cell refinement were performed 
using CrystalClear software.
9
 The total number of data were measured in 
the range 5.2° < 2θ < 50.1° and 4.5° < 2θ < 50.1° using ω scans, 
respectively. Data processing and absorption correction, giving minimum 
and maximum transmission factors of 0.407 and 1.000 for C21H18N2O2 





 respectively. The structure, using Olex2,
11
 
was solved with the ShelXT
12
 structure solution program using direct 
methods and refined (on F
2
) with the ShelXL
13
 refinement package using 
full-matrix, least-squares techniques. All non-hydrogen atoms were 
refined with anisotropic displacement parameters. All hydrogen atom 
positions were determined by geometry and refined by a riding model. 
 
 
Table 2.8 Crystallographic data and structure refinement for cd1309 (4) 
and cd1383 (6') 
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Identification code cd1309 cd1383 
Empirical formula C21H18N2O2 C20H18N2O 
Formula weight 330.37 302.36 
Crystal system Monoclinic Orthorhombic 
Space group P 1 21/c 1 P n a 21 
a (Ǻ) 17.920(7) 6.727(9) 
b (Ǻ) 6.022(2) 23.55(3) 
c (Ǻ) 15.745(6) 9.860(13) 
α (°) 90 90 
β (°) 99.297(6) 90 
γ (°) 90 90 
Volume (Ǻ
3
) 1676.8(11) 1562(4) 
Z 4 4 
ρ (calc.) 1.309 1.286 
λ 0.71075 0.71075 
Temp. (K) 98(2) 98(2) 
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F(000) 696 640 
μ (mm
-1
) 0.085 0.080 
Tmin, Tmax 0.407, 1.000 0.474, 1.000 
2θrange (°) 5.2 to 50.1 4.5 to 50.1 






[R(int) = 0.067] 
Completeness 99.4% 97.6% 
Data / restraints / 
parameters 
2953 / 0 / 226 2538 / 1 / 209 
Observed data 




 all data) 0.1761 0.1984 
R(F obsd data) 0.0785 0.0900 
Goodness-of-fit on F
2
 1.015 1.04 
Largest diff. peak and 0.48/−0.48 0.37 / −0.37 
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wR2 = { Σ [w(Fo2 – Fc2)2] / Σ [w(Fo2)2] }1/2 
R1 = Σ ||Fo| – |Fc|| / Σ |Fo| 
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Chapter 3: Unprecedented Intramolecular 
[4+2]-Cycloaddition Between a 1,3-Diene 
and a Diazo Ester 
I. Introduction 
1.1 Isoelectronic Principle and Isoelectronic Systems: Diazo 
Compounds, Ketenes and Allenes 
The term, isoelectronic, is used to describe chemical entities 
(atoms, molecules, or ions) that have the same number of electrons and 
the same number of heavy-atoms.
1
 The “isoelectronic principle” states 
that when two or more molecular entities are isoelectronic, they tend to 
have similar physical and chemical properties.
2
 For instance, carbon 
dioxide and nitrous oxide are isoelectronic with each other; and their 
physical properties including critical pressure, critical temperature, 
density of liquid, and dielectric constant of liquid are found to be 
remarkably similar.
3
 More importantly, the isoelectronic principle 
provides an opportunity for chemists to predict some possible properties 
and reactions of compounds as being isoelectronic with some already 
known ones.  
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Diazo compounds, ketenes and allenes are isoelectronic and share 
similar electronic structures of cumulated double-bond systems (Figure 
3.1).
4
 Based on the isoelectronic principle, the rich chemistry of allenes 
and ketenes might provide some clues for us to discover possible 
properties and reactions of diazo compounds that have not been explored. 
 
Figure 3.1 Isoelectronic Systems: Allenes-Ketenes-Diazo Compounds  
1.2 [4+2]-Cycloaddition of Dienes with Allenes or Ketenes 
The Diels-Alder reaction is noted for its ability to construct 
unsaturated six-membered rings and has been extensively used in 
synthesis of drugs, natural products, and compounds with biological 
activity.
5
 Allene and ketene have been reported to undergo these 
reactions and have received considerable attention.
6
 However, in the long 
history of Diels-Alder reactions there has not been a reported example of 
[4+2]-cycloaddition between a diene and a diazo compound.
7
 
1.2.1 4+2]-Cycloaddition of Diene with Allene 
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Concerted thermal [4+2]-cycloaddition reactions of dienes with 
highly polarized allenes were extensively investigated in the last century, 
but favorable competing stepwise [2+2]-cycloaddition reactions 
diminished their importance.
8
 For instance, Houk and coworkers have 
investigated the cycloaddition reaction of 1,1-difluoroallene and 1,3-
butadiene. Although the total yield of [4+2]-adduct and [2+2]-adduct is 




Scheme 3.1 [4+2]- versus [2+2]-Cycloaddition of 1,1-Difluoroallene and 
1,3-Butadiene. 
Transition metal complex catalyzed allene-diene cycloaddition 
reactions, although recent in their discovery, have circumvented this 
competition and become a mainstay of new process developments.
10
 
Under catalysis of transition metal complexes these [4+2]-cycloaddition 
reactions were proposed to proceed through a multistep mechanism that 
always involved organometallic complexes as reaction intermediates; the 
nature of these transition metal complexes has a great influence on the 
selectivity of [4+2]-cycloaddition reactions of allenes which have two 
reactive carbon-carbon double bonds.
11
 For instance, Wender and 
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coworkers reported a transition metal-catalyzed intramolecular [4+2]-
cycloaddition of diene-allene.
12
 They found, interestingly, that treatment 
of the diene-allene with Ni(COD)2/P(O-o-BiPh)3 gave products with 6,6-
fused rings, while when [RhCl(COD)]2/P(O-o-BiPh)3 was used as the 





Scheme 3.2 Divergent Outcomes of Transition Metal-Catalyzed [4+2]-
Cycloaddition Reactions of Allenes with Dienes. 
1.2.2 [4+2]-Cycloaddition of Dienes with Ketenes 
The development of [4+2]-cycloaddition reactions of ketenes has 
been a challenge for a long period of time.
13
 One major problem is that 
ketenes readily undergo [2+2]-cycloaddition reactions with one double 
bond of dienes.
14
 However, diene equivalents that include α,β-
unsaturated ketones bearing a strong electron-donating group (EWG) at 
the α position react with ketenes to produce [4+2]-cycloaddition products 





Scheme 3.3 [4+2]-Cycloaddition Reaction of Diphenylketene and (E)-4-
Methoxybut-3-en-2-one. 
Recently, organocatalysis has emerged as a powerful method in 
organic synthesis.
16
 Organocatalyzed [4+2]-cycloaddition reactions of 
ketenes have also been explored.
17
 These transformations involve 
zwitterionic “ketene” enolates that are generated in situ from the 
reactions of cinchona alkaloids or N-heterocyclic carbenes with 
ketenes.
17f
 These organocatalysts have not only expanded upon the 
substrate scope of dienes, but have also permitted access to the 
asymmetric version of these [4+2]-cycloaddition reactions. Cinchona 
alkaloid-based catalysts were first applied in the [4+2]-cycloaddition 
reaction of o-quinones with ketene enolates, which are derived in situ 
from readily available acid chlorides.
17b
 To inhibit the [2+2]-
cycloaddition products, o-quinones were used as the dienes so that 
restoration of aromaticity occurs by [4+2]-cycloaddition (Scheme 3.4). 
Ye and coworkers have developed a chiral N-heterocyclic carbene-
catalyzed formal [4+2]-cycloaddition of disubstituted ketenes with 
enones to produce δ-lactones with a quaternary-β-tertiary stereocenter in 
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good yields with high diastereo- and enantioselectivities.
17f
 The authors 
proposed that the [4+2]-cycloaddition reaction initiated by the 
nucleophilic addition of N-heterocyclic carbene (NHC) to ketenes 
produce ketene enolates, which could undergo an inverse electron 
demand Diels–Alder reaction to afford triazolium zwitterionic 
intermediates, followed by elimination of the NHC to furnish the 
corresponding δ–lactones (Scheme 3.5).  
 
Scheme 3.4 Cinchona Alkaloid-Based Catalyst-Catalyzed [4+2]-
Cycloaddition of o-Quinones with Ketene Enolates 
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Scheme 3.5 N-Heterocyclic Carbene-Catalyzed [4+2]-Cycloaddition 
Reaction of Ketenes with Enones. 
1.3 Original Considerations of [4+2]-Cycloaddition of Diene 
with Diazo Compounds 
Compared with allenes or ketenes, diazo compounds commonly 
react with one double bond of dienes by dipolar cycloaddition or, 






Scheme 3.6 Dipolar Cycloaddition and Cyclopropanation of 1,3-Dienes 
with Diazo Compounds. 
That [4+2]-cycloaddition reactions occur with allenes and ketenes, 
but not with diazo compounds suggested to us that the facility with which 
diazo compounds undergo dipolar cycloaddition prevent [4+2]-
cycloaddition and that, if dipolar cycloaddition could be electronically 
and/or sterically inhibited, perhaps [4+2]-cycloaddition should be 
observed. Inhibition of dipolar cycloaddition with deactivation of the 
carbon-carbon double bond towards dipolar cycloaddition would require 
constraints in the alignment of the diazo functional group with either one 
of the double bonds of the diene. To design such a system we were 
encouraged by a recent report by M. Brewer and coworkers of a polar 
intramolecular [4 ○+ +2]-cycloaddition of aryl-1-aza-2-azoniaallene salts 
that produced protonated azomethine imines.
18
 When they used 
heteroallenes as starting materials, [3○+ +2]-cycloaddition products, 5,5-
bridged bicyclic diazenium salts,
19
 were not observed, but instead, [4○+
+2]-cycloaddition products, tricyclic azomethine imine salts containing a 
1,2,3,4-tetrahydrocinnoline scaffold, were obtained in good yields. To 
further understand this transformation, Brewer and Houk have employed 
computational studies indicating that the formation of a four-membered 
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ring transition state prevents the formation of the [3○+ +2]-cycloaddition 




Scheme 3.7 Intramolecular Cycloaddition of 1-Aza-2-Azoniaallene Salts. 
One such structural design appropriate for intramolecular [4+2]-
cycloaddition between a diene and a diazocarbonyl compound (Scheme 
3.8) would produce a dipolar azomethine species (2) that could serve as a 
suitable stabilized product. Add to this design activation of the diene with 
electron-donating substituents, as well as further stabilization of the 
dipolar azomethine product; and this cycloaddition reaction appears 
feasible. However, additional constraints that include the linkage between 
the diene and the diazo units, as well as the geometry of attachment to the 
diene, remain unresolved.  
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Scheme 3.8 Proposed Intramolecular [4+2]-Cycloaddition of Dienes with 
Diazo Compounds. 
For this investigation we chose to synthesize diene-linked 
aryldiazoacetates 1 (Scheme 3.9). This structure contains the elements of 
activation and stabilization that we believe to be requirements for diene-
diazo [4+2]-cyclization. Gold-catalyzed 1,3-acyloxy migration of 
propargylic carboxylates is known to form allene intermediates (3) 
suitable for diene formation, and the generation of dienes from 
propargylic esters through a gold(I)-catalyzed 1,3-migratory cascade 





Scheme 3.9 Synthesis of Diene-linked Aryldiazoacetates. 
II. Results and Discussion 
2.1 Initial Screening of Additives and Reaction Conditions  
Treatment of propargyl phenyldiazoacetate 4a with a broad 
selection of neutral gold catalysts under various conditions of 
temperatures and solvents gave either no reaction or 1,5-dihydro-4H-
pyrazol-4-ones as dominant products (discussed in Chapter 2) and minor 
amounts of diene (Z)-1a, although not in high yield. Sensing that proton 
transfer might be limiting this process, a variety of inorganic bases, 
organic bases, and organic acids were used as additives. Results are 
shown in Table 3.1. Organic bases that include triethylamine (NEt3), 
pyridine, and 1,8-diazabicycloundec-7-ene (DBU) were found to poison 
the gold catalyst (Table 3.1, entries 1-3). With sodium hydroxide as the 
base, the starting material 4a was also recovered in over 95% after 4 days 
under the same reaction conditions (Table 3.1, entry 4). Sodium acetate 
and sodium bicarbonate changed the yields of (Z)-1a slightly with over 
95% conversion of 4a (Table 3.1, entries 5 and 6). Another mild Lewis 
base, nitrosobenzene (PhNO), was also tested and was found to slightly 
deactivate the gold catalyst (Table 3.1, entry 7). Interestingly, when 1.0 
equivalent of dimethyl sulfoxide (DMSO) was added, the reaction 
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resulted in the formation of (Z)-1a and a product anticipated from a 
diene-diazo [4+2]-cycloaddition (2a) in a combined yield of 30% (Table 
3.1, entry 8). Further investigations of other organic-oxide-containing 
bases including triphenylphosphine oxide and pyridine-N-oxide have 
shown that pyridine-N-oxide gave improved results (Table 3.1, entry 9 
and 10). The use of benzoic acid did not yield the [4+2]-cycloaddition 
product 2a (Table 3.1, entry 11). 
Table 3.1 Sreening the Additives for Gold-Catalyzed Reactions of 











1 NEt3 <10 <10 -
d
  
2 Pyridine <10 <5 -
d
 
3 DBU <10 <10 -
d
 
4 NaOH <10 <10 -
d
 
5 NaOAc >95 15 >20:1 
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6 NaHCO3 >95 18 >20:1 
7 PhNO 80 23 >20:1 
8 DMSO >95 30 60:40 




>95 74 65:35 
11 Benzoic acid 90% 9 >20:1 
aTo a flame-dried 10 mL Schlenk flask charged with a magnetic stirring bar, AuCl(SMe2) (2.90 mg, 0.010 mmol), 
an additive (0.20 mmol) and 2.0 mL of toluene were added sequentially under nitrogen atmosphere. Then 4a (0.20 
mmol) dissolved in 3.0 mL of toluene was added sequentially into the solution under the flow of nitrogen. The 
resulting mixture was allowed to stir for 48 h at room temperature. bThe percent conversion of 4a was determined 
1H NMR spectroscopy using 2,4,6-trimethoxybenzaldehyde as an internal standard. cThe total yields of [(Z)-1a+2a] 
and the ratios were determined by the 1H NMR analyses of characteristic absorptions. dNot determined. 
 
Pyridine-N-oxides with different substituent groups including nitro, 
methoxy, and chloro at the para-position were also tested (Table 3.2, 
entries 1-4). 4-Chloropyridine-N-oxide was optimal. 4-Nitropyridine-N-
oxide 6c did not give the product from [4+2]-cycloaddition, which might 
be because of its decreased basicity; however, 4-methoxypyridine-N-
oxide, which is a stronger base compared to pyridine-N-oxide, was found 
to deactivate the gold catalyst and resulted in a lower yield of products. 
With 4-chloropyridine-N-oxide, gold catalysts that include AuCl, AuCl3, 
IPrAuCl, PPh3AuCl were examined, but did not give improved results 
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(Table 3.2, entries 5-8). A variety of solvents that include hexanes, 
tetrahydrofuran (THF), acetonitrile (CH3CN), and toluene were examined 
subsequently (Table 3.2, entries 9-12): all of the solvents were tolerated, 
but their use did give significant variation in the (Z)-1a:2a product ratios. 
Finally, AuCl(Me2S) and 4-chloropyridine-N-oxide were optimal for the 
reaction performed in toluene at 20℃. 
Table 3.2 Optimization of Catalyst and Reaction Condition for Gold-

















1 AuCl(SMe2) CH2Cl2 6a >95 74 65:35 
2 AuCl(SMe2) CH2Cl2 6b >95 80 62:38 




4 AuCl(SMe2) CH2Cl2 6d 50 31 65:35 
5 AuCl CH2Cl2 6b >95 76 65:35 
6 AuCl3 CH2Cl2 6b >95 52 67:33 
7 IPrAuCl CH2Cl2 6b <5 trace -
d
 
8 PPh3AuCl CH2Cl2 6b <5 trace -
d
 
9 AuCl(SMe2) hexane 6b >95 42 52:48 
10 AuCl(SMe2) THF 6b >95 81 62:38 
11 AuCl(SMe2) CH3CN 6b >95 55 65:35 







aReactions were performed at 20℃ on a 0.20 mmol scale:  a solution of 4a in 2.0 mL solvent was added to the 
solution of 6 (1.0 equiv) and 5 mol% of catalyst 3.0 mL of solvent under a nitrogen atmosphere, and the resulting 
reaction mixture was stirred for 4 days. bThe percent conversion of 4a was determined 1H NMR spectroscopy 
using 2,4,6-trimethoxybenz-aldehyde as an internal standard. cThe total yields of [(Z)-1a + 2a] and the ratios were 
determined by the 1H NMR analyses of characteristic absorptions. dNot determined. eThe combined isolated yield 
of (Z)-1a and 2a. fThe ratio (Z)-1a:2a of the isolated product.  
 
Structures for both the diene (Z)-1e and cycloaddition product 2f 
were confirmed by X-ray diffraction (Figure 3.2). Neither the cascade 
reaction anticipated from initial dinitrogen extrusion by the catalyst at the 
diazo carbon nor the product(s) from dipolar cycloaddition between the 
diazo compound and diene were observed, and the absence of the cascade 
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reaction product indicated a high preference of the gold catalyst for 
reaction at the carbon-carbon triple bond rather than with the 
phenyldiazoacetate.  
 
Figure 3.2 X-ray Structures of Diene (Z)-1e and Cycloaddition Product 
2f. 
2.2 Substrate Scope  
Using optimum reaction conditions (Table 3.2, entry 12) the 
influence of substituents on the arylpropargyl aryldiazoacetate was 
examined to further understand the formation of diene-linked 
aryldiazoacetates and the diene-diazo [4+2]-cycloaddition process. As 
shown in Table 3.3, arylacetic acid-derived substituents – including 
ethers, halides, nitro, trifluoromethyl, alkyl, aryl – underwent the 
rearrangement reaction smoothly within 4 days at 20
o
C, affording the 
diene and cycloaddition products in good to excellent combined yields 
(Table 3.3, entries 1-8). o-Bromophenylacetic acid-derived compound 4j 
(Table 3.3, entry 9) underwent reaction much slower than the p-
bromophenylacetic acid-derived substitutent 4e, suggesting a possible 
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steric influence. We also examined arylacetylene-derived substituents. 
Generally, those with electron-donating substituents in the para-position 
(Table 3.3, entries 10 and 11) underwent rearrangement reaction faster 
than 4a. However, those with electron-withdrawing substituents were 
potential challenges because of the reduced nucleophilicity of (E)-1 
dienes that are suggested to be the precursors to cycloaddition products 2. 
The success of the p-fluorophenylacetylene-substituted 4n encouraged us 
to examine more electron-deficient substituents (4o and 4p). The dienes 
and cycloaddition products from these reactants were successfully 
obtained in reasonable yields after 20 days at room temperature (Table 
3.3, entries 14 and 15). However, the p-nitrophenylacetylene-substituted 
4q failed to deliver the corresponding diene and cycloaddition product 
(Table 3.3, entry 16) even after 20 days.  































Ph 4 >95 92 41:59 
2 4c 4-MeC6H4 Ph 4 >95 94 42:58 
3 4d 4-PhC6H4 Ph 4 >95 91 42:58 
4 4e 4-BrC6H4 Ph 4 >95 89 44:56 
5 4f 4-ClC6H4 Ph 4 >95 88 41:59 
6 4g 4-FC6H4 Ph 4 >95 84 40:60 
7 4h 4-CF3C6H4 Ph 4 90 77 42:58 
8 4i 4-NO2C6H4 Ph 4 85 70 26:74 
9 4j 2-BrC6H4 Ph 20 >95 75 27:73 
10 4k Ph 4-OMeC6H4 2.5 >95 82 50:50 
11 4l Ph 4-MeC6H4 3 >95 86 48:52 
12 4m Ph 4-ClC6H4 7 >95 85 47:53 
13 4n Ph 4-FC6H4 9 >95 81 45:55 
14 4o Ph 
4-
MeO2CC6H4 
20 >95 81 45:55 
15 4p Ph 
4-
(OHC)C6H4 
20 >95 77 47:53 
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16 4q Ph 4-NO2C6H4 20 45% <10% -
f
 
aReactions were performed at 20℃ on 0.20 mmol scale:  the solution of 4 in 2.0 mL toluene was added to the 
solution of 6b and 5 mol % of AuCl(SMe2) in 3.0 mL of toluene under a nitrogen atmosphere, and the resulting 
reaction mixture was stirred for the stated reaction time. bThe reaction time was determined from the 
disappearance of 4 by thin-layer chromatography or no improved conversion with longer times. cThe % 
conversion of 4 was determined by 1H NMR analysis using 2,4,6-trimethoxybenzaldehyde as the internal standard. 
dIsolated combined yields. eIsolated ratios. fNot determined. 
 
2.3 Kinetic Studies  
To determine if both (E)-1 and (Z)-1 were formed initially after 
which (E)-1 underwent cycloaddition to 2 we examined the gold 
catalyzed reaction at shorter reaction times. If (E)-1 was the precursor to 
2, this diene should be observed as an initially formed product. 
Fortunately, during 6-12 h reaction time at room temperature with 
relatively low conversion of 4, both (E)-1 and (Z)-1 were obtained at 
apparent equivalent rates. Isolation of (E)-1a by column chromatography 
at room temperature provided sufficient material to examine if this diene 
could undergo uncatalyzed formation of 2a or if cycloaddition required 
the intervention of a catalyst. In the absence of catalyst, isolated (E)-1a 
underwent quantitative conversion to cycloaddition product 2a in toluene 
at room temperature for 4 days. Furthermore, compound (E)-1a was 
dissolved in CDCl3 and the progress of the reaction was monitored by 
1
H 





 at 41℃ in CDCl3 (Figure 3.3); and the addition of the gold catalyst 
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in amounts similar to those used for reactions with propargyl 
aryldiazoacetates 4 did not influence the rate of conversion of (E)-1a to 
2a, confirming that the cycloaddition reaction was uncatalyzed. The 
variation of the rate constant over temperatures ranging from 20℃ to 
49℃ provided Eact = 16.2 kcal/mol, H
‡
298 = 15.6 kcal/mol and S
‡
298 = -
27.3 cal/(mol•degree).22 Multiple determinations of reaction rates after 
separations of (E)-1a from different reaction mixtures were made to 
ensure that there was consistency in results. Cycloaddition occurred with 
rate constants that were independent of the batch source of (E)-1a. 
 
 
Figure 3.3 Linear Relationship Between Reaction Time and Ln [(E)-
1a/(E)-1a0]. Reaction Performed in CDCl3 at 41℃. 
y = -0.000096x + 0.003189 
























Surprisingly, the geometrical isomer of (Z)-1a did not undergo 
[4+2]-cycloaddition. Stable at room temperature in the absence of 
catalyst for more than 7 days in toluene, (Z)-1a underwent complete 
decomposition resulting in complex mixtures at 60℃ in CDCl3 for 24 h 
that did not include evidence for 2a or similar cycloaddition products. In 
contrast, (E)-1a underwent what is a facile [4+2]-cycloaddition reaction 
that occurred without evidence for formation of a dipolar cycloaddition 
product.  
The design of (E)-1 with its strategically placed phenyl groups 
allows the examination of the influence substituents on the rates for 
cycloaddition for both the dienophile and the diene in the same 
compound. To perform these determinations we isolated (E)-1 from a 
representative series of gold-catalyzed reactions of 4, determined the 
yields for their conversion to [4+2]-cycloaddition product, and measured 
the rates for their conversion to 2 at constant temperature. As shown in 
Table 3.4, the intramolecular [4+2]-cycloaddition reaction of (E)-1 gave 
2 in high yields with complete diastereocontrol. Reaction rates were 
dependent on compounds (E)-1 with arylacetic acid-derived substituents 
Ar
1
 and with arylacetylene-derived aryl substituents Ar
2
. The p-
methylsubstituent slightly decreased the reaction rate (Table 3,4, entry 
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2); other substituents, such as p-Ph, p-Br, p-Cl, and p-F, increased the 
reaction rate (Table 3,4, entries 3-6); moreover, the aryldiazoacetate with 
the strongly electron-withdrawing p-NO2 group gave the highest reaction 
rate (Table 3.4, entry 7). In contrast, electron-withdrawing groups on the 
benzene ring of the phenylacetylene-derived substituents decreased the 
reaction rate (Table 3.4, entries 11-14), whereas electron-donating groups 
increased the reaction rate (Table 3.4, entries 9 and 10). Hammett plots 
of the intermolecular [4+2]-cycloaddition reaction of (E)-1 showed good 
correlations between σ values and log (kX/kH) with -values of +0.89 (R
2
 
= 0.96) for the para-substituted aryldiazo esters and -1.65 (R
2
 = 0.95) for 
the para-substituted aryldienes (Figures 3.4 and 3.5).
23
 The diazo 
functional group exhibits electrophilic character in these reactions 
(discussed in Chapter 2) while the diene is its nucleophilic partner. In 
addition, the o-bromo substituent underwent a much slower reaction than 
did the p-bromo-derived compound, suggesting a possible steric 
inhibition (Table 3.4, entry 8). 
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aReactions were performed at 20 ± 0.5℃ on a 0.05 mmol scale: under a nitrogen atmosphere. The solution of (E)-1 
in 0.5 mL CDCl3 was monitored by 
1H NMR spectroscopy every a period of time until over 80% of (E)-1 was 
converted into the cycloaddition product 2. bThe reaction time was determined from the disappearance of (E)-1 by 
1H NMR spectroscopy. cIsolated yields from the conversions of (E)-1 to 2. dDetermined by 1H NMR. eThe 
solution of (E)-1 and (Z)-1 in 0.5 mL CDCl3 was monitored by 














p-NO2 y = 0.8907x + 0.0934 

























Figure 3.5 Hammett Plot for the para-Substituted Aryldienes. 
2.4 Reaction Mechanism 
A plausible mechanism for the neutral gold(I)-catalyzed formation 
of diene-diazo and cycloaddition product is outlined in Scheme 3.10. 
Gold-catalyzed 1,3-acyloxy rearrangement of 4a produces gold-
coordinated carboxyallene A (discussed in Chapter 2). In the presence of 
4-chloropyridine N-oxide, subsequent protonation of gold-coordinated 
carboxyallene A produces (E)- and (Z)-gold-coordinated diene-diazo 
intermediates B and C, which are protodeaurated by protonated 4-
chloropyridine N-oxide (Pry-OH ○+ ) to produce (E)- and (Z)-1a and 
regenerate gold catalyst and 4-chloropyridine N-oxide. The (E)-1a further 
undergoes an intramolecular [4+2]-cycloaddition to furnish the dipolar 
azomethine species 2a. 
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Scheme 3.10 Proposed Mechanism for Gold(I)-Catalyzed 
Rearrangements in Presence of 4-Chloropyridine N-Oxide. 
2.4a Gold-Catalyzed Isomerization of Allenes into 1,3-Dienes with an 
Additive 
 
As discussed in Chapter 2, gold-coordinated carboxyallene A, 
which is initially formed by gold-catalyzed 1,3-acyloxy rearrangement of 
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4a, is the key intermediate for further transformation. Gold-catalyzed 
synthesis of 1,3-dienes via allene intermediates has been reported 
previously (also discussed in Chapter 2). In some cases, additives play 
an important role in these transformations. For instance, Liu and 
coworkers found that in presence of AuCl3 and nitrosobenzene, the (3-
methylbuta-1,2-dien-1-yl)benzene undergoes isomerization and furnishes 
(E)-(3-methylbuta-1,3-dien-1-yl)benzene in good yield. Nitrosobenzene 
is found to be essential to this transformation; no 1,3-diene is formed in 
absence of nitrosobenzene. In the paper, the authors suggested that the 
role of nitrosobenzene is as a mild base accelerating proton transfer for 




Scheme 3.11 Gold-Catalyzed Isomerization of Unreactive Allenes into 
1,3-Dienes. 
2.4b Pyridine N-Oxides as Mild Bases in Gold Catalysis 
Although pyridine-N-oxides are noted for their role in oxygen 
transfer that provides access to α-oxo gold carbenes,
25
 uses of pyridine-




 For instance, studies of reactions using diynes as 
substrates with pyridine-N-oxides in presence of BrettPhosAuNTf 
afforded tricyclicindenes instead of oxidation products. Zhang and 
coworkers proposed a mechanism which describes the N-oxide as a mild 
base to facilitate the deprotonation of the terminal alkyne to form 
alkynylgold E with subsequent coordination with another BrettPhosAu 
cation to produce F, which further undergoes complex transformations to 
form intermediate G, which react with protonated pyridine N-oxide (Pry-
OH○+) to produce the tricyclicindenes, and regenerate the gold catalysts 




Scheme 3.12 Gold-Catalyzed Rearrangement of Diynes: Pyridine-N-
Oxides as Mild Bases.  
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In another example, Zhang and co-workers reported a novel 
strategy for in situ generation of furan-based ortho-quinodimethanes from 
2-(1-alkynyl)-2-alken-1-ones with catalytic amount of pyridine N-oxides 
and Ph3PAuCl. They demonstrated that pyridine-N-oxide plays a key role 
in this transformation and serves as the mild base. Interestingly, 
replacement of pyridine-N-oxide with a series of inorganic and organic 
bases including K2CO3, 1,4-diazabicyclo[2,2,2]octane (DABCO), Et3N, 
and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) failed to produce the any 




Scheme 3.13 Gold-catalyzed Rearrangement of 2-(1-Alkynyl)-2-Alken-
1-Ones: Pyridine-N-Oxides as Mild Bases.  
2.4c Deuterium Labeling Experiments 
Based on the proposed mechanism, we hypothesized that 
protonated 4-chloropyridine N-oxide (Pry-OH○+) may undergo deuterium-
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hydrogen exchange with external deuterium source such as deuterium 
oxide (D2O) to form deuterated 4-chloropyridine N-oxide (Pry-OD○
+); if 
this proposed process occurs, the deuterated dienes should be observed.  
 
Scheme 3.14 Proposed Deuterium-Hydrogen Exchange Process. 
To test our hypothesis, deuterium oxide (D2O) was added to the 
reaction mixtures under optimized reaction conditions. And the results 
were reported in Scheme 3.15. Both deuterated diene-diazo and [4+2]-
cycloaddition products were obtained; and the percentage of two 
deuterated products was almost the same even with changing the amount 
of deuterium oxide (D2O).  
 
Scheme 3.15 Deuterium Labeling Experiments. 
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2.4d Theoretical Study 
To further understand this unique intramolecular [4+2]-
cycloaddition reaction, we are collaborating with Professor Kenneth 
Houk’s group at UCLA, whose calculated results fit our observations 
very well. Although there is an intrinsic preference for diazoketones and 
dienes to give the 1,3-dipolar cycloaddition [3+2]-cycloaddition products, 
our reaction strongly favors the intramolecular [4+2] across the diazo 
N=N bond because the tether distortion is much less than that of the 1,3-
dipolar cycloaddition (this work will published) . 
Figure 3.6 shows the energetics and transition states of 
intramolecular [4+2] cycloaddition across the N=N double bond of diazo 
ester for (E)- and (Z)-alkenes. The (E)-alkene is 2.5 kcal/mol stable than 
the (Z)-alkene. The observed product from (E)-alkene is formed with a 
barrier of only 26.9 kcal/mol. The reaction of the (Z)-alkene has a much 
high barrier (39.2 kcal/mol), and the product is slightly unstable 
compared to the reactant.  
 
Figure 3.6 Energetics and Transition States of Intramolecular [4+2]-
Cycloaddition (E vs Z) 
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Figure 3.7 shows the two possible competing [4+2] and [3+2] 
cycloadditions. The observed [4+2] cycloaddition has a lower barrier (by 
4 kcal/mol) compared to the (3+2) cycloaddition. Therefore, only the 
[4+2] product was observed experimentally, although the (3+2) product 
is more stable. 
 
Figure 3.7 Energetics and Transition States of [4+2]- and [3+2]-
Cycloadditions 
2.5 Further Applications of [4+2]-Cycloaddition Products 
The [4+2]-cycloaddition products formed from (E)-1 are stable 
dipolar species, and their suitability for dipolar cycloaddition with 
reactive alkenes and alkynes was examined.
29
 Treatment of 2e with N-
phenylmaleimide at room temperature for 6 h gave the nitrogen-fused 
pentacyclic compound 5e in 85% yield with complete diastereocontrol 






Figure 3.8 X-Ray Structure of 5e. 
III. Conclusion 
In summary, aryl-substituted 1-(1,3-dienyl) aryldiazoacetates were 
formed selectively and in moderate to high yields by Au(I)-catalyzed 
rearrangement of propargyl phenyldiazoacetates performed in the 
presence of a pyridine-N-oxide. Complete selectivity for Au(I) activation 
of the alkyne rather than metallocarbene formation from the diazoacetate 
occurred, and both aryl-substituted 1-(1,3-dienyl) aryldiazoacetates and 
the products from intramolecular [4+2]-cycloaddition of the diazo N=N 
bond to the diene were formed. Aryl-substituted (E)-1-(1,3-dienyl) 
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aryldiazoacetates underwent intramolecular [4+2]-diene-diazo 
cycloaddition under mild conditions without catalysis by the Au(I) 
reagent used in its formation and without evidence of a competing 
dipolar cycloaddition.
30
 Cycloaddition was first order in the substrate, 
and both the activation parameters and the Hammett relationships for the 
conversion of (E)-1 to 2 are consistent with those for other intramolecular 
Diels-Alder reactions.
31 
IV. Experimental Section 
4.1 General Information 
Unless noted all reactions were carried out under inert atmosphere 
of dinitrogen in oven-dried glassware with magnetic stirring using freshly 
distilled solvents. All solvents were purified and dried using standard 
methods. Analytical thin layer chromatography (TLC) plates were 
purchased from EM Science (silica gel 60 F254 plates). High-resolution 
mass spectra (HRMS) were performed on a microTOF-ESI mass 
spectrometer using CsI as the standard. Accurate masses are reported for 






. Melting points were 
determined on an Electrothermo Mel-Temp DLX 104 device and were 
uncorrected. Column chromatography was performed on CombiFlash
®
 
Rf 200 purification system using normal phase disposable columns. IR 
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spectra were recorded using Bruker Vectcr 22 spectrometer. All NMR 
spectra were recorded on a Bruker spectrometer at 400 MHz (
1
H NMR) 
and 100 MHz (
13
C NMR) or an Agilent spectrometer at 500 MHz (
1
H 
NMR) and 125 MHz (
13
C NMR). Chemical shifts are reported in ppm 
with the solvent signals as reference (in CDCl3 as solvent), and coupling 
constants (J) are given in Hertz (Hz). The peak information is described 
as: br = broad singlet, s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, comp = composite of magnetically non-equivalent protons. 
4.2 Materials 
AuCl, AuCl3, (PPh3)AuCl, (IPr)AuCl were purchased from Sigma-
Aldrich. AuCl(C4H8S) and AuCl3(C5H6N) were purchased from Strem 
Chemicals. Pyridine N-oxides were purchased from Sigma-Aldrich or 
prepared according to the literature procedures.
32
 Other chemicals were 
obtained from commercial sources and used without further purification. 
4.3 Experimental Procedures 




To a solution of Et2NH (20 mL) in an oven-dried flask equipped 
with a magnetic stirring bar was added 1-ethynylcyclopentan-1-ol (1.10 g, 
10.0 mmol), 1-chloro-4-iodobenzene (2.62 g, 11.0 mol), Pd(PPh3)2Cl2 
(700 mg, 1.0 mmol), CuI (38 mg, 2.0 mmol), and the reaction mixture 
was degassed with nitrogen. After stirring under refluxing conditions for 
24 h, the solvent of the reaction mixture was removed with the use of a 
vacuum pump. The residue was purified by column chromatography 
(hexane/ethyl acetate = 10/1) to give 1-((4-
chlorophenyl)ethynyl)cyclopentan-1-ol as a colorless oil (1.98 g, 90% 
yield).  
To a solution of 1-[(4-chlorophenyl)ethynyl]cyclopentan-1-ol (1.10 
mg, 5 mmol), phenylacetic acid (816 mg, 6 mmol) and DMAP (122 mg, 
1 mmol) in dry DCM (30 mL) was added to a solution of DCC (1.24 g, 6 




resulting mixture was allowed to warm to room temperature, and stirred 
for another 10 h, and a white solid was formed in the process. The 
reaction solution was added to 30 mL of hexanes and then  filtered 
through a Büchner funnel. After evaporating the solvent, the resulting 
reaction mixture was purified by column chromatography (hexane/ethyl 
acetate = 25/1) to give the 1-[(4-chlorophenyl)ethynyl]cyclopentyl 2-
phenylacetate as a colorless oil (1.39 g, 82% yield). 
To a solution of 1-[(4-chlorophenyl)ethynyl]cyclopentyl 2-
phenylacetate (1.29 g, 4.1 mmol) and p-ABSA (1.20 g, 5 mmol) in dry 
CH3CN (30 mL) was added DBU (0.76g, 5mmol) dropwise at 0
o
C. The 
resulting mixture was allowed to warm to room temperature, and stirred 
for another 10 h. The reaction was quenched with aqueous NH4Cl 
solution (60 mL), and then extracted with diethyl ether (50 mL×2) and 
dried over anhydrous MgSO4. After evaporating the solvent, the reaction 
mixture was purified by column chromatography (hexane/ethyl acetate = 
30/1) to give the 1-[(4-chlorophenyl)ethynyl]cyclopentyl α-diazo-α-
phenylacetate 4m as a yellow oil (1.30 g, 85% yield). 
Compounds 4n – 4q were prepared from corresponding iodo(bromo)-
arenes using the same synthetic procedure with 4m. 
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General Procedure for Gold Catalyzed Rearrangement of Propargyl 
Aryldiazoacetates in the Presence of 4-Chloropyridine N-Oxide:  
To a flame-dried 10 mL Schlenk flask charged with a magnetic 
stirring bar, AuCl(SMe2) (2.90 mg, 0.010 mmol), 4-chloropyridine N-
oxide 6b (25.9 mg, 0.20 mmol) and 2.0 mL toluene were added 
sequentially under nitrogen atmosphere. Then 4 (0.20 mmol) dissolved in 
3.0 mL of toluene was added at once into the solution under the flow of 
nitrogen. The resulting mixture was allowed to stir for the stated time at 
room temperature, then purified by column chromatography (with 100:1 
to 10:1 gradient of hexanes: ethyl acetate as eluents) to give isolated (Z)-
1 and 2. 
General Procedure for Deuterium Labeling Experiments 
To a flame-dried 10 mL Schlenk flask charged with a magnetic 
stirring bar, AuCl(SMe2) (2.90 mg, 0.010 mmol), 4-chloropyridine N-
oxide 6b (25.9 mg, 0.20 mmol), x (x = 1.0, 2.0, 5.0, 10.0) equiv. of 
deuterium oxide (D2O) and 2.0 mL toluene were added sequentially 
under nitrogen atmosphere. Then 4a (0.20 mmol) dissolved in 3.0 mL of 
toluene was added at once into the solution under the flow of nitrogen. 
The resulting mixture was allowed to stir for the 4 days at room 
temperature, then purified by column chromatography (with 100:1 to 
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10:1 gradient of hexanes: ethyl acetate as eluents) to give isolated (Z)-1a 





Kinetic Measurements:  
 
Isolation of (E)-1a: To a flame-dried 10 mL Schlenk flask charged 
with a magnetic stirring bar, AuCl(SMe2) (2.90 mg, 0.010 mmol), 4-
chloropyridine-N-oxide (25.9 mg, 0.20 mmol) and 2.0 mL toluene were 
added sequentially under nitrogen atmosphere. Then 4 (0.20 mmol) 
dissolved in 3.0 mL of toluene was added at once into the solution under 
the flow of nitrogen. The resulting mixture was allowed to stir for 6 - 12 
h at room temperature. The mixture of diene (E)-1a with (Z)-1a was 
isolated following the separation on the silica gel column 
chromatography (with 100:1 to 30:1 gradient of hexanes:ethyl acetate as 
eluents) and removal solvents in a water bath at 5 - 10
o
C under vacuum. 
The mixture of diene (E)-1a with (Z)-1a was obtained as light yellow oil 
and kept under nitrogen atmosphere at -78
o
C. Pure diene (E)-1a could be 
isolated by preparative TLC plates.  
Data collection for the intermolecular cycloaddition reaction: 
Because (E)-1a is inert to [4+2]-cycloaddition and stable in CDCl3 at 
room temperature, we decided to use the mixture of diene (E)-1a with 
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(Z)-1a for data collection. The mixture of diene (E)-1a with (Z)-1a (0.1 
M for combined concentration) was diluted in CDCl3 and placed in an 
NMR tube. The ratio of diene (E)-1a [δ 6.39 (s, 1H), 5.84 (t, J = 2.2 Hz, 
1H) with (Z)-1a (1:1) [δ 6.55 (s, 1H), 5.90 (t, J = 2.4 Hz, 1H) was 
determined by 
1
H NMR analysis (Agilent spectrometer at 500 MHz  for 
1
H NMR). The NMR tube was placed in an oil bath at 41
o
C with 
temperature stability of ±0.5
o
C for 10.0 min and quenched by dry ice-
acetone bath. The 
1
H NMR spectra were recorded after the heating of 
each 10.0 (or 30.0) min. A control experiment was carried out which 
proved that the presence of (Z)-1a had no effect on the rate of 
intramolecular [4+2]-reaction or on the yield of products.  
Computational methods for determining the progress of the 
intramolecular cycloaddition reaction: The amount of (E)-1a was 
determined by the integration of (E)-1a olefinic protons at δ = 6.39 (s, 1H, 
normalized as “1.00”), 5.84 (t, J = 2.2 Hz, 1H), and the difference was 
less than 5%. The amount of (E)-1a0
 
was calculated by combined 
integration of (E)-1a with 2a [δ 8.69 (d, J = 8.5, 2H), 6. 57 – 6.54 (m, 
1H)] or the integration of (Z)-1a [δ 6.63 (s, 1H), 5.98 (t, J = 2.4 Hz, 1H), 
and the difference of two methods was less than 5%.  
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For other substituted derivatives: The mixture of diene (E)-1 with 
(Z)-1 was isolated following the same procedure as 1a and was used 
directly for data collection of the intermolecular cycloaddition reaction. 
The amount of (E)-1 was determined by the integration of (E)-1 olefinic 
protons δ = 6.45 – 6.35 (s, 1H, normalize as “1.00”), 5.85 – 5.75, (t, 1H) 
and the difference was less than 5%. The amount of (E)-10
 
was calculated 
by combined integration of (E)-1 with 2 [δ 8.80 – 8.60 (d, 2H), 6. 60 – 
6.50 (m, 1H)] or the integration of (Z)-1a [δ 6.70 – 6.50 (s, 1H), 5.95 – 











C) were obtained by the same procedure: the time in oil bath ranged 
from every 5 min (49
o
C) to 1 h (20
o
C) with a temperature stability of 
±0.5
o
C (Figure 3.9 to Figure 3.12). This intramolecular process was 
recorded at least 8 times. An Arrhenius plot was obtained from the 
kinetic rate constants that were obtained and their corresponding 
temperature (Table 3.5 and Figure 3.13). The activation energy Eact was 





298 were calculated by the Eyring equation. 
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Table 3.5 Data for Arrhenius plot 
 
lnk -11.09 -10.12 -9.25 -8.52 














Figure 3.11 First-order Rate Constant at 30
 o









Figure 3.13 Arrhenius plot: (E)-1a Activation Energy. 
 
4.4 Characterization Data for New Compounds 
(The characterization data for 4a, 4a-g has been reported on Chapter 




diazoacetate 4b: 63% yield. Red solid, m.p. 69.1 – 71.0℃. 1H NMR 
(500 MHz, CDCl3) δ 7.47 – 7.39 (comp, 2H), 7.31 – 7.24 (comp, 3H), 
7.10 (s, 1H), 6.88 (d, J = 8.2 Hz, 1H), 6.82 (d, J = 8.2 Hz, 1H), 5.96 (s, 
2H), 2.44 – 2.35 (comp, 2H), 2.33 – 2.25 (comp, 2H), 1.86 – 1.75 (comp, 
4H).
 13
C NMR (125 MHz, CDCl3) δ 163.79, 148.31, 145.92, 131.81, 
128.27, 128.10, 122.64, 118.71, 117.71, 108.73, 105.68, 101.19, 89.33, 
85.05, 82.13, 40.75, 23.42. IR (neat) 2085, 1700, 1492, 1235, 903 cm
-1
. 








phenyl]acetate 4h: 58% yield. Yellow oil. 
1
H NMR (500 MHz, CDCl3) 
δ 7.68 – 7.57 (comp, 4H), 7.47 – 7.43 (comp, 2H), 7.33 – 7.25 (comp, 
3H), 2.48 – 2.38 (comp, 2H), 2.37 – 2.26 (comp, 2H), 1.90 – 1.79 (comp, 
4H).
 13
C NMR (125 MHz, CDCl3) δ 162.73, 131.82, 130.27, 128.42, 
128.17, 127.47 (q, J = 32.5 Hz), 125.73 (q, J = 3.8 Hz), 124.09 (q, J = 
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270.2 Hz), 123.45, 122.53, 89.02, 85.39, 82.68, 40.78, 23.45. IR (neat) 
2092, 1704, 1325, 1125, 1070, 903 cm
-1





 421.1134, found: 421.1131. 
 
1-(Phenylethynyl)cyclopentyl 2-Diazo-2-(4-nitrophenyl)acetate 
4i: 54% yield. Yellow solid, m.p. 113.4 – 114.5℃. 1H NMR (500 MHz, 
CDCl3) δ 8.22 (d, J = 9.0 Hz, 2H), 7.68 (d, J = 9.0 Hz, 2H), 7.47 – 7.42 
(comp, 2H), 7.32 – 7.27 (comp, 3H), 2.46 – 2.38 (comp, 2H), 2.35 – 2.28 
(comp, 2H), 1.92 – 1.78 (comp, 4H). 
13
C NMR (125 MHz, CDCl3) δ 
162.03, 144.95, 134.04, 131.80, 128.49, 128.18, 124.20, 123.18, 122.38, 
88.72, 85.57, 83.07, 40.75, 23.42. IR (neat) 2095, 1708, 1594, 1335, 
1245, 1152, 903 cm
-1









diazoacetate 4j: 60% yield.  Yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 
7.62 (d, J = 8.1 Hz, 1H), 7.57 (d, J = 7.7 Hz, 1H), 7.47 – 7.43 (comp, 2H), 
7.36 (t, J = 7.7 Hz, 1H), 7.31 – 7.27 (comp, 3H), 7.19 (t, J = 7.7 Hz, 1H), 
2.43 – 2.37 (comp, 2H), 2.33 – 2.25 (comp, 2H), 1.86 – 1.78 (comp, 4H). 
13
C NMR (125 MHz, CDCl3) δ 163.77, 133.28, 132.80, 131.80, 129.86, 
128.24, 128.08, 127.55, 125.86, 122.69, 89.39, 85.01, 82.29, 40.72, 23.40. 
IR (neat) 2098, 1700, 1153, 902 cm
-1





 431.0366, found: 431.0386. 
 
1-[(4-Methoxyphenyl)ethynyl]cyclopentyl α-Diazo-α-phenyl-
acetate 4k: 52% yield.  Yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 7.52 
(d, J = 7.7 Hz, 2H), 7.43 – 7.36 (comp, 4H), 7.18 (t, J = 8.5 Hz, 1H), 6.84 
– 6.80 (d, J = 8.5 Hz, 2H), 3.79 (s, 3H), 2.47 – 2.40 (comp, 2H), 2.35 – 
2.27 (comp, 2H), 1.88 – 1.80 (comp, 4H). 
13
C NMR (125 MHz, CDCl3) δ 
163.43, 159.56, 133.24, 128.77, 125.59, 123.86, 114.70, 113.68, 87.89, 









383.1366, found: 383.1364. 
 
1-(p-Tolylethynyl)cyclopentyl α-Diazo-α-phenylacetate 4l: 60% 
yield.  Yellow oil. 
1
H NMR (500 MHz, CDCl3) 7.51 (d, J = 8.1 Hz, 2H), 
7.40 – 7.32 (comp, 4H), 7.19 – 7.15 (m, 1H), 7.09 (d, J = 8.1 Hz, 2H), 
2.46 – 2.38 (comp, 2H), 2.35 – 2.26 (comp, 5H), 1.88 – 1.79 (comp, 4H). 
13
C NMR (125 MHz, CDCl3) δ 163.49, 138.35, 131.71, 128.86, 128.83, 
125.66, 123.95, 119.58, 88.61, 85.21, 82.29, 40.78, 23.43, 21.43. IR (neat) 
2079, 1703, 1598, 1498, 1244, 1142, 1003 cm
-1





 367.1417, found: 367.1426.  
 
1-[(4-Chlorophenyl)ethynyl]cyclopentyl α-Diazo-α-
phenylacetate 4m: 62% yield.  Yellow oil. 
1
H NMR (500 MHz, CDCl3) 
δ 7.51 (d, J = 7.7 Hz, 2H), 7.41 – 7.36 (comp, 4H), 7.27 (d, J = 7.7 Hz, 
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2H), 7.19 (t, J = 9.6 Hz, 1H), 2.47 – 2.38 (comp, 2H), 2.36 – 2.28 (comp, 
2H), 1.89 – 1.80 (comp, 4H). 
13
C NMR (125 MHz, CDCl3) δ 163.48, 
134.30, 133.03, 128.86, 128.44, 125.74, 125.52, 123.93, 121.16, 90.33, 
83.96, 81.97, 40.71, 23.44. IR (neat) 2087, 1701, 1149, 903 cm
-1
. HRMS 








acetate 4n: 61% yield.  Yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 7.50 
(d, J = 8.4 Hz, 2H), 7.45 – 7.40 (comp, 2H), 7.40 – 7.35 (comp, 2H), 7.18 
(t, J = 7.5, 1H), 7.98 (t, J = 7.5, 1H), 2.45 – 2.38 (comp, 2H), 2.33 – 2.25 
(comp, 2H), 1.87 – 1.79 (comp, 4H). 
13
C NMR (125 MHz, CDCl3) δ 
163.51, 162.52 (d, J = 249.9 Hz), 133.74 (d, J = 8.3 Hz), 128.87, 125.73, 
125.58, 123.95, 118.74(d, J = 3.5 Hz), 115.39 (d, J = 22.4 Hz), 89.05, 
84.03, 82.07, 40.74, 23.44. IR (neat) 2085, 1702, 1505, 1246, 1147, 905 
cm
-1









benzoate 4o: 57% yield.  Yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 7.96 
(d, J = 8.2 Hz, 2H), 7.52 – 7.48 (comp, 4H), 7.38 (t, J = 7.9 Hz, 2H), 7.18 
(t, J = 10.6, 1H), 3.90 (s, 3H), 2.45 – 2.37 (comp, 2H), 2.35 – 2.25 (comp, 
2H), 1.88 – 1.79 (comp, 4H). 
13
C NMR (125 MHz, CDCl3) δ 166.50, 
163.49, 131.69, 129.54, 129.28, 128.88, 127.39, 125.77, 125.48, 123.94, 
92.38, 84.35, 81.86, 52.16, 40.71, 23.46. IR (neat) 2081, 1703, 1605, 
1273, 1145, 1004 cm
-1





 411.1315, found: 411.1314. 
 
1-[(4-Formylphenyl)ethynyl]cyclopentyl α-Diazo-α-phenyl-
acetate 4p: 53% yield. Yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 9.99 (s, 
1H), 7.81 (d, J = 8.1 Hz, 2H), 7.60 (d, J = 8.1 Hz, 2H), 7.51 (d, J = 7.7 
Hz, 2H), 7.40 (t, J = 7.7 Hz, 2H), 7.19 (t, J = 7.7 Hz, 1H), 2.46 – 2.40 
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(comp, 2H), 2.36 – 2.29 (comp, 2H), 1.89 – 1.83 (comp, 4H). 
13
C NMR 
(125 MHz, CDCl3) δ 191.41, 163.48, 135.47, 132.28, 129.34, 128.97, 
128.89, 125.80, 125.42, 123.93, 93.49, 84.23, 81.75, 40.69, 23.47. IR 
(neat) 2087, 1709, 1497 cm
-1





 381.1210, found: 381.1219. 
 
1-[(4-Nitrophenyl)ethynyl]cyclopentyl α-Diazo-α-phenylacetate 
4q: 47% yield. Yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 8.14 (d, J = 9.0 
Hz, 2H), 7.58 (d, J = 9.0 Hz, 2H), 7.48 (d, J = 7.5 Hz, 2H), 7.39 (t, J = 
7.5 Hz, 2H), 7.19 (t, J = 7.5 Hz, 1H), 2.47 – 2.39 (comp, 2H), 2.35 – 2.28 
(comp, 2H), 1.88 – 1.82 (comp, 4H). 
13
C NMR (125 MHz, CDCl3) δ 
163.49, 147.07, 132.48, 129.60, 128.91, 125.86, 125.33, 123.92, 123.37, 
94.81, 83.30, 81.56, 40.65, 23.48. IR (neat) 2090, 1703, 1521, 1346, 
1150, 906 cm
-1









acetate 1a: 32% yield. 
 1
H NMR (500 MHz, CDCl3) δ 7.47 (d, J = 7.6 Hz, 
2H), 7.40 (d, J = 7.5 Hz, 2H), 7.32 (t, J = 7.6 Hz, 2H), 7.26 (t, J = 7.5 Hz, 
2H), 7.20 – 7.18 (m, 1H), 7.15 – 7.12 (m, 1H), 6.55 (s, 1H), 5.90 (t, J = 
2.4 Hz, 1H), 2.60 (t, J = 6.4 Hz, 2H), 2.32 (dt, J = 7.6, 2.4 Hz, 2H), 1.90 
– 1.80 (comp, 2H). 
13
C NMR (125 MHz, CDCl3) δ 163.24, 143.72, 
138.56, 135.57, 135.44, 129.03, 128.62, 128.23, 126.09, 124.79, 124.47, 





 463.0417, found: 463.0437. 
 
(Z)-2-(Cyclopent-1-en-1-yl)-1-phenylvinyl 2-(Benzo[d][1,3]-
dioxol-5-yl)-2-diazoacetate 1b: 38% yield. 
1
H NMR (500 MHz, CDCl3) 
δ 7.46 (d, J = 7.0 Hz, 2H), 7.34 (t, J = 7.0 Hz, 2H), 7.29 – 7.27 (m, 1H), 
7.14 – 7.09 (m, 1H), 6.92 (d, J = 8.2 Hz, 1H), 6.85 (d, J = 8.2 Hz, 1H), 
6.61 (s, 1H), 5.97 (t, J = 2.0 Hz, 1H),  5.96 (s, 2H), 2.67 (t, J = 6.3 Hz, 
2H), 2.40 (dt J = 7.3, 2.0 Hz, 2H), 1.97 – 1.90 (comp, 2H).
 13
C NMR 
(126 MHz, CDCl3) δ 163.61, 148.50, 146.27, 143.75, 138.55, 135.58, 
135.42, 128.62, 128.23, 124.47, 124.38, 117.82, 115.06, 108.87, 105.63, 
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101.33, 33.06, 32.20, 23.83.
 





 507.0316, found: 507.0319.  
 
(Z)-2-(Cyclopent-1-en-1-yl)-1-phenylvinyl α-Diazo-α-(p-tolyl)-
acetate 1c: 40% yield. 
 1
H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 7.3 Hz, 
2H), 7.43 (d, J = 8.5 Hz, 2H), 7.34 (t, J = 7.3 Hz, 2H), 7.31 -7.28 (m, 1H), 
7.22 (d, J = 8.5 Hz, 2H), 6.63 (s, 1H), 5.98 (t, J = 2.3 Hz, 1H), 2.68 (t, J = 
6.5 Hz,  2H), 2.40 (dt, J = 7.5, 2.3 Hz, 2H), 2.35 (s, 3H), 1.92 – 1.83 
(comp, 2H). 
13
C NMR (125 MHz, CDCl3) δ 163.48, 143.76, 138.60, 
136.03, 135.61, 135.38, 129.75, 128.60, 128.20, 124.47, 123.94, 121.40, 





 477.0574, found: 477.0592. 
 
(Z)-2-(Cyclopent-1-en-1-yl)-1-phenylvinyl 2-([1,1'-Biphenyl]-4-
yl)-2-diazoacetate 1d: 38% yield. 
  1
H NMR (500 MHz, CDCl3) δ 7.66 – 
7.62 (comp, 3H), 7.61 – 7.57 (comp, 3H), 7.51 – 7.47 (comp, 2H), 7.43 – 
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7.46 (comp, 2H), 7.37 – 7.33 (comp, 3H), 7.30 – 7.28 (m, 1H), 6.64 (s, 
1H), 5.99 (t, J = 2.4 Hz, 1H), 2.69 (t, J = 6.5 Hz, 2H), 2.41 (dt, J = 7.5, 
2.4 Hz, 2H), 1.88 (tt, J = 7.5, 6.5 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) δ 
163.27, 143.73, 140.21, 138.93, 138.55, 135.56, 135.52, 128.84, 128.65, 
128.26, 127.68, 127.43, 126.87, 124.48, 124.15, 123.64, 115.12, 33.08, 





539.0730, found: 539.0757. 
 
(Z)-2-(Cyclopent-1-en-1-yl)-1-phenylvinyl 2-(4-Bromophenyl)-
2-diazoacetate 1e: 39% yield. 
  1
H NMR (500 MHz, CDCl3) δ 7.51 (d, J 
= 8.8 Hz, 2H), 7.46 (d, J = 7.5 Hz, 2H), 7.42 (d, J = 8.8 Hz, 2H), 7.36 – 
7.32 (comp, 2H), 7.29 (t, J = 7.5 Hz, 1H), 6.62 (s, 1H), 5.98 (t, J = 2.2 Hz, 
1H), 2.65 (t, J = 6.3 Hz, 2H), 2.40 (dt J = 8.2, 2.2 Hz, 2H), 1.96 – 1.91 
(comp, 2H). 
13
C NMR (125 MHz, CDCl3) δ 162.97, 143.61, 138.40, 
135.65, 135.44, 132.10, 128.65, 128.30, 125.23, 124.43, 123.98, 119.67, 









2-diazo-acetate 1f: 36% yield. 
  1
H NMR (500 MHz, CDCl3) δ 7.48 
(comp, 4H), 7.38 – 7.33 (comp, 4H), 7.29 (t, J = 7.3 Hz, 1H), 6.62 (s, 
1H), 5.99 (t, J = 2.5 Hz ,1H), 2.66 (t, J = 6.6 Hz, 2H), 2.40 (dt, J = 7.6, 
2.5 Hz, 2H), 1.97 – 1.90 (comp, 2H). 
13
C NMR (125 MHz, CDCl3) δ 
163.00, 143.64, 138.42, 135.64, 135.47, 131.83, 129.19, 128.66, 128.31, 





 497.0028, found:497.0047. 
 
(Z)-2-(Cyclopent-1-en-1-yl)-1-phenylvinyl 2-Diazo-2-(4-fluoro-
phenyl)-acetate 1g: 34% yield. 
  1
H NMR (500 MHz, CDCl3) δ 7.53 – 
7.44 (comp, 4H), 7.34 (t, J = 7.5 Hz, 1H), 7.30 – 7.26 (comp, 1H), 7.10 
(d, J = 7.5 Hz, 2H), 6.62 (s, 1H), 6.97 (t, J = 2.5 Hz ,1H), 2.66 (t, J = 6.5 
Hz ,2H), 2.40 (dt, J = 7.6, 2.5 Hz, 2H), 1.98 – 1.89 (comp, 2H). 
13
C NMR 
(125 MHz, CDCl3) δ 163.33, 161.20 (d, J = 247.9 Hz), 143.70, 138.48, 
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135.56, 135.53, 128.65, 128.29, 125.81(d, J = 7.8 Hz), 124.46, 120.52 (d, 
J = 1.9 Hz), 116.15 (d, J = 21.9 Hz), 115.13, 33.07, 32.20, 23.83. HRMS 








(trifluoromethyl)phenyl]acetate 1h: 32% yield. 
  1
H NMR (500 MHz, 
CDCl3) δ 7.69 – 7.64 (comp, 4H), 7.48 (d, J = 8.3 Hz, 2H), 7.36 (t, J = 
7.6 Hz, 2H), 7.32 – 7.28 (m, 1H), 6.65 (s, 1H), 6.01 (t, , J = 2.6 Hz, 1H), 
2.67 (t, J = 6.7 Hz, 2H), 2.42(dt, J = 7.8 Hz, 2.6 Hz,  2H), 1.98 – 1.92 (m, 
2H). 
13
C NMR (125 MHz, CDCl3) δ 162.57, 143.55, 138.33, 135.83, 
135.37, 129.36, 128.69, 128.41, 127.91 (q, J = 32.4 Hz), 125.93 (q, J = 
3.8 Hz), 124.44, 123.96 (q, J = 270.2 Hz), 123.42, 115.24, 33.06, 32.19, 









phenyl)-acetate 1i: 18% yield. 
  1
H NMR (500 MHz, CDCl3) δ 8.24 (d, J 
= 9.0 Hz, 2H), 7.70 (d, J = 9.0 Hz, 2H), 7.46 (d, J = 7.4 Hz, 2H), 7.36 (t, 
J = 7.4 Hz, 2H), 7.32 - 7.28 (m, 1H), 6.64 (s, 1H), 6.01  (t, J = 2.4 Hz, 
1H), 2.65 (t, J = 6.4 Hz, 2H), 2.41 (dt, J = 7.5, 2.4 Hz, 2H), 1.97 – 1.91 
(comp, 2H). 
13
C NMR (125 MHz, CDCl3) δ 162.00, 145.34, 143.46, 
138.17, 136.11, 135.22, 133.05, 128.75, 128.48, 124.43, 124.37, 123.30, 





 508.0268, found: 508.0286. 
 
(Z)-2-(Cyclopent-1-en-1-yl)-1-phenylvinyl 2-(2-Bromophenyl)-
2-diazo-acetate 1j: 20% yield. 
  1
H NMR (500 MHz, CDCl3) δ 7.66 (d, J 
= 8.0 Hz, 1H), 7.59 (d, J = 7.2 Hz, 1H), 7.49 (d, J = 8.0 Hz, 2H), 7.41 – 
7.33 (comp, 3H), 7.31 – 7.27 (m, 1H), 7.26 – 7.23 (m, 1H), 6.59 (s, 1H), 
5.97 (t, J = 2.2 Hz, 1H), 2.75 – 2.65 (comp, 2H), 2.40 (dt, J = 7.0, 2.2 Hz, 
2H), 2.00 – 1.92 (comp, 2H). 
13
C NMR (125 MHz, CDCl3) δ 163.78, 
144.00, 138.59, 135.56, 135.27, 135.23, 133.34, 130.52 130.51, 128.58, 
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128.19, 127.83, 124.52, 114.95, 114.91, 33.21, 32.24, 23.80. HRMS (ESI) 




 540.9522, found: 540.9552. 
 
(Z)-2-(Cyclopent-1-en-1-yl)-1-(4-methoxyphenyl)vinyl α-Diazo-
α-phenylacetate 1k: 42% yield. 
  1
H NMR (500 MHz, CDCl3) δ 7.55 (d, 
J = 8.9 Hz, 2H), 7.42– 7.38  (comp, 4H), 7.21 (t, J = 7.4 Hz, 1H), 6.87 (d, 
J = 8.9 Hz, 2H), 6.51 (s, 1H), 5.93 (t,  J = 2.4 Hz, 1H), 3.80 (s, 3H), 2.66 
(t, J = 6.8 Hz, 2H), 2.39 (dt, J = 7.8, 2.4 Hz, 2H), 1.95 – 1.89 (comp, 2H). 
13
C NMR (125 MHz, CDCl3) δ 159.69, 143.65, 138.59, 134.37, 129.02, 
128.24, 126.06, 125.90, 124.84, 123.82, 114.09, 113.90, 113.42, 55.30, 





 493.0523, found: 493.0539. 
 
(Z)-2-(Cyclopent-1-en-1-yl)-1-(p-tolyl)vinyl α-Diazo-α-phenyl-
acetate 1l: 41% yield. 
1
H NMR (500 MHz, CDCl3) δ 7.55(d, J = 8.0 Hz, 
2H), 7.42 – 7.36 (comp, 4H), 7.21 (t, J = 7.57, 1H), 7.15 (d, J = 7.7 Hz, 
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2H), 6.58 (s, 1H), 5.95 (t, J = 2.0 Hz, 1H), 2.67 (t, J = 6.6 Hz, 2H), 2.39 
(dt, J = 7.6, 2.0 Hz, 2H), 2.34 (s, 3H), 1.97 – 1.89 (comp, 2H). 
13
C NMR 
(125 MHz, CDCl3) δ 163.25, 143.90, 138.61, 138.23, 134.88, 132.79, 
129.36, 129.02, 126.05, 124.85, 124.41, 123.82, 114.20, 33.10, 32.17, 





477.0574, found: 477.0587. 
 
(Z)-1-(4-Chlorophenyl)-2-(cyclopent-1-en-1-yl)vinyl α-Diazo-α-
phenyl-acetate 1m: 40% yield. 
  1
H NMR (500 MHz, CDCl3) δ 7.54 (d, J 
= 8.5 Hz, 2H), 7.44 – 7.38 (comp, 4H), 7.34 – 7.29 (d, J = 7.4 Hz, 2H), 
7.23 (t, J = 7.4 Hz, 1H), 6.61 (s, 1H), 6.00 (t, J = 2.4 Hz, 1H), 2.67 (t, J = 
6.3 Hz, 2H), 2.41 (dt, J = 7.7, 2.4 Hz, 2H), 1.98 – 1.91 (comp, 2H). 
13
C 
NMR (125 MHz, CDCl3) δ 163.17, 142.69, 138.40, 136.12, 134.22, 
134.02, 129.08, 128.84, 126.21, 125.75, 124.60, 123.84, 115.58, 32.99, 









phenylacetate 1n: 36% yield. 
  1
H NMR (500 MHz, CDCl3) δ 7.55 (d, J 
= 8.1 Hz, 2H), 7.46 (d, J = 8.1 Hz, 2H), 7.42 (d, J = 8.0 Hz, 2H), 7.23 (t, 
J = 8.0 Hz, 1H), 7.04 (t, J = 8.0 Hz, 2H), 6.56 (s, 1H), 5.97 (t, J = 2.5 Hz, 
1H), 2.67 (t, J = 6.5 Hz, 2H), 2.40 (dt, J = 7.9, 2.5 Hz, 2H), 1.98 – 1.90 
(comp, 2H). 
13
C NMR (125 MHz, CDCl3) δ 163.20, 162.65 (d, J = 247.1 
Hz), 142.86, 138.40, 135.73 (d, J = 3.3 Hz), 131.90, 129.07, 126.35(d, J 
= 8.1 Hz), 126.19, 124.64, 123.84, 115.65 (d, J = 21.8 Hz), 115.02, 33.02, 





481.0323, found: 481.0332.  
 
Methyl (Z)-4-(2-(Cyclopent-1-en-1-yl)-1-[(2-diazo-2-phenyl-
acetoxy)vinyl]benzoate 1o: 36% yield. 
 1
H NMR (500 MHz, CDCl3) δ 
8.01(d, J = 8.6 Hz, 2H), 7.56 – 7.52 (comp, 4H), 7.44 – 7.38 (comp, 2H), 
7.21 (t, J = 7.4 Hz, 1H), 6.58 (s, 1H), 6.08 – 6.05 (m, 1H), 3.91 (s, 3H), 
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2.71 – 2.65 (comp, 2H), 2.45 – 2.39 (comp, 2H), 1.99 – 1.91 (comp, 2H). 
13
C NMR (126 MHz, CDCl3) δ 166.59, 163.15, 142.69, 139.92, 138.48, 
137.27, 129.97, 129.09, 126.24, 124.56, 124.23, 123.87, 117.18, 52.12, 





 521.0472, found: 521.0494. 
 
(Z)-2-(Cyclopent-1-en-1-yl)-1-(4-formylphenyl)vinyl α-Diazo-α-
phenylacetate 1p: 36% yield. 
  1
H NMR (500 MHz, CDCl3) δ 9.98 (s, 
1H), 7.86 (d, J = 8.6 Hz, 2H), 7.63 (d, J = 8.6 Hz, 2H), 7.54 (d, J = 7.7 
Hz, 2H), 7.41 (t, J = 7.7 Hz, 2H), 7.23 (t, J = 7.7 Hz, 1H), 6.79 (s, 1H), 
6.10 (t, J = 2.5 Hz, 1H), 2.69 (t, J = 7.3 Hz, 2H), 2.43 (dt, J = 7.5, 2.5 Hz, 
2H), 1.95 (dd, J = 15.0, 7.4 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) δ 
191.41, 163.05, 142.42, 141.42, 138.49, 138.02, 135.66, 130.11, 129.12, 
126.31, 124.79, 124.46, 123.87, 118.02, 32.91, 32.35, 23.82. HRMS (ESI) 








oxazolo[3,2-b]pyridazin-4-ium-5-ide 2a: 48% yield. 
 
Light yellow solid, 
100 ℃(dec.); 1H NMR (400 MHz, CDCl3) δ 8.69 d, J = 8.5, 2H), 7.69 – 
7.42 (comp, 2H), 7.41 – 7.10 (comp, 6H), 6. 57 – 6.54 (m, 1H), 3.82 (t, J 
= 8.2 Hz, 1H), 2.66 – 2.36 (comp, 3H), 2.16 – 1.85 (comp, 2H), 1.83 – 
1.61 (m, 1H).
 13
C NMR (101 MHz, CDCl3) δ 163.94, 148.42, 135.16, 
130.09, 128.89, 128.10, 127.70, 127.61, 126.01, 125.43, 115.87, 104.8, 





 331.1441, found: 331.1461. 
 
3-(Benzo[d][1,3]dioxol-5-yl)-2-oxo-9a-phenyl-2,5a,6,7,8,9a-
hexahydro-cyclopenta[e]oxazolo[3,2-b]pyridazin-4-ium-5-ide 2b: 54% 
yield. Yellow solid, 100 ℃(dec.);  1H NMR (500 MHz, CDCl3) δ 8.32 (d, 
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J = 8.8 Hz, 2H), 7.42 – 7.32 (comp, 3H), 7.28 (d, J = 7.3 Hz, 2H), 6.96 – 
6.92 (m, 1H), 6.56 – 6.52 (m, 1H), 6.01 (s, 2H), 3.78 (t, J = 8.6 Hz, 1H), 
2.59 – 2.44 (comp., 3H), 2.05 - 1.90 (comp, 2H), 1.80 – 1.74 (m, 1H).
13
C 
NMR (125 MHz, CDCl3) δ 163.93, 148.52, 147.28, 146.79, 135.30, 
130.04, 128.87, 125.96, 121.87, 120.26, 115.83, 108.13, 105.56, 101.05, 





 375.1339, found: 375.1358. 
 
2-Oxo-9a-phenyl-3-(p-tolyl)-2,5a,6,7,8,9a-hexahydrocyclo-
penta[e]-oxazolo[3,2-b]pyridazin-4-ium-5-ide 2c: 54% yield. Light 
yellow solid, 100 ℃ (dec.); 1H NMR (500 MHz, CDCl3) δ 8.58 (d, J = 
8.2 Hz, 2H), 7.39 – 7.36 (m, 1H), 7.36 – 7.27 (comp, 6H), 6.56 – 6.53 (m, 
1H), 3.78 (t, J = 8.7 Hz, 1H), 2.58 – 2.44 (comp, 3H), 2.40 (s, 3H), 2.04 – 
1.98 (comp, 1H), 1.97 – 1.90 (m, 1H), 1.80 – 1.74 (m, 1H). 
13
C NMR 
(125 MHz, CDCl3) δ 163.99, 148.46, 137.67, 135.32, 130.03, 128.86, 
128.80, 126.02, 125.44, 124.90, 115.86, 105.61, 96.56, 68.03, 32.21, 









hexahydro-cyclopenta[e]oxazolo[3,2-b]pyridazin-4-ium-5-ide 2d: 53% 
yield. Light yellow solid, 100 ℃ (dec.); 1H NMR (500 MHz, CDCl3) δ 
8.80 (d, J = 8.7 Hz, 2H), 7.74 (d, J = 8.7 Hz, 2H), 7.69 – 7.66 (comp, 2H), 
7.49 – 7.45 (comp, 2H), 7.41 – 7.36 (comp, 3H), 7.36 – 7.33 (comp, 3H), 
6.60 – 6.57 (m, 1H), 3.84 (t, J = 8.7 Hz, 1H), 2.63 – 2.44 (comp, 3H), 
2.10 – 2.01 (m, 1H), 2.00 – 1.91 (m, 1H), 1.85 – 1.74 (m, 1H). 
13
C NMR 
(125 MHz, CDCl3) δ 163.95, 148.45, 140.65, 140.00, 135.16, 130.12, 
128.91, 128.80, 127.38, 126.97, 126.73, 126.69, 126.01, 125.76, 115.88, 









cyclopenta[e]-oxazolo[3,2-b]pyridazin-4-ium-5-ide 2e: 50% yield. 
Light yellow solid, 100 ℃ (dec.); 1H NMR (500 MHz, CDCl3) δ 8.58 (d, 
J = 8.8 Hz,, 2H), 7.56 (d, J = 8.8 Hz, 2H), 7.40 – 7.30 (comp, 3H), 7.28– 
7.24 (comp, 2H), 6.54 – 5.51 (m, 1H), 3.76 (t, J = 8.7 Hz, 1H), 2.60 – 
2.42 (comp, 3H), 2.03 – 1.89 (comp, 2H), 1.80 – 1.72 (m, 1H). 
13
C NMR 
(125 MHz, CDCl3) δ 163.71, 148.46, 134.99, 131.24, 130.21, 128.97, 
126.89, 126.67, 125.97, 121.20, 115.83, 104.87, 96.98, 68.32, 32.15, 





409.0546, found: 409.0565. 
 
3-(4-Chlorophenyl)-2-oxo-9a-phenyl-2,5a,6,7,8,9a-hexahydro-
cyclopenta[e]oxazolo[3,2-b]pyridazin-4-ium-5-ide 2f: 52% yield. Light 
yellow solid, 100 ℃ (dec.); 1H NMR (500 MHz, CDCl3) δ 8.66 (d, J = 
8.6 Hz, 2H), 7.42 (d, J = 8.6 Hz, 2H), 7.38 (t, J = 7.6 Hz, 1H), 7.34 (t, J = 
7.6 Hz, 2H), 7.29 (d, J = 7.6 Hz, 2H), 6.55 – 6.52 (m, 1H), 3.79 (t, J = 8.6 
Hz, 1H), 2.60 – 2.44 (comp, 3H), 2.04 – 1.92 (comp, 2H), 1.78 (m, 1H). 
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13
C NMR (125 MHz, CDCl3) δ 163.78, 148.45, 134.95, 132.90, 130.20, 
128.95, 128.27, 126.64, 126.21, 125.95, 115.79, 104.79, 96.93, 68.26, 





 365.1051, found: 365.1071. 
 
3-(4-Fluorophenyl)-2-oxo-9a-phenyl-2,5a,6,7,8,9a-hexahydro-
cyclopenta[e]oxazolo[3,2-b]pyridazin-4-ium-5-ide 2g: 50% yield. 
Light yellow solid, 100 ℃ (dec.); 1H NMR (500 MHz, CDCl3) δ 8.70 (d, 
J = 8.7 Hz, 2H),, 7.41 – 7.32 (comp, 3H), 7.29 (t, J = 7.4 Hz, 2H), 7.15 (d, 
J = 7.4 Hz, 2H), 6.57– 6.53 (m, 1H), 3.79 (t, J = 8.2 Hz, 1H), 2.62 – 2.40 
(comp, 3H), 2.05 – 1.90 (comp, 2H), 1.82 – 1.73 (m, 1H). 
13
C NMR (125 
MHz, CDCl3) δ 163.93, 161.60 (d, J=248.2 Hz), 148.51, 135.07, 130.15, 
128.92, 127.54 (d, J=7.5 Hz), 125.96, 123.98, 115.5 (d, J=21.3 Hz), 









hexahydrocyclopenta[e]oxazolo [3,2-b]pyridazin-4-ium-5-ide 2h: 52% 
yield. Light yellow solid, 100 ℃ (dec.); 1H NMR (500 MHz, CDCl3) δ 
8.82 (d, J = 8.4 Hz, 2H), 7.70 (d, J = 8.4 Hz, 2H), 7.40 (t, J = 7.5 Hz, 1H), 
7.36 (t, J = 7.5 Hz, 2H), 7.30 (d, J = 7.5 Hz, 2H), 6.57 – 6.54 (m, 1H), 
3.83 (t, J = 8.8 Hz, 1H), 2.60 – 2.47 (comp, 3H), 2.06 – 2.01 (m, 1H), 
1.98 – 1.93 (m, 1H), 1.82 – 1.77 (m, 1H). 
13
C NMR (125 MHz, CDCl3) δ 
163.72, 148.39, 134.70, 131.00, 130.33, 129.03, 128.67 (q, J = 32.2 Hz), 
128.47 (q, J = 276.4 Hz), 125.89, 125.17, 124.97 (q, J = 3.4 Hz), 115.76, 









cyclopenta[e]oxazolo[3,2-b]pyridazin-4-ium-5-ide 2i: 42% yield. Light 
yellow solid, 100 ℃ (dec.); 1H NMR (500 MHz, CDCl3) δ 8.90 (d, J = 
9.0 Hz, 2H), 8.30 (d, J = 9.0 Hz, 2H), 7.42 (t, J = 7.3 Hz, 1H), 7.37 (t, J = 
7.3 Hz, 2H), 7.28 (d, J = 7.3 Hz, 2H), 6.59 – 6.55 (m, 1H), 3.86 (t, J = 9.0 
Hz, 1H), 2.62 – 2.55 (comp, 2H), 2.54 – 2.46 (m, 1H), 2.10– 2.05 (m, 
1H),  2.02– 1.95  (m, 1H), 1.86 – 1.79 (m, 1H). 
13
C NMR (125 MHz, 
CDCl3) δ 163.48, 148.35, 145.62, 142.78, 134.34, 133.83, 130.53, 129.14, 
125.93, 125.25, 123.52, 115.73, 97.57, 68.95, 31.99, 29.36, 24.43. 








cyclopenta[e]oxazolo[3,2-b]pyridazin-4-ium-5-ide 2j: 55% yield. Light 
yellow solid, 100 ℃ (dec.); 1H NMR (500 MHz, CDCl3) δ 7.69 – 7.65 (m, 
1H), 7.63 – 7.53 (comp, 3H), 7.44 – 7.36 (comp, 4H), 7.29 – 2.25 (m, 
1H), 6.54 – 6.51 (m, 1H), 3.81 – 3.76 (m, 1H), 2.62 – 2.55  (m, 1H), 2.53 
 202 
– 2.45 (m, 1H), 2.44 – 2.38  (m, 1H),  1.96 – 1.86 (comp, 2H), 1.71 – 
1.78 (m, 1H). 
13
C NMR (125 MHz, CDCl3) δ 163.80, 148.53, 133.35, 
132.58, 130.45, 130.22, 128.83, 128.75,  128.04, 127.38, 126.39, 125.01, 





 409.0546, found: 409.0557. 
 
9a-(4-Methoxyphenyl)-2-oxo-3-phenyl-2,5a,6,7,8,9a-
hexahydro-cyclopenta[e]oxazolo[3,2-b]pyridazin-4-ium-5-ide 2k: 42% 
yield. Light yellow solid, 100 ℃ (dec.); 1H NMR (500 MHz, CDCl3) δ 
8.67 (d, J = 8.1 Hz, 2H), 7.47 (t, J = 8.1 Hz, 2H), 7.31 (t, J = 8.1 Hz, 1H), 
7.24(d, J = 8.9 Hz, 2H), 6.83 (d, J = 8.9 Hz, 2H), 6.52 – 6.50 (m, 1H), 
3.81 (t, J = 8.6 Hz, 1H), 3.78 (s, 3H), 2.59 – 2.44  (m, 3H), 2.04 – 1.99 
(m, 1H), 1.96 – 1.90 (m, 1H), 1.79 – 1.76  (m, 1H). 
13
C NMR (125 MHz, 
CDCl3) δ 164.10, 160.84, 148.33, 128.10, 127.79, 127.70, 127.54, 127.01, 
125.43, 116.00, 114.16, 105.25, 96.77, 68.13, 55.38, 32.14, 29.41, 24.49. 









penta[e]-oxazolo[3,2-b]pyridazin-4-ium-5-ide 2l: 45% yield. Light 
yellow solid, 100 ℃ (dec.); 1H NMR (500 MHz, CDCl3) δ 8.67 (d, J = 
8.3 Hz, 2H), 7.47 (t, J = 8.3 Hz, 2H), 7.32 (t, J = 8.3 Hz, 1H), 7.21(d, J = 
7.8 Hz, 2H), 7.14 (d, J = 7.8 Hz, 2H), 6.54 – 6.51 (m, 1H), 3.81 (t, J = 8.2 
Hz, 1H), 2.60 – 2.41 (comp, 3H), 2.33 (s, 3H), 2.04 – 1.98 (m, 1H), 1.96 
– 1.90 (m, 1H), 1.80 – 1.74 (m, 1H). 
13
C NMR (125 MHz, CDCl3) δ 
164.05, 148.26, 140.32, 132.20, 129.53, 128.09, 127.79, 127.55, 126.02, 
125.44, 115.99, 105.36, 96.81, 68.13, 32.14, 29.40, 24.46, 21.17. HRMS 




 345.1598, found: 345.1606. 
 
9a-(4-Chlorophenyl)-2-oxo-3-phenyl-2,5a,6,7,8,9a-hexahydro-
cyclopenta[e]oxazolo[3,2-b]pyridazin-4-ium-5-ide 2m: 45% yield. 
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Light yellow solid, 100 ℃(dec.); 1H NMR (500 MHz, CDCl3) δ 8.67 (d, J 
= 8.4 Hz, 2H), 7.48 (t, J = 7.8 Hz, 2H), 7.35 – 7.29 (comp, 3H), 7.25 (t, J 
= 7.8 Hz, 2H), 6.55 - 6.52 (m, 1H), 3.78 (t, J = 8.6 Hz, 1H), 2.60 – 2.42 
(comp, 3H), 2.05 – 1.91 (comp, 2H), 1.82 – 1.75 (m, 1H). 
13
C NMR (125 
MHz, CDCl3) δ 163.68, 148.95, 136.31, 133.76, 129.16, 128.15, 127.80, 
127.51, 125.46, 115.55, 105.40, 95.95, 68.23, 32.17, 29.44, 24.39. 








hexahydro-cyclopenta[e]oxazolo[3,2-b]pyridazin-4-ium-5-ide 2n: 45% 
yield. Light yellow solid, 100 ℃ (dec.); 1H NMR (500 MHz, CDCl3) δ 
8.68 (d, J = 8.1 Hz, 2H), 7.48 (t, J = 8.1 Hz, 2H), 7.36 – 7.30 (comp, 3H), 
7.04 (t, J = 8.5 Hz, 2H), 6.54 – 6.51  (m, 1H), 3.79 (t, J = 8.6 Hz, 1H), 
2.59 – 2.45 (comp, 3H), 2.05 – 2.00 (m, 1H), 1.98 – 1.93 (m, 1H), 1.81 – 
1.76 (m, 1H). 
13
C NMR (125 MHz, CDCl3) δ 163.76, 163.50 (d, J = 
249.6 Hz), 148.83, 131.17 (d, J = 3.3 Hz), 128.25, 128.14, 127.76, 
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127.56, 125.45, 115.98 (d, J = 21.9 Hz), 115.73, 105.37, 96.05, 68.20, 





349.1347, found: 349.1359. 
 
9a-(4-(Methoxycarbonyl)phenyl)-2-oxo-3-phenyl-2,5a,6,7,8,9a-
hexahydrocyclopenta[e]oxazolo[3,2-b]pyridazin-4-ium-5-ide 2o: 45% 
yield. Light yellow solid, 100 ℃ (dec.); 1H NMR (500 MHz, CDCl3) δ 
8.67 (d, J = 7.5 Hz, 2H), 8.01 (d, J = 8.6 Hz, 2H), 7.48 (t, J = 7.5 Hz, 2H), 
7.38 (d, J = 8.6 Hz, 2H), 7.34 (t, J = 7.5 Hz, 1H), 6.56 – 6.53 (m, 1H), 
3.91 (s, 3H), 3.76 (t, J = 8.6 Hz, 1H), 2.58 – 2.45 (comp, 3H), 2.06 – 2.00 
(m, 1H), 1.97 – 1.92 (m, 1H), 1.81 – 1.74 (m, 1H). 
13
C NMR (125 MHz, 
CDCl3) δ 165.98, 163.62, 149.00, 139.65, 131.75, 130.15, 128.17, 127.87, 
127.49, 126.10, 125.51, 115.56, 105.52, 95.94, 68.26, 52.39, 32.21, 29.45, 









cyclopenta[e]oxazolo[3,2-b]pyridazin-4-ium-5-ide 2p: 41% yield. 
Light yellow solid, 100 ℃ (dec.); 1H NMR (500 MHz, CDCl3) δ 10.02 (s, 
1H), 8.69 (d, J = 7.7 Hz, 2H), 7.88 (d, J = 8.5 Hz, 2H), 7.52 – 7.47 (comp, 
4H), 7.36 (t, J = 7.7 Hz, 1H), 6.58 – 6.55 (m, 1H), 3.78 (t, J = 8.7 Hz, 
1H), 2.62 – 2.46 (comp, 3H), 2.08 – 2.02 (m, 1H), 2.00 – 1.94 (m, 1H), 
1.83 – 1.74 (m, 1H). 
13
C NMR (125 MHz, CDCl3) δ 191.41, 163.05, 
142.42, 141.42, 138.49, 138.02, 135.66, 130.11, 129.12, 126.31, 124.79, 










H NMR (500 MHz, CDCl3) δ 7.49 – 7.44 (comp, 4H), 7.39 – 
7.34 (comp, 5H), 7.18 (t, J = 7.4 Hz, 1H), 6.39 (s, 1H), 5.84 (t, J = 2.2 Hz, 
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1H) 2.34 – 2.30 (comp, 2H), 2.02 - 1.91 (comp, 2H), 1.79 – 1.74 (comp, 
2H).:
13
C NMR (125 MHz, CDCl3) δ 163.83, 146.02, 137.87, 135.16, 
134.87, 129.80, 128.92, 128.82, 127.71, 125.94, 125.12, 123.93, 118.69, 
33.58, 32.30, 24.11. (The 
13
C NMR for 1a contains around 10% of 
cycloaddition product 2a because (E)-1a was converted to 2a in process 









[1,2,3-cd]-s-indacene-1,3,4(2H,3bH)-trione 5e: 85% yield. White solid, 
80 ℃ (dec.), .); 1H NMR (500 MHz, CDCl3) δ 7.41 –7.37 (comp, 3H), 
7.35 –7.25 (comp, 4H), 7.09 –7.01 (comp, 5H), 6.80 – 6.76 (m, 1H), 6.68 
– 6.64 (m, 1H), 5.57 – 5.55 (m, 1H), 4.55 –4.50 (comp, 2H), 4.10 (d, J = 
7.5 Hz, 1H), 2.65–2.50 (comp, 3H), 2.04 – 1.97 (m, 1H), 1.93 – 1.87 (m, 
1H), 1.70 – 1.61 (m, 1H). 
13
C NMR (126 MHz, cdcl3) δ 166.59, 166.17, 
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163.54, 142.16, 131.11, 124.27, 123.83, 123.77, 122.92, 122.07, 121.68, 
121.12, 120.75, 120.66, 118.57, 115.73, 110.53, 93.01, 70.76, 54.53, 





582.1028, found: 582.1035.  
NMR spectra can be obtained from the supporting information of: H. Qiu, 
H. D. Srinivas, P.Y. Zavalij, M. P. Doyle. J. Am. Chem. Soc. 2016, 138, 
1808–1811. 
4.5 X-ray Crystal Structure Information for 2f, (Z)-1e, and 
5e 
Details X-ray analysis of compounds 2f, (Z)-1e, and 5e can be found in 
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Chapter 4: Unexpected [4+3]-
Cycloaddition/Extrusion of Dinitrogen and 
Rearrangement in Gold-Catalyzed 
Reactions of Propargylic Diazoesters with 
Unsaturated Imines 
I. Introduction 
1.1 Discovery of the Unexpected Cascade Process 
With access to metal carbenes from both diazo and acetylenic 
precursors we considered whether we could selectively form one of two 
metal carbene intermediates and, in doing so, either retain the unreacted 
functional group or expect a synergy between the two groups that, like 
the cascade reactions developed from previously reported reactions of 
diazo compounds with both functional groups, provides unique access to 
complex chemical structures (see examples in Chapter 2 and Chapter 3). 
Using the gold-catalyzed reaction process for [4+3]-cycloaddition 
established by Toste and coworkers,
1
 we have employed the slightly 
modified propargyl system in which benzoate is replaced by 
phenyldiazoacetate (2a) that was expected to produce dihydroazepines (3) 
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which retained the phenyldiazoacetate functionality. Instead, an 
unexpected cascade [4+3]-cycloaddition/extrusion of dinitrogen and 
rearrangement occurred that reorganized the reactant atoms, including 
conversion of the reactant ester to a diketone. 
 
Scheme 4.1 Discovery of the Unexpected Cascade Process. 
1.2 Gold Catalyzed 1,2-Acyloxy Migration of Propargyl 
Esters and Subsequent Reactions 
For the past several decades, alkynes have been reported to 
effectively serve as precursors to metal carbenes via direct reactions with 
transition metal complexes.
2
 Gold catalyzed 1,2-acyloxy migration of 
propargyl esters is a highly versatile route to access gold vinylcarbene 




 Similar to other transition metal complex-catalyzed 
rearrangements of propargyl esters, which have been described in 
Chapter 1, the outcomes of the regioselectivity in the gold catalyzed of 
propargylic esters are mainly dependent on the R
3
 group: if R
3
 is a 
hydrogen atom, the formation of the gold vinylcarbene complexes is 
preferred.
4
 These gold vinylcarbene intermediates are capable of 
undergoing a variety of intermolecular transformations including 





Scheme 4.2 Formation of Gold Vinylcarbenes and Subsequent 
Transformations. 
1.3 [4+3]-Cycloaddition Reactions of Metal Vinylcarbenes 
with Unsaturated Imines 
Cycloaddition reactions of imines with metal carbene species 
provide access to a wide range of nitrogen-containing heterocyclic 
compounds with remarkable selectivities and high yields under mild 
reaction conditions.
6
 These reactions typically involve reactive 
azomethine ylide intermediates.
7
 In the process of investigating rhodium-
catalyzed azomethine ylide-derived reactions of vinyldiazo compounds 
with imines, Doyle and coworkers have discovered the first example of a 
[4+3]-cycloaddition reaction of styryldiazoacetates with α,β-unsaturated 
imines. This reaction provides rapid entry into substituted dihydroazepine 
derivatives from easily obtained starting materials. A stepwise 
mechanism involving addition of α,β-unsaturated imines to a rhodium 





Scheme 4.3 Rhodium-Catalyzed [4+3]-Cycloaddition Reaction of 
Styryldiazoacetates with α,β-Unsaturated Imines. 
By analogy with to the [4+3]-cycloaddition reaction of rhodium 
vinylcarbenes with α,β-unsaturated imines, Toste and coworkers have 
demonstrated that propargyl esters can serve as gold vinylcarbene 
precursors, which undergo similar [4+3]-cycloaddition reactions with 
α,β-unsaturated imines. Similar to the mechanism proposed by Doyle and 
coworkers, this formal [4+3]-cycloaddition reaction proceeds via a 
stepwise process involving addition of the α,β-unsaturated imines to a 
gold vinylcarbene intermediate to form an allyl−gold intermediate, which 
undergoes intramolecular cyclization to produce the [4+3]-adduct and 





Scheme 4.4 Gold-Catalyzed [4+3]-Cycloaddition Reaction of Propargyl 
Esters with α,β-Unsaturated Imines. 
1.4 Seven-Membered Carbocycles and Previous Synthesis  
Seven-membered carbocycles exist in many natural products, and 
some of them are potential therapeutic compounds, such as ingenol, 
cortistatin guanacastepene family tropolonoids.
9
 However, constructing 
seven-membered carbocycles is considered to be generally more 
challenging in comparison to five- and six-membered carbocycles.
10
 
Although several synthetic approaches that lead to seven-membered 
carbocycles have been developed over the past decades, discovering 
novel synthetic methods to highly functionalized seven-membered 





Scheme 4.5 Various Routes to Seven-Membered Carbocycles. 
II. Results and Discussion 
2.1 Discovery of the Unexpected Cascade Process and 
Optimization of Reaction Conditions  
With 5 mol% AuPicCl2 as the catalyst, treatment of propargyl 
phenyldiazoacetate 2a with α-methyl-trans-cinnamyl phenylimine 1a, 
which was the optimum cinnamylimine previously used in reactions with 
,-dimethylpropargyl benzoate (Scheme 4.4), resulted in a complex 
product mixture that occurred with complete reaction of propargyl 
phenyldiazoacetate 2a within 30 minutes at room temperature but with 
<10% production of the anticipated [4+3]-cycloaddition product 3aa 
(Table 4.1, entry 1). The use of alternative Au(I) catalysts, including 
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AuCl, Au(JohnPhos)SbF6, and IPrAuBF4 that are commonly used in the 
transformations of propargyl esters, also failed to give the desired [4+3]-
cycloaddition product 3aa. Replacing α-methyl-trans-cinnamyl N-
phenylimine 1a with trans-cinnamyl N-phenylimine 1b, which was 
disfavored in reactions with ,-dimethylpropargyl benzoate, under the 
same reaction conditions for 72 h resulted in a 40% conversion of 
propargyl phenyldiazoacetate 2a, but gave as the predominant product 
4ba in 10% isolated yield a compound that did not have the diazo 
functional group or the anticipated ester functionality and was highly 
colored (Table 4.1, entry 2). Cationic gold catalysts that include 
(ArO)3PAuSbF6, Au(IPr)SbF6 and Au(JohnPhos)SbF6 failed to give 4ba 
at room temperature in dichloromethane (DCM) with low conversion of 
1a (Table 4.1, entries 3-5). The use of neutral AuCl produced this 
unexpected product but in low yield (Table 4.1, entry 6), However, 
increasing the reaction temperature dramatically increased percent 
conversion and the yield of this product, as well as reducing the reaction 
time (Table 4.1, entries 7-9). At 80ºC in 1,2-dichloroethane (DCE) for 6 
h in the presence of 5 mol% PicAuCl2 this highly colored product was 
obtained in 62% isolated yield. A further increase in temperature slightly 
decreased the yield of this product (Table 4.1, entry 10). Changing the 
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solvent to toluene, acetonitrile, or N,N-dimethylformamide did not 
provide improvement (Table 4.1, entries 11-13). 
Table 4.1 Optimization of gold-catalyzed reaction of propargyl 
























 1a PicAuCl2 20/0.5 DCM >95 --
d
 
2 1a Ph3PAuSbF6 20/72  DCM <10 <5 
3 1a IPrAuSbF6 20/24 DCM <10 <5 
4 1a (ArO)PAuSbF6 20/24 DCM <10 <5 
5 1a AuCl 20/24 DCM 25 8 
6 1a PicAuCl2 20/72 DCM 40 10 
7 1b PicAuCl2 40/48 DCE 60 31 
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aReactions were performed on 0.20 mmol scale: a solution of 2a (0.24 mmol) in 2.0 mL solvent was added to a 
solution of 1b (or 1a) (0.20 mmol) and 5 mol% of selected catalyst in 2.0 mL of solvent under a nitrogen 
atmosphere at stated temperature, and the resulting reaction mixture was stirred for the stated time. bThe percent 
conversion of 2a was determined by 1H NMR spectroscopy using 2,4,6-trimethoxybenzaldehyde as the internal 
standard. cThe yield of 4ba was determined by 1H NMR analyses of characteristic absorptions. d Neither 3aa nor 
4aa was observed. e The isolated yield of 4ba. Ar = 2,4-di-tert-butylphenyl. 
Attempts to determine the structure of 4 spectroscopically gave 
partial connectivities, demonstrated the loss of dinitrogen, and pointed to 
the conversion of the ester to ketones, but its final confirmation awaited 
X-ray determination. Various derivatives were prepared, but only with 
4ha from the reaction between propargyl phenyldiazoacetate 2a, and 
cinnamyl 1-naphthylimine 1h was a compound suitable for single crystal 
analysis obtained. X-ray diffraction revealed a structure in which the 
carbon atoms of the original propargyl phenyldiazoacetate were 
rearranged, that the ester was converted to a diketone, and depicted the 
presence of an intramolecular hydrogen bond between nitrogen and a 
8 1b PicAuCl2 60/12 DCE 85 47 





10 1b PicAuCl2 100/2 DCE >95 57 
11 1b PicAuCl2 80/6 toluene >95 25 
12 1b PicAuCl2 80/6 CH3CN 80 38 
13 1b PicAuCl2 80/6 DMF <20 <5 
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carbonyl group (Figure 4.1). Extrusion of dinitrogen from propargyl 
phenyldiazoacetate 2a and the fact that the carbon atoms of seven-
membered ring came from three parts of the starting materials 
demonstrated extensive structural rearrangement. 
 
Figure 4.1 X-ray Structure of 4ha. 
2.2 Substrate Scope  
In efforts to determine the scope of the gold-catalyzed reaction, 
structural modifications on both the propargyl aryldiazoacetates and the 
cinnamyl arylimines were investigated under the optimized reaction 
conditions (Table 4.1, entry 9). Propargylic aryldiazoacetates 2 with 
electron-donating groups and electron-withdrawing groups at the para 
position underwent the gold-catalyzed transformation smoothly in 6 h 
with moderate to high yields (Table 4.2, entries 1-4). Ortho substituted 
propargylic aryldiazoacetates (2f and 2g) gave reasonable yields of 4bf 
and 4bg (Table 4.2, entries 5 and 6). Unsaturated imines 1c-1g with 
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arylimine-derived para substituents Ar
1
 – including ethers, phenols, and 
halides –underwent this cycloaddition favorably under the stated reaction 
conditions (Table 4.2, entries 7-11). Sterically hindered 1-
naphthylamine-derived 1h also underwent this transformation smoothly 
and gave the product 4ha in 68% yield (Table 4.2, entry 12). Imine 1i 
with a bulky N-mesityl group gave the highest yield in all cases (Table 
4.2, entry 13). That p-nitrocinnamylaldehyde-derived and p-
methoxycinnamylaldehyde-derived unsaturated imines 1j and 1k gave 
the corresponding products 4ja and 4ka in comparable yields shows 
electronic tolerance in the reactant trans-cinnamyl phenylimines (Table 
4.2, entries 14 and 15). Using cyclopentylpropargyl phenyldiazoacetate, 
which was easily obtained from 1-ethynylcyclopentanol, the rearranged 
product 4bg was formed in basically the same yield as its dimethyl 
analog 4ba (Table 4.2, entry 16). 
Table 4.2 Substrate Scope of Gold-Catalyzed Reactions of Propargylic 













1 1c 4-HOC6H4/Ph 2b 4-MeOC6H4/Me  4cb 68 
2 1b Ph/Ph 2c 4-MeC6H4/Me  4bc 65 
3 1b Ph/Ph 2d 4-BrC6H4/Me  4bd 55 
4 1b Ph/Ph 2e 4-NO2C6H4/Me  4be 43 
5 1b Ph/Ph 2f 2-BrC6H4/Me  4bf 52 
6 1b Ph/Ph 2g 2-NO2C6H4/Me  4bg 55 
7 1c 4-HOC6H4/Ph 2a Ph/Me  4ca 64 
8 1d 4-MeOeC6H4/Ph 2a Ph/Me  4da 65 
9 1e 4-BrC6H4/Ph 2a Ph/Me  4ea 61 
10 1f 4-ClC6H4/Ph 2a Ph/Me  4fa 60 
11 1g 4-FC6H4/Ph 2a Ph/Me  4ga 56 
12 1h 2-Naphthyl/Ph 2a Ph/Me  4ha 68 
13 1i 2,4,6-Me3C6H2/Ph 2a Ph/Me  4ia 70 
14 1j Ph/4-MeOC6H4 2a Ph/Me  4ja 67 
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15 1k Ph/4-NO2C6H4 2a Ph/Me  4ka 59 
16 1b Ph/ Ph 2g Ph/-(CH2)4-  4bg 65 
aReactions was performed on a 0.20 mmol scale: a solution of 2 (0.24 mmol) in 2.0 mL solvent was added to a 
solution of 1 (0.20 mmol) and 5 mol% of PicAuCl2 in 2.0 mL of DCE under a nitrogen atmosphere at 20
oC, and 
the resulting reaction mixture was stirred at 80 ºC for 6 h. Yields are isolated yields after chromatography. 
 
2.3 Isolation of [4+3]-Cycloaddition Products and Kinetic 
Studies  
The extraordinary structural rearrangement that was uncovered in 
this investigation obviously occurred after the combination of the imine 
reactant with an intermediate formed by a gold catalyzed reaction with 
the propargyl phenyldiazoacetate.
1
 We understood that gold catalysis 
occurred with the acetylenic functional group rather than with the diazo 
group, but was this rearrangement the result of a transformation from the 
gold-catalyzed [4+3]-cycloaddition product? To address this question 
propargyl phenyldiazoacetate 2a was reacted with N-phenyl 
cinnamylimine 1b at the lower reaction temperature of refluxing CDCl3 
in presence of 5 mol% AuPicCl2. An intermediate 3ba was observed 
within 5 min that was completely converted to 4ba after 12 h (Figure 
4.2). To obtain the separable and relatively stable [4+3]-adducts for 
further investigation of this cascade process, a variety of reactions with 
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different starting materials as well as reaction conditions was performed. 
Fortunately, [4+3]-cycloaddition product 3cb was isolated by silica-based 
columns in 36% yield from 1c and 2b by quenching the reaction after 5 
min at 80ºC in DCE. To determine if intermediate 3 was converted to 
diketone 4 by a metal-free process or required a catalyst, 3cb was 
allowed to react in the absence and presence of 5 mol% AuPicCl2. The 
stable product 4cb was obtained in 90% isolated yield from the solution 
of 3cb in DCE at 80 
o
C for 6 h in the absence of any catalysts. However, 
when the [4+3]-cycloaddition 3cb was treated with 5 mol% PicAuCl2 in 
DCE at 80
o
C, decomposition occurred within 1 h and resulted in a 
complex product mixture in which only a trace (less than 10%) of 4cb 









Scheme 4.6 Control Experiments for the formation of 4bd from 3bd.  
Furthermore, we carried out a series of kinetic studies with the 
isolated [4+3]-cycloaddition product 3cb for the subsequent 





at 61 °C in DCE. The variation of the rate 
constant over temperatures ranging from 61℃ to 75℃ provided Eact = 
22.6 kcal/mol, H
‡
298 = 22.0 kcal/mol and S
‡


























Figure 4.7 Arrhenius Plot: 16cb Activation Energy. 
 
2.4 The Role of the Unsaturated Imines in Diketones 
Formation 
y = -0.00036 x + 0.00114  



















T = 61oC 
y = -0.00049 x - 0.01628  



















T = 65oC 
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As shown in precious section, the [4+3]-cycloaddition product 3cb 
undergoes a metal free process to form the rearranged products. However, 
the AuPicCl2, which is capable of destroying the [4+3]-cycloaddition 
product 3cb, exists in the reaction mixture. We speculated that there is a 
base (it might be the unsaturated imine), which prevented the gold 
species from decomposing the [4+3]-cycloaddition product 3cb in the 
reaction mixture. Thus, we carried out several control experiments, and 
four types of bases were tested in the presence of 5 mol% AuPicCl2. 
From the Table 4.3, we can easily find that: a) adding base increased the 
yields of diketone 4cb; and b) decreasing the amount of base resulted in a 
decreasing the yield of diketone 4cb. These results supported that the 
imines also served as a base, which assists in the formation of 4cb in 
presence of 5 mol% AuPicCl2. We also found the formation of metallic 
gold in the presence of imines (A2 to A4), which was confirmed by a 
SEM (Scanning Electron Microscope) examination.  
 
















equiv of additive 
(mol%) 
1
HNMR yield (%) 
1 A1 50 56 
2 A2 50 40 
3 A3 50 72 
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4 A4 50 73 
5 A4 40 69 
6 A4 30 63 
7 A4 20 55 
8 A4 10 45 
aReactions was performed on a 0.05 mmol scale: a solution of 3cb (0.05 mmol) in 0.5mL DCE was added to a 
solution of stated amount of additive and 5 mol% of PicAuCl2 in 0.5 mL of DCE under a nitrogen atmosphere at 
20oC, and the resulting reaction mixture was stirred at 80 ºC for 6 h. Yield is determined by 1H NMR analyses of 
characteristic absorptions. 
2.5 Reaction Mechanism 
Based on these observations and previous reports,
1
 a plausible 
mechanism for the formation of seven-membered conjugated 1,4-
diketones 4 is shown in Scheme 4.7. The vinyl gold carbene 
intermediates generated by 1,2-acyloxy migration of propargylic 
aryldiazoesters undergo formal [4+3]-cycloaddition with unsaturated 
imines 2 to afford phenyldiazoacetate-tethered dihydroazepines 3. We 
propose that 3 can undergo an intramolecular [3+2]-cycloaddition to 
form pyrazolines.
13
 (The formal [3+2]-cycloaddition might be stepwise, 
which involves diazo group as an electrophile that has been discussed in 
Chapter 2, and followed by subsequent ring-closing to produce the [3+2]-









 as shown in Scheme 4.7, and 
finally afford 4 under thermal conditions.  
 
 
Scheme 4.7 Proposed Mechanism for the Gold-Catalyzed Reaction of 
Propargyl Arylyldiazoacetates 1 with Unsaturated Imines 2. 
III. Conclusion 
In conclusion, we have developed a general and efficient method 
for the synthesis of seven-membered conjugated 1,4-diketones 4 from 
easily synthesized materials. To undergo this process vinyl gold carbene 
intermediates generated by 1,2-acyloxy migration of propargylic 
aryldiazoesters undergo a formal [4+3]-cycloaddition, and the resulting 
aryldiazoesters tethered dihydroazepines 3 undergo an intricate metal-
free process to form observed 4 with moderate to high yields. Current 
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efforts aimed at understanding the metal-free process in detail and 
utilizing propargylic aryldiazoesters as switchable carbene precursors in 
other transformations are ongoing in our lab. 
IV. Experimental Section 
4.1 General Information 
Unless noted all reactions were carried out under inert atmosphere 
of dinitrogen in oven-dried glassware with magnetic stirring using freshly 
distilled solvents. All solvents were purified and dried using standard 
methods. Analytical thin layer chromatography (TLC) plates were 
purchased from EM Science (silica gel 60 F254 plates). High-resolution 
mass spectra (HRMS) were performed on a microTOF-ESI mass 
spectrometer using CsI as the standard. Accurate masses are reported for 






. Melting points were 
determined on an Electrothermo Mel-Temp DLX 104 device and were 
uncorrected. Column chromatography was performed on CombiFlash
®
 
Rf 200 purification system using normal phase disposable columns. IR 
spectra were recorded using Bruker Vector 22 spectrometer. All NMR 
spectra were recorded on a Bruker spectrometer at 400 MHz (
1
H NMR) 
and 100 MHz (
13




NMR) and 125 MHz (
13
C NMR). Chemical shifts are reported in ppm 
with the solvent signals as reference (in CDCl3 as solvent), and coupling 
constants (J) are given in Hertz (Hz). The peak information is described 
as: br = broad singlet, s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, comp = composite of magnetically non-equivalent protons. The 
wavelength of maximum absorbance and molar extinction coefficients 
measurements were performed on a Carey 50 Bio UV-vis spectrometer 
(200-800 nm) in DCM at room temperature. 
4.2 Materials 
AuCl(PPh3), AuCl[P(OMe)3], Chloro[2-dicyclohexyl(2′,6′-
dimethoxybiphenyl)phosphine] gold(I), and AuPicCl2 were purchased 
from Sigma-Aldrich; AuCl was purchased from Strem Chemicals. 
Unsaturated imines
17
 and propargylic diazoesters
18
 were prepared 
according to the literature procedures. All other chemicals were obtained 
from commercial sources and used as received without further 
purification.  
4.3 Experimental Procedures. 
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General Procedure for Gold Catalyzed Reaction of Propargylic 
Diazoesters with Unsaturated Imines: To a flame-dried 10 mL Schlenk 
flask charged with a magnetic stirring bar, N-aryl imine 2 (0.20 mmol), 
1,2-dichloroethane (DCE) (2.0 mL) and AuPicCl2 (3.9 mg, 0.01 mmol) 
were sequentially added under a nitrogen atmosphere. Propargyl 
diazoester 1 (0.24 mmol) dissolved in 2.0 mL of DCE was added in one 
portion into the solution under the flow of nitrogen. The mixture was 
stirred for 6h at 80
o
C. Solvent was evaporated, and products were 
purified by column chromatography (100:1 to 10:1 gradient of hexanes: 




General Procedure for Synthesis of 3cb: To a flame-dried 10 mL 
Schlenk flask charged with a magnetic stir bar, N-aryl imine 1c (0.20 
mmol), 1,2-dichloroethane (DCE) (2.0 mL) and AuPicCl2 (3.9 mg, 0.01 
mmol) were sequentially added under nitrogen atmosphere. Propargyl 
diazoester 2b (0.24 mmol) dissolved in 2.0 mL of DCE was added in one 
portion into the solution under the flow of nitrogen. The mixture was 
stirred for 5 min at 80
o
C. The reaction mixture was directly purified by 
column chromatography (100:1 to 10:1 gradient of hexanes: ethyl acetate 




General Procedure for Synthesis of 4cb from 3cb without Gold 
Catalyst: To a flame-dried 10 mL Schlenk flask charged with a magnetic 
stir bar, 3cb (0.1 mmol) dissolved in 2.0 mL of DCE was added under 
nitrogen atmosphere, The reaction mixture was stirred for 6h at 80
o
C. 
Solvent was evaporated, and products were purified by column 
chromatography (100:1 to 10:1 gradient of hexanes: ethyl acetate as 
eluents) to afford pure compound 4cb in 90% isolated yield. 
 
 238 
General Procedure for Synthesis of 4cb from 3cb with Gold 
Catalyst: To a flame-dried 10 mL Schlenk flask charged with a magnetic 
stir bar, 3cb (0.1 mmol) dissolved in 2.0 mL of DCE and AuPicCl2 (2.0 
mg, 0.005 mmol) were added under nitrogen atmosphere. The reaction 
mixture was stirred for 5 min at 80
o
C. The color of reaction mixture 
turned dark black. Checking the reaction mixture shows that the starting 
material was consumed completely, and the yield of 4cb was less than 
10%.  
 
General Procedure for Control Experiment: To a flame-dried 
10 mL Schlenk flask charged with a magnetic stir bar, a solution of 3cb 
(0.05 mmol) in 0.05 mL of DCE was added to a solution of 1c (A4) and 5 
mol% of PicAuCl2 in 0.5 mL of DCE under a nitrogen atmosphere at 
20
o
C. The reaction mixture was stirred for 6 h at 80
o
C. The solvent was 
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evaporated; the yield of 4cb was determined by 
1
H NMR analysis using 
2,4,6-trimethoxybenzaldehyde as an internal standard. 
Other stated additives were also tested using the same procedure. 
4.4 Characterization Data for New Compounds 
 
2-Methylbut-3-yn-2-yl 2-Diazo-2-phenylacetate 2a: 80% yield. 
Yellow solid, m.p. 70.2 – 71.4℃. 1H NMR (500 MHz, CDCl3) δ 7.50 (d, 
J = 8.5 Hz, 2H), 7.38 (t, J = 8.5 Hz, 2H), 7.19 (t, J = 8.5 Hz, 1H), 2.62 (s, 
1H), 1.78 (s, 6H). 
13
C NMR (125 MHz, CDCl3) δ 163.45, 128.84, 125.75, 
125.44, 123.96, 84.51, 72.84, 72.77, 29.21. IR (neat) 2082, 1701, 1286, 
1145 cm
-1
; HRMS (ESI) m/z calculated for C13H12N2O2Na
+
 [M+Na]+ 




2-Methylbut-3-yn-2-yl 2-Diazo-2-(4-methoxyphenyl)acetate 2b: 
75% yield. Red solid, 67.0 – 68.5℃. 1H NMR (500 MHz, CDCl3) δ 7.39 
(d, J = 9.1 Hz, 2H), 6.93 (d, J = 9.1 Hz, 2H), 3.80 (s, 3H), 2.59 (s, 1H), 
1.76 (s, 6H).
 13
C NMR (125 MHz, CDCl3) δ 164.03, 158.00, 125.89, 
116.87, 114.54, 84.62, 72.71, 72.68, 55.34, 29.24. IR (neat) 2084, 1702, 
1127, 903 cm-1; HRMS (ESI) m/z calculated for C14H14N2O3Na 
[M+Na]
+
 281.0897, found: 281.0900. 
 
 2-Methylbut-3-yn-2-yl 2-Diazo-2-(p-tolyl)-acetate 2c: 78% 
yield. Yellow solid, 58.0 – 59.2℃. 1H NMR (500 MHz, CDCl3) δ 7.38 (d, 
J = 8.4 Hz, 2H), 7.20 (d, J = 8.4 Hz, 2H), 2.61 (s, 1H), 2.35 (s, 3H), 1.78 
(s, 6H). 
13
C NMR (125 MHz, CDCl3) δ 163.70, 135.60, 129.57, 124.08, 
122.07, 84.58, 72.70, 29.22, 20.95. IR (neat) 2083, 1702, 1124, 906 cm-1; 








2-Methylbut-3-yn-2-yl 2-(4-Bromophenyl)-2-Diazoacetate 2d: 
82% yield. Yellow solid, 90.1 – 91.5℃. 1H NMR (500 MHz, CDCl3) δ 
7.49 (d, J = 8.6 Hz, 2H), 7.38 (d, J = 8.6 Hz, 2H), 2.62 (s, 1H), 1.77 (s, 
6H).
 13
C NMR (125 MHz, CDCl3) δ 163.08, 131.93, 125.33, 124.69, 
119.28, 84.35, 73.12, 72.93, 29.20. IR (neat) 2087, 1703, 1126, 907 cm
-1
; 







2-Methylbut-3-yn-2-yl 2-Diazo-2-(4-nitrophenyl)acetate 2e: 65% 
yield. Yellow solid, 107.2 – 108.5℃. 1H NMR (500 MHz, CDCl3) δ 8.22 
(d, J = 7.1 Hz, 2H), 7.68 (d, J = 7.1 Hz, 2H), 2.64 (s, 1H), 1.80 (s, 6H).
 
13
C NMR (125 MHz, CDCl3) δ 161.98, 145.00, 133.85, 124.19, 123.18, 
84.00, 73.78, 73.28, 29.14. IR (neat) 2095, 1710, 1334, 904 cm-1; HRMS 








2-Methylbut-3-yn-2-yl 2-(2-Bromophenyl)-2-Diazoacetate 2f: 
65% yield. Yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 8.0 Hz, 
1H), 7.54 (d, J = 7.8 Hz, 1H), 7.35 (dd, J = 8.0, 7.7 Hz, 1H), 7.18 (dd, J = 
7.8, 7.7 Hz, 1H), 2.60 (s, 1H), 1.74 (s, 6H).
 13
C NMR (125 MHz, CDCl3) 
δ 163.58, 133.16, 132.73, 129.81, 127.44, 125.55, 124.13, 84.39, 72.88, 





 328.9896, found 328.9893. 
 
2-Methylbut-3-yn-2-yl 2-Diazo-2-(2-nitrophenyl)acetate 2g: 52% 
yield. Yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 8.04 (d, J = 8.2 Hz, 1H), 
7.63 (dd, J = 7.9, 2.3 Hz, 1H), 7.55 (d, J = 7.9 Hz, 1H), 7.46 (dd, J = 8.2, 
2.3 Hz, 1H), 2.58 (s, 1H), 1.70 (s, 7H).
 13
C NMR (125 MHz, CDCl3) δ 
162.94, 147.17, 133.12, 130.96, 128.74, 125.60, 121.01, 84.18, 73.74, 
72.94, 28.97. IR (neat) 2085, 1702, 1513, 1259, 903 cm-1; HRMS (ESI) 




 296.0642, found 296.0637. 
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Ethynylcyclopentyl 2-Diazo-2-phenylacetate 2h: 81% yield. 
Yellow solid, m.p. 31.8 – 33.0℃. 1H NMR (500 MHz, CDCl3) δ 7.52 – 
7.47 (m, 2H), 7.39 – 7.35 (m, 2H), 7.20 – 7.15 (m, 1H), 2.64 (s, 1H), 2.37 
– 2.30 (m, 2H), 2.27 – 2.20 (m, 2H), 1.82 – 1.76 (m, 4H). 
13
C NMR (125 
MHz, CDCl3) δ 163.64, 128.84, 125.75, 125.37, 123.91, 83.97, 81.27, 
73.36, 40.59, 23.32. IR (neat) 2081, 1701, 1598, 1286, 907 cm-1; HRMS 








[(phenylamino)methylene]cyclohept-2-ene-1,4-dione 4ba: 63% yield. 
Red viscous oil. TLC Rf =0.3 (10:1 hexanes/EtOAc); 
1
H NMR (400 MHz, 
CDCl3) δ 12.60 (d, J = 12.3 Hz, 1H), 7.58 (d, J = 12.3 Hz, 1H), 7.41 – 
7.34 (comp, 5H), 7.34 – 7.27 (comp, 6H), 7.26 – 7.21 (m, 1H), 7.08 (t, J 
= 7.4 Hz, 1H), 7.00 (d, J = 7.5 Hz, 2H), 6.55 (s, 1H), 4.10 (s, 1H), 1.50 (s, 
3H), 1.23 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 206.6, 189.7, 149.2, 
147.1, 140.0, 139.8, 138.9, 131.1, 129.8, 129.8, 128.7, 128.4, 128.3, 
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126.8, 124.2, 116.7, 111.4, 54.5, 52.5, 27.9, 23.2; IR (neat) 2977, 2248, 
1625, 1596 cm
-1




408.1958, found: 408.1944; UV/vis absorption spectra of 4ba recorded at 
20
o
C in dichloromethane (DCM): UV (λ max) = 308 nm, 411 nm, and 













68% yield. Red viscous oil. TLC Rf = 0.15 (5:1 hexanes/EtOAc). 
1
H 
NMR (500 MHz, CDCl3) δ 12.72 (d, J = 12.3 Hz, 1H), 7.47 (d, J = 12.3 
Hz, 1H), 7.36 – 7.28 (m, 4H), 7.28 – 7.23 (m, 4H), 6.91 – 6.83 (m, 4H), 
6.78 – 6.73 (m, 2H), 6.53 (d, J = 1.1 Hz, 1H), 5.86 (s, 1H), 4.10 (s, 1H), 
3.81 (s, 3H), 1.48 (s, 3H), 1.21 (s, 3H).
13
C NMR (125 MHz, CDCl3) δ 
207.32, 189.05, 160.19, 153.08, 149.13, 148.13, 140.06, 133.10, 131.12, 
129.89, 129.88, 129.47, 128.35, 126.72, 118.49, 116.55, 113.82, 110.71, 
 245 





454.2018, found: 454.2014; UV/vis absorption 
spectra of 4cb recorded at 20
o
C in dichloromethane (DCM): UV (λ max) 
= 303 nm, 419 nm, and corresponding molar extinction coefficients are 











tolyl)cyclohept-2-ene-1,4-dione 4bc: 65% yield. Red viscous oil. TLC 
Rf = 0.25 (10:1 hexanes/EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 12.61 (d, 
J = 12.2 Hz, 1H), 7.56 (d, J = 12.2 Hz, 1H), 7.37 – 7.28 (comp, 6H), 7.25 
– 7.22 (m, 1H), 7.19 – 7.15 (comp, 4H), 7.08 (t, J = 7.5 Hz, 1H), 7.00 (d, 
J = 7.5 Hz, 2H), 6.54 (s, 1H), 4.09 (s, 1H), 2.36 (s, 3H), 1.49 (s, 3H), 
1.22 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 206.8, 189.9, 149.3, 147.0, 
140.0, 139.9, 138.9, 136.0, 130.5, 129.8, 129.8, 129.0, 128.4, 128.3, 
126.7, 124.2, 116.7, 111.5, 54.5, 52.5, 27.9, 23.2, 21.3; IR (neat) 2973, 
1628, 1598 cm
-1





422.2115, found: 422.2118; UV/vis absorption spectra of 4bc recorded at 
20
o
C in dichloromethane (DCM): UV (λ max) = 311 nm, 405 nm, and 












[(phenylamino)-methylene]cyclohept-2-ene-1,4-dione 4bd: 55% yield. 
Red viscous oil. TLC Rf =0.3 (10:1 hexanes/EtOAc); 
1
H NMR (400 MHz, 
CDCl3) δ 12.60 (d, J = 12.3 Hz, 1H), 7.59 (d, J = 12.3 Hz, 1H), 7.48 (d, J 
= 8.5 Hz, 2H), 7.35 – 7.28 (comp, 6H), 7.25 – 7.21 (m, 1H), 7.14 (d, J = 
8.5 Hz, 2H), 7.10 (t, J = 7.4 Hz, 1H), 7.01 (d, J = 7.5 Hz, 2H), 6.50 (s, 
1H), 4.04 (s, 1H), 1.50 (s, 3H), 1.23 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 
δ 206.2, 188.9, 148.2, 147.4, 139.9, 139.6, 137.8, 131.4, 131.3, 130.0, 
129.8, 129.7, 128.4, 126.8, 124.4, 123.1, 116.8, 111.4, 54.6, 52.3, 27.9, 
23.5; IR (neat) 2975, 1625, 1597 cm
-1





486.1063, found: 486.1052; UV/vis absorption 
spectra of 4bd recorded at 20
o
C in dichloromethane (DCM): UV (λ max) 
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= 311 nm, 411 nm, and corresponding molar extinction coefficients are 












methylene]cyclohept-2-ene-1,4-dione 4be: 43% yield. Red viscous 
solid. TLC Rf =0.4 (5:1 hexanes/EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 
12.61 (d, J = 12.4 Hz, 1H), 8.21 (d, J = 8.8 Hz, 2H), 7.64 (d, J = 12.4 Hz, 
1H), 7.40 (d, J = 8.8 Hz, 2H), 7.38 – 7.30 (comp, 6H), 7.29 – 7.22 (m, 
1H), 7.13 (t, J = 7.5 Hz, 1H), 7.04 (d, J = 7.5 Hz, 2H), 6.53 (s, 1H), 4.00 
(s, 1H), 1.53 (s, 3H), 1.27 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 205.6, 
187.9, 148.0, 147.7, 147.3, 145.7, 139.8, 139.4, 132.8, 129.9, 129.6, 
129.5, 128.5, 126.9, 124.7, 123.4, 117.0, 111.5, 54.7, 52.2, 27.9, 23.8; IR 
(neat) 2926, 1626, 1596 cm
-1





453.1809, found: 408.1813; UV/vis absorption 
spectra of 4be recorded at 20
o
C in dichloromethane (DCM): UV (λ max) 
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= 288 nm, 420 nm, and corresponding molar extinction coefficients are 











amino)-methylene]cyclohept-2-ene-1,4-dione 4bf: 52% yield. Red 
viscous solid. TLC Rf =0.2  (10:1 hexanes/EtOAc); 
1
H NMR (400 MHz, 
CDCl3) δ 12.44 (d, J = 12.3 Hz, 1H), 7.59 (s, 2H), 7.43 – 7.37 (comp, 
3H), 7.37 – 7.34 (comp, 2H), 7.34 – 7.27 (comp, 4H), 7.25 – 7.21 (m, 
1H), 7.05 (t, J = 7.4 Hz, 1H), 6.95 (d, J = 7.5 Hz, 2H), 6.46 (s, 1H), 4.37 
(s, 1H), 1.49 (s, 3H), 1.24 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 206.6, 
188.2, 149.5, 147.4, 140.7, 139.9, 139.8, 132.9, 132.5, 131.1, 130.0, 
129.9, 129.7, 128.5, 127.5, 126.9, 124.1, 122.0, 116.6, 110.4, 54.3, 52.6, 
27.5, 22.2; IR (neat) 2975, 1759, 1624, 1597 cm
-1





486.1063, found: 486.1020; UV/vis 
absorption spectra of 4bf recorded at 20
o
C in dichloromethane (DCM): 
UV (λ max) = 311 nm, 410 nm, and corresponding molar extinction 












methylene]cyclohept-2-ene-1,4-dione 4bg: 55% yield. Red viscous 
solid. TLC Rf =0.3 (5:1 hexanes/EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 
12.30 (d, J = 12.4 Hz, 1H), 8.19 (dd, J = 8.2, 1.3 Hz, 1H), 7.72 (td, J = 
7.5, 1.3 Hz, 1H), 7.62 – 7.55 (m, 1H), 7.52 – 7.44 (comp, 4H), 7.40 – 
7.34 (comp, 2H), 7.31 – 7.26 (comp, 2H), 7.26 – 7.23 (m, 1H), 7.04 (t, J 
= 7.4 Hz, 1H), 6.88 (d, J = 7.5 Hz, 2H), 6.58 (s, 1H), 1.49 (s, 3H), 1.30 (s, 
3H); 
13
C NMR (100 MHz, CDCl3) δ 206.5, 187.0, 148.4, 147.7, 147.5, 
140.2, 139.6, 135.0, 134.0, 132.2, 131.5, 129.8, 129.7, 129.6, 128.6, 
127.0, 124.6, 124.3, 116.8, 110.2, 27.2; IR (neat) 2976, 1623, 1597 cm
-1
; 





453.1802; UV/vis absorption spectra of 4bg recorded at 20
o
C in 
dichloromethane (DCM): UV (λ max) = 292 nm, 413 nm, and 













diphenylcyclohept-2-ene-1,4-dione 4ca: 64% yield. Red viscous solid. 
TLC Rf =0.2  (5:1 hexanes/EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 12.71 
(d, J = 12.3 Hz, 1H), 7.47 (d, J = 12.3 Hz, 1H), 7.39 – 7.32 (comp, 6H), 
7.31 – 7.27 (comp, 3H), 7.26 – 7.21 (m, 1H), 6.88 (d, J = 8.9 Hz, 2H), 
6.77 (d, J = 8.9 Hz, 2H), 6.53 (s, 1H), 5.23 (br, 1H), 4.06 (s, 1H), 1.49 (s, 
3H), 1.23 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 206.9, 188.8, 152.8, 
149.5, 148.2, 140.1, 139.1, 133.3, 130.9, 129.8, 128.7, 128.4, 128.4, 
128.3, 126.7, 118.5, 116.5, 110.8, 54.6, 52.6, 27.8, 23.2; IR (neat) 3321, 
2975, 1733, 1620 cm
-1





424.1907, found: 424.1889; UV/vis absorption spectra of 4ca 
recorded at 20
o
C in dichloromethane (DCM): UV (λ max) = 305 nm, 418 













diphenylcyclohept-2-ene-1,4-dione 4da: 65% yield. Red viscous solid. 
TLC Rf =0.5  (5:1 hexanes/EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 12.71 
(d, J = 12.3 Hz, 1H), 7.47 (d, J = 12.3 Hz, 1H), 7.39 – 7.32 (comp, 6H), 
7.31 – 7.27 (comp, 3H), 7.26 – 7.21 (m, 1H), 6.88 (d, J = 8.9 Hz, 2H), 
6.77 (d, J = 8.9 Hz, 2H), 6.53 (s, 1H), 5.23 (br, 1H), 4.06 (s, 1H), 1.49 (s, 
3H), 1.23 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 206.9, 188.8, 152.8, 
149.5, 148.2, 140.1, 139.1, 133.3, 130.9, 129.8, 128.7, 128.4, 128.4, 
128.3, 126.7, 118.5, 116.5, 110.8, 54.6, 52.6, 27.8, 23.2; IR (neat) 2919, 
2850, 1622 cm
-1




438.2064, found: 438.2057; UV/vis absorption spectra of 4da recorded at 
20
o
C in dichloromethane (DCM): UV (λ max) = 305 nm, 420 nm, and 













diphenylcyclohept-2-ene-1,4-dione 4ea: 61% yield. Red viscous solid,; 
TLC Rf =  (10:1 hexanes/EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 12.55 
(d, J = 12.2 Hz, 1H), 7.49 (d, J = 12.2 Hz, 1H), 7.41 (d, J = 8.8 Hz, 2H), 
7.39 – 7.31 (comp, 7H), 7.31 – 7.27 (comp, 2H), 7.26 – 7.22 (m, 1H), 
6.86 (d, J = 8.8 Hz, 2H), 6.56 (s, 1H), 4.09 (s, 1H), 1.50 (s, 3H), 1.22 (s, 
3H); 
13
C NMR (100 MHz, CDCl3) δ 206.4, 190.2, 149.0, 146.4, 139.8, 
139.0, 138.8, 132.7, 131.3, 129.8, 128.8, 128.4, 128.4, 128.3, 126.9, 
118.2, 116.7, 111.9, 54.5, 52.4, 27.9, 23.2; IR (neat) 2976, 1623, 1590 
cm
-1





found: 486.1035; UV/vis absorption spectra of 4ea recorded at 20
o
C in 
dichloromethane (DCM): UV (λ max) = 301 nm, 413 nm, and 













diphenylcyclohept-2-ene-1,4-dione 4fa: 60% yield. Red viscous solid. 
TLC Rf =0.2  (10:1 hexanes/EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 
12.57 (d, J = 12.1 Hz, 1H), 7.49 (d, J = 12.1 Hz, 1H), 7.39 – 7.36 (comp, 
3H), 7.35 – 7.31 (comp, 4H), 7.31 – 7.27 (comp, 3H), 7.26 – 7.23 (comp, 
2H), 6.92 (d, J = 8.9 Hz, 2H), 6.56 (s, 1H), 4.10 (s, 1H), 1.50 (s, 3H), 
1.23 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 206.5, 190.1, 149.0, 146.6, 
139.8, 138.8, 138.5, 131.3, 129.8, 129.8, 129.3, 128.8, 128.4, 128.4, 
128.3, 126.9, 117.8, 111.8, 54.5, 52.4, 27.9, 23.2; IR (neat) 2976, 1623, 
1595 cm
-1




442.1568, found: 442.1573; UV/vis absorption spectra of 4fa recorded at 
20
o
C in dichloromethane (DCM): UV (λ max) = 300 nm, 410 nm, and 













diphenylcyclohept-2-ene-1,4-dione 4ga: 56% yield. Red viscous solid. 
TLC Rf =0.2 (10:1 hexanes/EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 
12.64 (d, J = 12.2 Hz, 1H), 7.47 (d, J = 12.2 Hz, 1H), 7.39 – 7.36 (comp, 
3H), 7.35 – 7.33 (comp, 2H), 7.32 – 7.31 (m, 1H), 7.31 – 7.26 (comp, 
3H), 7.25 – 7.22 (m, 1H), 7.06 – 6.98 (comp, 2H), 6.98 – 6.92 (comp, 
2H), 6.55 (s, 1H), 4.09 (s, 1H), 1.50 (s, 3H), 1.23 (s, 3H); 
13
C NMR (100 
MHz, CDCl3) δ 206.5, 189.7, 159.55 (d, J = 244.2 Hz), 149.1, 147.5, 
139.9, 138.9, 136.2 (d, J = 2.8 Hz), 131.2, 129.8, 128.8, 128.4, 128.4, 
128.3, 126.8, 118.25 (d, J = 8.0 Hz), 116.59 (d, J = 23.1 Hz), 111.4, 54.5, 
52.5, 27.9, 23.2; IR (neat) 2975, 1735, 1624, 1600 cm
-1





426.1864, found: 426.1867; UV/vis 
absorption spectra of 4ga recorded at 20
o
C in dichloromethane (DCM): 
UV (λ max) = 299 nm, 408 nm, and corresponding molar extinction 












diphenylcyclohept-2-ene-1,4-dione 4ha: 68% yield. Red viscous solid 
TLC Rf =0.3  (10:1 hexanes/EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 
13.43 (d, J = 11.8 Hz, 1H), 8.16 – 8.08 (m, 1H), 7.89 – 7.81 (m, 1H), 
7.77 (d, J = 11.8 Hz, 1H), 7.63 (d, J = 8.3 Hz, 1H), 7.55 – 7.50 (comp, 
2H), 7.44 (d, J = 7.8 Hz, 1H), 7.42 – 7.31 (comp, 9H), 7.29 – 7.23 (m, 
1H), 7.16 (d, J = 7.5 Hz, 1H), 6.61 (s, 1H), 4.22 (s, 1H), 1.54 (s, 3H), 
1.25 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 206.9, 190.2, 149.2, 148.3, 
139.9, 138.8, 136.2, 134.2, 131.0, 129.9, 128.9, 128.5, 128.5, 128.4, 
128.4, 126.8, 126.8, 126.8, 125.7, 124.9, 124.8, 121.1, 112.3, 111.7, 54.4, 
52.8, 27.9, 23.0; IR (neat) 2975, 2268, 1616 cm
-1





458.2115, found: 458.2088; UV/vis 
absorption spectra of 4ha recorded at 20
o
C in dichloromethane (DCM): 
UV (λ max) = 325 nm, 424 nm, and corresponding molar extinction 












cyclohept-2-ene-1,4-dione 4ia: 70% yield. Red viscous solid. TLC Rf 
=0.3  (10:1 hexanes/EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 12.13 (d, J 
= 12.5 Hz, 1H), 7.41 – 7.34 (comp, 5H), 7.34 – 7.26 (comp, 4H), 7.24 – 
7.18 (m, 1H), 7.06 (d, J = 12.5 Hz, 1H), 6.87 (s, 2H), 6.57 (s, 1H), 4.19 (s, 
1H), 2.26 (s, 3H), 2.16 (s, 6H), 1.49 (s, 3H), 1.19 (s, 3H); 
13
C NMR (100 
MHz, CDCl3) δ 207.8, 189.1, 155.2, 149.0, 140.3, 138.8, 135.9, 135.9, 
131.7, 130.3, 129.9, 129.5, 128.7, 128.4, 128.4, 128.3, 126.6, 109.3, 53.8, 
53.2, 27.7, 22.3, 20.8, 18.5; IR (neat) 2974, 1622, 1602 cm
-1
; HRMS (ESI) 




450.2428, found: 450.2401; 
UV/vis absorption spectra of 4ia recorded at 20
o
C in dichloromethane 
(DCM): UV (λ max) = 300 nm, 393 nm, and corresponding molar 












amino)methylene]cyclohept-2-ene-1,4-dione 4ja: 67% yield. Red 
viscous solid. TLC Rf =0.30 (10:1 hexanes/EtOAc); 
1
H NMR (500 MHz, 
CDCl3) δ 12.60 (d, J = 12.1 Hz, 1H), 7.57 (d, J = 12.1 Hz, 1H), 7.41 – 
7.36 (comp., 3H), 7.35 – 7.30 (comp., 4H), 7.30 – 7.25 (comp., 4H), 7.10 
– 7.07 (m, 1H), 7.01 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 6.56 (s, 
1H), 4.10 (s, 1H), 3.81 (s, 3H), 1.48 (s, 3H), 1.21 (s, 3H).; 
13
C NMR (125 
MHz, CDCl3) δ 206.90, 189.82, 158.22, 149.17, 147.05, 139.87, 138.91, 
131.88, 130.96, 130.85, 129.79, 128.76, 128.44, 128.33, 124.21, 116.76, 
113.76, 111.56, 55.25, 53.71, 52.79, 27.83, 22.85.; IR (neat) 2927, 1621, 
1427 cm
-1





found: 438.2061; UV/vis absorption spectra of 4ja recorded at 20
o
C in 
dichloromethane (DCM): UV (λ max) = 301 nm, 391 nm, and 













amino)methylene]cyclohept-2-ene-1,4-dione 4ka: 59% yield. Red 
viscous solid. TLC Rf =0.15  (10:1 hexanes/EtOAc); 
1
H NMR (400 MHz, 
CDCl3) δ 12.66 (d, J = 12.3 Hz, 1H), 8.15 (d, J = 8.8 Hz, 2H), 7.57 (d, J 
= 12.3 Hz, 1H), 7.52 (d, J = 8.8 Hz, 2H), 7.40 – 7.32 (comp, 5H), 7.25 – 
7.20 (comp, 2H), 7.13 (t, J = 7.4 Hz, 1H), 7.06 (d, J = 7.9 Hz, 2H), 6.53 
(s, 1H), 4.01 (s, 1H), 1.52 (s, 3H), 1.31 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ 204.8, 188.9, 149.9, 148.1, 147.5, 146.4, 139.4, 138.8, 131.4, 
130.3, 129.9, 129.0, 128.4, 128.3, 124.8, 123.4, 117.0, 110.6, 55.1, 51.6, 
28.0, 24.4; IR (neat) 2925, 1625, 1595 cm
-1





453.1809, found: 453.1810; UV/vis absorption 
spectra of 4ka recorded at 20
o
C in dichloromethane (DCM): UV (λ max) 
= 296 nm, 413 nm, and corresponding molar extinction coefficients are 












undec-7-ene-6,9-dione 4bh: 65% yield. Red viscous solid. TLC Rf =0.2  
(10:0 hexanes/EtOAc); 
1
H NMR (400 MHz, CDCl3) δ 12.53 (d, J = 12.3 
Hz, 1H), 7.61 (d, J = 12.3 Hz, 1H), 7.40 – 7.33 (comp, 2H), 7.31 – 7.28 
(m, 1H), 7.27 – 7.21 (comp, 6H), 7.17 – 7.11 (comp, 4H), 7.06 – 7.01 
(comp, 2H), 6.21 (s, 1H), 3.72 (s, 1H), 2.89 – 2.79 (m, 1H), 2.08 – 1.96 
(m, 1H), 1.93 – 1.83 (comp, 3H), 1.78 – 1.67 (comp, 2H), 1.66 – 1.55 (m, 
1H); 
13
C NMR (100 MHz, CDCl3) δ 205.0, 189.2, 149.8, 147.1, 141.5, 
139.8, 139.7, 132.2, 129.8, 128.3, 128.3, 128.3, 128.1, 128.0, 126.2, 
124.2, 116.7, 112.5, 62.2, 54.9, 40.0, 38.2, 26.3, 24.8; IR (neat) 2949, 
1625, 1595 cm
-1




434.2115, found: 434.2134; UV/vis absorption spectra of 4bh recorded at 
20
o
C in dichloromethane (DCM): UV (λ max) = 298 nm, 419 nm, and 














azepin-3-yl 2-diazo-2-(4-methoxyphenyl)acetate 3cb: 36% yield. 
Yellow oil.
1
H NMR (500 MHz, cdcl3) δ 7.30 (dd, J = 16.4, 8.3 Hz, 5H), 
7.24 (d, J = 6.6 Hz, 2H), 7.09 (d, J = 8.9 Hz, 2H), 6.91 (d, J = 8.9 Hz, 
2H), 6.82 – 6.77 (m, 2H), 6.39 (d, J = 9.9 Hz, 1H), 6.37 (s, 1H), 5.33 (s, 
1H), 4.92 (dd, J = 9.8, 6.6 Hz, 1H), 3.80 (s, 3H), 3.57 (d, J = 6.4 Hz, 1H), 
1.19 (s, 3H), 1.04 (s, 3H). 
13
C NMR (126 MHz, cdcl3) δ 165.96, 158.08, 
152.62, 144.09, 140.75, 138.84, 129.65, 129.17, 127.69, 126.27, 125.86, 
124.75, 122.96, 116.62, 115.85, 114.63, 107.79, 55.35, 54.90, 43.75, 
28.36, 25.01. IR (neat) 3406, 2086, 1671, 1152, 1253 cm
-1
; HRMS (ESI) 




482.2080, found: 482.2086. 
NMR spectra will be obtained from the Supporting Information of the 
published paper. 
4.5 X-ray Crystal Structure Information for 4ha 
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Crystal Structure Report for 4ha 
A specimen of C32H27NO2, approximate dimensions 0.07 mm × 0.08 mm 
× 0.47 mm, was used for the X-ray crystallographic analysis. The X-ray 
intensity data were measured on a Bruker APEX-II CCD system 
equipped with a graphite monochromator and a MoKα sealed tube (λ = 
0.71073 Å). Data collection temperature was 150 K. 
The total exposure time was 17.78 hours. The frames were integrated 
with the Bruker SAINT software package using a narrow-frame 
algorithm. The integration of the data using a monoclinicunit cell yielded 
a total of 15657 reflections to a maximum θ angle of 24.99° (0.84 Å 
resolution), of which 4299 were independent (average redundancy 3.642, 
completeness = 100.0%, Rint =7.86%) and 2251 (52.36%) were greater 
than 2σ(F
2
). The final cell constants of a = 18.041(4) Å, b = 12.292(3) Å, 
c = 11.066(2) Å, β = 94.663(3)°, V = 2445.9(9) Å
3
, are based upon the 
refinement of the XYZ-centroids of 1326 reflections above 20 σ(I) with 
5.328° < 2θ < 41.67°. Data were corrected for absorption effects using 
the multi-scan method (SADABS). The calculated minimum and 
maximum transmission coefficients (based on crystal size) are 0.8840 
and 0.9940. 
The structure was solved and refined using the Bruker SHELXTL 
Software Package, using the space group P21/c, with Z = 4 for the 
formula unit, C32H27NO2. The final anisotropic full-matrix least-squares 
refinement on F
2
 with 404 variables converged at R1 = 5.44%, for the 
observed data and wR2 = 9.80% for all data. The goodness-of-fit was 









 with an RMS 




. On the basis of the final model, the calculated 
density was1.243 g/cm
3




APEX2 Version 2010.11-3 (Bruker AXS Inc.)  
SAINT Version 7.68A (Bruker AXS Inc., 2009)  
SADABS Version 2008/1 (G. M. Sheldrick, Bruker AXS Inc.)  
XPREP Version 2008/2 (G. M. Sheldrick, Bruker AXS Inc.)  
XS Version 2008/1 (G. M. Sheldrick, Acta Cryst. (2008). A64, 112-122)  
XL Version 2012/4 (G. M. Sheldrick, (2012) University of Gottingen, 
Germany)  
Platon (A. L. Spek, Acta Cryst. (1990). A46, C-34). 
Table 1. Sample and crystal data for 4ha. 
Identification code 2608 
Chemical formula C32H27NO2 
Formula weight 457.54 
Temperature 150(2) K 
Wavelength 0.71073 Å 
Crystal size 0.07 × 0.08 × 0.47 mm 
Crystal system monoclinic 
Space group P21/c 
Unit cell dimensions a = 18.041(4) Å α = 90° 
 






















Table 2. Data collection and structure refinement for 
4ha. 
Diffractometer Bruker APEX-II CCD 
Radiation 
source 
sealed tube, MoKα 



















Max. and min. 
transmission 








ShelXS-97 (Sheldrick, 2008) 
Refinement 
method 















Data / restraints 
/ parameters 






Final R indices 2251 data; I>2σ(I) 






















peak and hole 

















R1 = Σ||Fo| - |Fc|| / Σ|Fo|  

























Table 3. Atomic coordinates and equivalent 




U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
x/a y/b z/c U(eq) 
C1 0.27599(16) 0.2147(2) 0.2860(3) 0.0371(8) 
C2 0.22310(14) 0.2913(2) 0.2500(2) 0.0353(7) 
C3 0.15699(15) 0.3060(3) 0.3262(3) 0.0405(8) 
C4 0.08121(15) 0.2776(3) 0.2558(3) 0.0437(8) 
C5 0.05480(17) 0.3616(3) 0.1603(3) 0.0450(8) 
O5 0.98856(11) 0.36475(18) 0.12510(18) 0.0610(7) 
C6 0.10421(17) 0.4408(3) 0.1064(3) 0.0414(8) 
C7 0.17840(15) 0.4432(2) 0.1021(2) 0.0371(7) 
C8 0.23122(15) 0.3540(2) 0.1442(2) 0.0367(7) 
O8 0.28433(10) 0.34054(14) 0.07800(16) 0.0399(5) 
N1 0.33667(12) 0.19550(19) 0.2260(2) 0.0347(6) 
C10 0.39469(15) 0.1210(2) 0.2515(2) 0.0339(7) 
C11 0.39531(17) 0.0481(2) 0.3448(3) 0.0420(8) 
C12 0.45455(18) 0.9744(3) 0.3645(3) 0.0497(9) 
C13 0.51227(19) 0.9752(3) 0.2931(3) 0.0481(9) 
C14 0.51321(15) 0.0486(2) 0.1947(3) 0.0377(7) 
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x/a y/b z/c U(eq) 
C15 0.57043(16) 0.0470(3) 0.1146(3) 0.0414(8) 
C16 0.56868(17) 0.1134(3) 0.0167(3) 0.0428(8) 
C17 0.50969(16) 0.1871(3) 0.9935(3) 0.0414(8) 
C18 0.45387(16) 0.1925(2) 0.0701(3) 0.0355(7) 
C19 0.45329(14) 0.1229(2) 0.1721(2) 0.0322(7) 
C31 0.16207(16) 0.4125(3) 0.3967(2) 0.0431(8) 
C32 0.22399(17) 0.4283(3) 0.4791(3) 0.0418(8) 
C33 0.23266(19) 0.5202(3) 0.5496(3) 0.0479(9) 
C34 0.1796(2) 0.6015(3) 0.5389(3) 0.0581(10) 
C35 0.1182(2) 0.5894(3) 0.4567(3) 0.0667(11) 
C36 0.10933(19) 0.4956(3) 0.3885(3) 0.0604(11) 
C41 0.08874(15) 0.1693(2) 0.1860(3) 0.0525(9) 
C42 0.02121(16) 0.2602(3) 0.3450(3) 0.0674(11) 
C71 0.21405(16) 0.5340(2) 0.0407(3) 0.0384(7) 
C72 0.18490(18) 0.5762(3) 0.9299(3) 0.0436(8) 
C73 0.2208(2) 0.6586(3) 0.8740(3) 0.0565(10) 
C74 0.2857(2) 0.7021(3) 0.9282(3) 0.0616(10) 
C75 0.3140(2) 0.6625(3) 0.0386(3) 0.0562(10) 
C76 0.27907(17) 0.5803(3) 0.0947(3) 0.0459(8) 
 
 
Table 4. Bond lengths (Å) for 4ha. 
C1-N1 1.347(3) C1-C2 1.376(4) 
C1-H1 0.98(2) C2-C8 1.419(3) 
C2-C3 1.526(3) C3-C31 1.524(4) 
C3-C4 1.557(4) C3-H3 1.00(2) 
C4-C5 1.525(4) C4-C42 1.539(4) 
C4-C41 1.550(4) C5-O5 1.227(3) 
C5-C6 1.479(4) C6-C7 1.344(4) 
C6-H6 0.98(2) C7-C71 1.481(4) 
C7-C8 1.502(4) C8-O8 1.264(3) 
N1-C10 1.402(3) N1-H1A 0.91(3) 
C10-C11 1.367(4) C10-C19 1.428(3) 
 266 
C11-C12 1.405(4) C11-H11 0.97(2) 
C12-C13 1.357(4) C12-H12 0.98(3) 
C13-C14 1.414(4) C13-H13 0.95(3) 
C14-C15 1.415(4) C14-C19 1.422(3) 
C15-C16 1.355(4) C15-H15 0.98(2) 
C16-C17 1.405(4) C16-H16 1.00(2) 
C17-C18 1.370(4) C17-H17 0.97(2) 
C18-C19 1.416(4) C18-H18 0.94(2) 
C31-C36 1.394(4) C31-C32 1.397(4) 
C32-C33 1.375(4) C32-H32 0.98(2) 
C33-C34 1.383(4) C33-H33 0.98(3) 
C34-C35 1.382(4) C34-H34 0.99(2) 
C35-C36 1.380(4) C35-H35 1.01(3) 
C36-H36 0.99(3) C41-H41A 0.98 
C41-H41B 0.98 C41-H41C 0.98 
C42-H42A 0.98 C42-H42B 0.98 
C42-H42C 0.98 C71-C76 1.394(4) 
C71-C72 1.394(4) C72-C73 1.376(4) 
C72-H72 0.94(3) C73-C74 1.379(4) 
C73-H73 0.99(3) C74-C75 1.375(4) 
C74-H74 0.96(3) C75-C76 1.367(4) 
C75-H75 0.95(3) C76-H76 0.98(2) 
 
 
Table 5. Bond angles (°) for 4ha. 
N1-C1-C2 123.4(3) N1-C1-H1 114.2(13) 
C2-C1-H1 122.3(13) C1-C2-C8 119.7(2) 
C1-C2-C3 118.4(3) C8-C2-C3 121.9(3) 
C31-C3-C2 111.6(2) C31-C3-C4 117.6(2) 
C2-C3-C4 113.0(2) C31-C3-H3 106.9(13) 
C2-C3-H3 104.7(13) C4-C3-H3 101.5(13) 
C5-C4-C42 110.0(2) C5-C4-C41 105.7(2) 
C42-C4-C41 107.2(3) C5-C4-C3 114.0(3) 
C42-C4-C3 110.2(2) C41-C4-C3 109.4(2) 
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O5-C5-C6 117.0(3) O5-C5-C4 118.9(3) 
C6-C5-C4 124.1(3) C7-C6-C5 131.6(3) 
C7-C6-H6 117.1(14) C5-C6-H6 111.3(14) 
C6-C7-C71 120.3(3) C6-C7-C8 125.6(3) 
C71-C7-C8 113.9(2) O8-C8-C2 122.8(3) 
O8-C8-C7 114.0(2) C2-C8-C7 123.2(2) 
C1-N1-C10 129.7(3) C1-N1-H1A 111.5(18) 
C10-N1-H1A 118.7(18) C11-C10-N1 122.7(3) 
C11-C10-C19 121.0(3) N1-C10-C19 116.3(2) 
C10-C11-C12 120.0(3) C10-C11-H11 120.4(15) 
C12-C11-H11 119.7(15) C13-C12-C11 121.0(3) 
C13-C12-H12 121.7(17) C11-C12-H12 117.3(17) 
C12-C13-C14 120.7(3) C12-C13-H13 122.6(17) 
C14-C13-H13 116.7(16) C13-C14-C15 121.9(3) 
C13-C14-C19 119.3(3) C15-C14-C19 118.8(3) 
C16-C15-C14 121.5(3) C16-C15-H15 119.2(15) 
C14-C15-H15 119.3(15) C15-C16-C17 120.2(3) 
C15-C16-H16 122.6(15) C17-C16-H16 117.2(15) 
C18-C17-C16 120.1(3) C18-C17-H17 120.2(16) 
C16-C17-H17 119.7(16) C17-C18-C19 121.2(3) 
C17-C18-H18 117.7(14) C19-C18-H18 121.0(14) 
C18-C19-C14 118.2(3) C18-C19-C10 123.6(3) 
C14-C19-C10 118.1(3) C36-C31-C32 116.5(3) 
C36-C31-C3 125.8(3) C32-C31-C3 117.7(3) 
C33-C32-C31 122.2(3) C33-C32-H32 120.1(14) 
C31-C32-H32 117.7(14) C32-C33-C34 119.9(3) 
C32-C33-H33 119.2(16) C34-C33-H33 120.8(16) 
C35-C34-C33 119.4(3) C35-C34-H34 117.1(15) 
C33-C34-H34 123.3(16) C36-C35-C34 120.1(4) 
C36-C35-H35 118.5(17) C34-C35-H35 121.4(17) 
C35-C36-C31 121.9(3) C35-C36-H36 118.0(17) 























109.5 C76-C71-C72 118.0(3) 
C76-C71-C7 119.5(3) C72-C71-C7 122.5(3) 
C73-C72-C71 120.8(3) C73-C72-H72 120.4(16) 
C71-C72-H72 118.8(16) C72-C73-C74 120.3(3) 
C72-C73-H73 121.0(17) C74-C73-H73 118.7(17) 
C75-C74-C73 119.3(4) C75-C74-H74 122.2(18) 
C73-C74-H74 118.5(18) C76-C75-C74 120.9(4) 
C76-C75-H75 118.1(17) C74-C75-H75 120.8(17) 




Table 6. Torsion angles (°) for 4ha. 
N1-C1-C2-C8 0.3(4) N1-C1-C2-C3 
-
179.6(3) 





C31-C3-C4-C5 59.3(3) C2-C3-C4-C5 -72.9(3) 
C31-C3-C4-C42 -64.9(3) C2-C3-C4-C42 162.9(3) 
C31-C3-C4-C41 177.5(2) C2-C3-C4-C41 45.3(3) 











C5-C6-C7-C71 179.8(3) C5-C6-C7-C8 6.4(5) 







C6-C7-C8-O8 142.0(3) C71-C7-C8-O8 -31.8(3) 











































































C2-C3-C31-C36 121.6(3) C4-C3-C31-C36 -11.2(4) 























C6-C7-C71-C76 137.2(3) C8-C7-C71-C76 -48.7(4) 




























Table 7. Anisotropic atomic displacement 
parameters (Å
2
) for 4ha. 
The anisotropic atomic displacement factor exponent 










 U12 ] 
 
U11 U22 U33 U23 U13 U12 





C2 0.0251(16) 0.056(2) 0.0253(16) 0.0015(14) 0.0034(13) 0.0041(15) 
C3 0.0301(18) 0.065(2) 0.0264(17) 0.0026(16) 0.0037(14) 0.0051(16) 




























U11 U22 U33 U23 U13 U12 




O8 0.0303(12) 0.0548(13) 0.0357(12) 0.0046(10) 0.0093(10) 0.0075(10) 
N1 0.0271(14) 0.0497(17) 0.0275(15) 0.0035(12) 0.0029(12) 0.0057(12) 






C11 0.037(2) 0.054(2) 0.0349(19) 0.0070(16) 0.0022(16) 0.0061(17) 

















































C32 0.0303(19) 0.058(2) 0.0373(19) 0.0060(17) 0.0021(15) 0.0046(18) 

















C41 0.038(2) 0.072(2) 0.046(2) 0.0050(18) - -
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U11 U22 U33 U23 U13 U12 
0.0045(16) 0.0088(17) 
C42 0.036(2) 0.127(3) 0.040(2) 0.006(2) 0.0097(17) -0.005(2) 










C73 0.071(3) 0.052(2) 0.044(2) 0.0075(18) -0.007(2) 0.001(2) 
C74 0.067(3) 0.053(3) 0.065(3) 0.010(2) 0.004(2) -0.006(2) 
C75 0.045(2) 0.061(2) 0.061(3) 0.000(2) -0.008(2) -0.008(2) 






Table 8. Hydrogen atomic coordinates and 
isotropic atomic displacement parameters 
(Å
2
) for 4ha. 
 
x/a y/b z/c U(eq) 
H1 0.2742(12) 0.1728(18) 0.361(2) 0.033(7) 
H3 0.1620(12) 0.2461(17) 0.387(2) 0.023(7) 
H6 0.0758(13) 0.5023(19) 0.069(2) 0.037(8) 
H1A 0.3371(15) 0.238(2) 0.158(2) 0.053(10) 
H11 0.3548(14) 0.0468(19) 0.398(2) 0.047(8) 
H12 0.4526(16) -0.077(2) 0.432(3) 0.067(10) 
H13 0.5541(15) -0.072(2) 0.307(2) 0.058(10) 
H15 0.6123(14) -0.003(2) 0.130(2) 0.043(8) 








H18 0.4145(13) 0.2415(18) 0.050(2) 0.031(8) 
H32 0.2611(13) 0.3695(19) 0.488(2) 0.034(8) 
H33 0.2754(15) 0.525(2) 0.610(2) 0.052(9) 
H34 0.1845(14) 0.671(2) 0.584(2) 0.048(9) 
H35 0.0798(17) 0.649(2) 0.443(3) 0.076(11) 
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x/a y/b z/c U(eq) 
H36 0.0647(16) 0.489(2) 0.331(3) 0.070(10) 
H41A 0.0398 0.1470 0.1494 0.079(6) 
H41B 0.1085 0.1129 0.2422 0.079(6) 
H41C 0.1227 0.1797 0.1221 0.079(6) 
H42A -0.0267 0.2457 0.2997 0.083(6) 
H42B 0.0172 0.3257 0.3946 0.083(6) 
H42C 0.0349 0.1981 0.3977 0.083(6) 












H75 0.3560(15) 0.696(2) 0.082(2) 0.057(10) 
H76 0.2979(14) 0.5512(19) 0.173(2) 0.042(8) 
 
 
Table 9. Hydrogen bond distances (Å) and angles 













0.91(3) 1.78(3) 2.550(3) 141.0 
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Chapter 5: Conclusions 
I. Diversity as a Function of Catalyst 
Divergent-oriented synthesis (DOS) is a strategy that emphasizes 
efficiency of chemical library synthesis of small molecules with 
complexity as well as skeletal diversity. Since both diazo compounds and 
alkynes can react with a wide array of transition metal complexes to form 
reactive transition metal complexes that are capable of undergoing further 
transformations, we asked the question “Is there diversity in product 
formation if both acetylenic and diazo functionalities are present in the 
same molecule?” To answer the question, we synthesized propargyl 
phenyldiazoacetates, which have a possibility to react with either 
functional group to form reactive transition metal complexes. Catalyst 
surveys under a variety of reaction conditions led to the discovery of the 
catalyst-directed divergent outcomes of propargylic diazoeacetates were 
discussed in Chapter 1.  
II. Intramolecular Electrophilic Addition Reaction of 
Diazo Ester with an Allene 
Under catalysis by neutral gold complexes, phenylpropargyl 
diazoacetates exist in equilibrium with 1-phenyl-1,2-dien-1-yl 
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diazoacetate allenes that are rapidly formed at room temperature through 
gold-catalyzed 1,3-acyloxy migration. Interestingly, these gold catalysts 
react solely with the π-donor rather than with the diazo group. The newly 
formed allene-aryldiazoacetates subsequently undergo a slow 
rearrangement that is not catalyzed by gold in which the terminal 
nitrogen of the diazo functional group adds to the central carbon of the 
allene initiating a sequence of bond forming reactions resulting in the 
production of 1,5-dihydro-4H-pyrazol-4-ones in good yields. These 1,5-
dihydro-4H-pyrazol-4-ones were found to undergo an intramolecular 1,3-
acyl migration to form an equilibrium mixture or quantitatively transfer 
the acyl group to an external nucleophile with formation of 4-
hydroxypyrazoles (Chapter 2).  
III. The Fisrt Discovery of Intramolecular [4+2]-
Cycloaddition Between a 1,3-Diene and a Diazo Ester 
In the process of studying propargyl phenyldiazoacetate with a 
broad selection of gold catalysts under various conditions of temperature, 
solvents and additives, we found reactions using a 4-chloropyridine-N-
oxide in stoichiometric amounts resulted in the formation of (Z)-diene 
and a product anticipated from diene-diazo [4+2]-cycloaddition. This led 
to the discovery of the first intramolecular. [4+2]-cycloaddition between 
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a 1,3-diene and a diazo ester. We successfully isolated the (E)-diene that 
was the presumed precursor to the cycloaddition product and studied the 
kinetic version of this reaction. Thermal reactions with the E-isomer form 
the product from [4+2]-cycloaddition with Eact = 16.2 kcal/mol, H
‡
298 = 
15.6 kcal/mol and S
‡
298 = -27.3 cal/ (mol•deg). The Z-isomer is inert to 
[4+2]-cycloaddition under these conditions; Hammett plots of this unique 
reaction were also created. In addition, to better understand this 
intramolecular [4+2]-cycloaddition reaction, we are collaborating with 
Professor Kenneth Houk’s group at UCLA from the viewpoint of 
computational chemistry, and the calculated results fit our observations 
very well (Chapter 3).  
IV. Intramolecular [3+2]-Cycloaddition with a Diazo 
with an Alkene and Subsequent Transformation 
Cascade reaction, a consecutive series of transformations occurred 
in one step, is noted for efficient construction of molecular complex, high 
atom economy and economies of time, labor, and resource management. 
Due to these benefits, discovery of novel cascade reactions has been in 
high demand as well as a challenging task of modern organic synthesis. 
Substrates with multiple functional groups are considered crucial and 
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fundamental to discovering cascade reactions. Inspired by gold-catalyzed 
[4+3]-cycloaddition of propargyl esters and unsaturated imines, we 
decided to use a modified propargyl system in which benzoate is replaced 
by phenyldiazoacetate that was expected to produce the azepine product 
that retained the phenyldiazoacetate functionality. Instead, a new and 
unexpected transformation occurred that reorganized the reactant atoms 
from the reactant ester to a diketone and rearranged the reactant atoms. 
To further understand this extensive process, we used the NMR 
spectroscopy to monitor the process. An intermediate, observed within 5 
min that rapidly rearranged to diketone, was isolated by quenching the 
reaction after 5 min. Purified by silica gel chromatography, the isolated 
product was converted to the previously observed diketone at 80ºC in 90% 
yield without added catalyst. Furthermore, we carried out a series of 
kinetic studies with the isolated [4+3]-cycloaddition product for the 
subsequent transformation. The transformation was first order in with a 




at 61 °C in DCE. The variation of the 
rate constant over temperatures ranging from 61℃ to 75℃ provided Eact 
= 22.6 kcal/mol, H
‡
298 = 22.0 kcal/mol and S
‡
298 = -9.21 cal/(mol•℃). 
This work was discussed in Chapter 4.  
V. Future Work 
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This work has demonstrated convincingly that the concept of 
“diversity as a function of catalyst” can be used in the discovery of novel 
transformations. The product diversity in a catalytic reaction and 
divergent reaction pathways could be achieved by the choice of catalysts. 
Our research with propargylic diazoesters have lead us to discover three 
new catalyst-free transformations of diazo compounds. The electrophilic 
capability of diazo compounds plays an important role in those 
intramolecular transformations. However, intermolecular versions of α-
diazoesters with alkenes, allenes, and dienes have not yet been explored. 
Since the chemical properties of diazo compounds are heavily influenced 
by their structures as well as the choice of catalysts, I believe that these 
intermolecular reactions, such as the [4+2]-cycloaddition reaction, will be 
achieved in the future, although a combination of hard work, reasonable 
design, and a bit of luck are necessary.  
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